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Abstract 
Cardiovascular diseases (CVD) represent one of the leading causes of mortality 
worldwide. Epidemiological studies have suggested an inverse association between the 
consumption of citrus fruit and the risk of CVD. However, the molecular mechanisms by 
which citrus flavonoids contribute to cardiovascular health have not been fully 
elucidated. In addition, evidence from human studies is limited and contradictory. 
Therefore, the aims of this thesis were to investigate mechanisms by which citrus 
flavonoids impact on endothelial cells and their effects on endothelial function and 
cardiovascular health in an acute manner and following regular consumption. 
 
The potential of selected citrus flavonoids to modulate gene expression relevant to nitric 
oxide (NO) production and antioxidant status was investigated in EA.hy926 cells; the 
acute effect of flavanone-rich blond orange juice (total flavanone content=81.7 mg/100 
ml) on vascular function (cardiac electrical activity, blood pressure, vascular compliance, 
peripheral blood flow, pulse transit time and pulse wave velocity) in healthy subjects 
(n=13) was determined; in a randomized controlled crossover trial, the effect of 
flavanone-rich blood orange juice (total flavanone content=89.7 mg/100 ml) on 
endothelial function, blood pressure, lipid profile, inflammation in overweight/obese 
men and premenopausal women of European origin (n=15) were examined following 2-
week consumption (400 ml/d) of blood orange juice and a sugar-matched control drink. 
 
The in vitro study demonstrates NOS3 mRNA and protein expression were significantly 
upregulated by nobiletin and tangeretin; incubation with nobiletin also resulted in a 
significant reduction in ET-1 mRNA levels and a significant induction of HO-1 and 
GCLC. Vascular related markers were not acutely altered at 2 h post consumption of a 
flavanone-rich orange juice in healthy subjects under the investigated conditions. 
Following 2-week consumption of blood orange juice, endothelial function was 
significantly improved from 8.15% ± 2.92% to 10.16% ± 3.31%, compared to the control 
drink (time by treatment interaction: P=0.002). Interestingly, this favourable effect on 
endothelial function was only observed in overweight subjects but not in obese subjects. 
Baseline blood pressure, lipid profile, hsCRP and ET-1 were generally within healthy 
ranges and not altered during juice supplementation. Present data indicate that regular 
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consumption of blood orange juice exerts beneficial effect on endothelial function in 
healthy overweight men and premenopausal women of European origin, which may be 
attributed to elevated NO bioavailability and the induction of cell-protective enzymes as 
evidenced by the in vitro findings.  
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Chapter 1 Introduction and literature review  
1.1 Introduction  
Cardiovascular disease (CVD) is a commonly used term to describe disorders of the heart 
and blood vessels, which are the leading cause of death worldwide (World Health 
Organization, 2017). Specifically, it is estimated that 17.7 million people die from CVDs 
each year, accounting for 31% of all deaths globally (World Health Organization, 2017). 
Worse still, industrialisation and urbanisation contribute to the emergence of CVDs in 
Africa (Sliwa et al., 2016) and prevalence in China (Wu et al., 2016). In addition, CVDs  
are the dominant contributors to the global economic burden of non-communicable 
diseases (NCDs) (Bloom et al., 2012). At a micro-economic level, ample evidence is 
emerging to suggest CVDs and other NCDs contribute to poverty in low- and middle-
income countries (Vorster and Kruger, 2007). Furthermore, deaths from CVDs in low- 
and middle-income countries account for over 75% of total deaths from CVDs 
worldwide, due to insufficient medical care and late detection of the disease.  
 
In order to reduce substantial economic loss by CVDs and improve the quality of life at 
an individual level, several modifiable factors can be controlled to reduce the risk of 
CVDs. Specifically, reduced risk of CVD has been associated with increased 
consumption of fruits and vegetables (Aune et al., 2017), reduction of unhealthy diet 
(high in sugar, salt, fat) (Mozaffarian et al., 2011), regular physical activity (Myers et al., 
2015), cessation of tobacco use (Clair et al., 2013) and avoiding excessive alcohol 
(Holmes et al., 2014).  
 
Notably, the consumption of the Mediterranean diet rich in fruits and vegetables has been 
associated with reduced rick of CVD (Widmer et al., 2015; Knoops et al., 2004). Its 
favourable effects on cardiovascular health have been, at least in part, attributed to its 
rich polyphenol content (Scoditti et al., 2012; Carluccio et al., 2007), which attracts 
increasing research interest in recent years. Increasing evidence from epidemiological 
studies has demonstrated an inverse association between consumption of polyphenol-
rich foods and the risk of CVD (Kim and Je, 2017; Tresserra-Rimbau et al., 2014; 
Mennen et al., 2004). Possible mechanisms by which polyphenol impact on endothelial 
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function and cardiovascular health have been explored via animal models (Anhê et al., 
2015; López-Sepúlveda et al., 2008), in vitro cell mechanistic studies (Kamiloglu et al., 
2017; Martínez-Fernández et al., 2015) and human intervention studies (Kerimi et al., 
2017; Kelishadi et al., 2011). The following literature review will be focused on current 
understanding of progression of CVD, effects of dietary polyphenols on CVD risk 
factors, identifying gaps in previous research, thereby introducing the rationale of the 
thesis.  
1.2 Endothelial function and cardiovascular health  
The endothelium is a monolayer of cells at the internal surface of blood and lymphatic 
vessels. Up to the mid-sixties, the function of the endothelium was believed to be a barrier 
between circulating blood in the lumen and  the tissues of the vessel wall (Florey, 1966). 
Its key function in maintaining vascular homeostasis has become evident following the 
use of endothelial cell culture techniques (Jaffe et al., 1973). Over the last few decades, 
the endothelium has been recognised to play a pivotal role in regulating vascular tone 
and structure (Zaborska et al., 2017; Busse et al., 1985). Specifically, in response to 
various physical and chemical stimuli, healthy endothelial cells produce and release a 
variety of vasodilators (such as nitric oxide (NO), prostacyclin (PGI2)) and 
vasoconstrictors (such as thromboxane A2, endothelin and angiotensin II) that not only 
modulate vascular smooth muscle contractility (Edwards et al., 2010) but also play a role 
in vascular remodelling (Deanfield et al., 2007). In addition, healthy endothelium plays 
a crucial role in maintaining cardiovascular homeostasis, exerting anti-inflammatory, 
anti-coagulant and anti-thrombotic functions (Figure 1.1) (Rubanyi, 1993).  
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Figure 1.1. Multiple roles of healthy endothelium (Landmesser et al., 2004; 
Rubanyi, 1993).  
 
Endothelial dysfunction, or endothelial activation, is characterised by a change in 
signalling from an NO-mediated silencing of cellular processes to reactive oxygen 
signalling, resulting in activation of the endothelial cells. It should be noted activation of 
the endothelial cells can occur physiologically as part of normal host defence in the 
context of immunity, or pathophysiologically as a result of cardiovascular risk factors, 
which differ in the nature, degree, duration and combination of the proinflammatory 
stimuli (Deanfield et al., 2007). As a consequence, endothelial dysfunction upregulates 
cytokines and inflammatory molecules, resulting in increased oxidative stress 
(Bauersachs et al., 1999). Numerus factors contribute to endothelial dysfunction, 
including conventional CVD risk factors such as unfavourable lipid profile (low levels 
of high-density lipoprotein (HDL) cholesterol, elevated low-density lipoprotein (LDL) 
cholesterol, oxidized LDL and triglycerides), hyperglycaemia, inflammation (systemic 
inflammatory marker C-reactive protein (CRP); vascular inflammatory marker 
lipoprotein-associated phospholipase A2 (Lp-PLA 2)), hypertension and smoking 
(Grover-Páez and Zavalza-Gómez, 2009). Chronic production of reactive oxygen species 
(ROS) and prolonged endothelial dysfunction then contribute to the development of 
CVDs, including atherosclerosis, hypertension and diabetes (Vanhoutte et al., 2009). 
Specifically, endothelial dysfunction occurs in the earliest stages of atherosclerosis, 
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preceding angiographic or ultrasonic detection of atherosclerotic plaque. This was first 
evidenced by the study conducted by Ludmer et al. (1986) demonstrating impaired 
endothelium-dependent vasodilation induced by acetylcholine in subjects with early and 
late atherosclerosis. Therefore, evaluation of endothelial function has significant clinical 
relevance in early detection of CVDs and prediction of future CVD incidents.  
 
1.2.1 Evaluation of endothelial function  
With growing recognition of the crucial role of the endothelium in cardiovascular health, 
a variety of methods have been developed to evaluate different aspects of endothelial 
function. Furchgott and Zawadzki (1980) discovered the functionally normal 
endothelium was responsible for the relaxation of preconstricted rabbit aorta strips with 
well-preserved endothelium in response to acetylcholine whereas the aortas did not dilate 
in response to acetylcholine following removal of the endothelium.  
 
Subsequently, flow mediated dilation (FMD) of the brachial artery was introduced by 
Celermajer et al. (1992) and has been widely used worldwide to evaluate endothelial 
function. Flow-mediated dilation is a non-invasive technique that can assess 
endothelium-derived NO bioavailability and endothelial function when measured 
appropriately (Green, 2005). The principle of FMD is that the brachial artery dilates 
when there is an increase in blood flow or, more precisely, sheer stress. During an FMD 
test, the baseline brachial artery diameter is measured first using Doppler ultrasound, 
followed by reactive hyperaemia caused by the cuff occlusion in either the upper arm or 
forearm for a period of time. Reactive hyperaemia created by cuff occlusion can be 
controlled to result in a primarily NO-dependent dilation of the branchial artery, with the 
distal occlusion for 5 min. Upon cuff deflation, the hyperaemia increases sheer forces 
parallel to the long axis of the artery and this change can be sensed by endothelial cells 
which then convert L-arginine to NO through endothelial NO synthase (eNOS) in the 
presence of cofactors (Nathan and Xie, 1994). Subsequently, NO diffuses into the tunica 
media and activates soluble guanylate cyclase (sGC) resulting in the conversion of GTP 
to cGMP, which leads to the relaxation of the smooth muscle and subsequent vasodilation 
(Figure 1.2). The result of FMD is the change in diameter post cuff deflation, technically 
expressed as a percentage of the baseline resting diameter (Harris et al., 2010). 
Importantly, endothelial dysfunction was detected using FMD (Celermajer et al., 1994) 
in patients with coronary risk factors, preceding angiographic or ultrasound evidence of 
structural coronary artery disease. Therefore, evaluation of endothelial function using 
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FMD provides evidence in the early detection of CVDs, thereby making early treatment 
of CVDs possible, which may possibly save substantial pain and cost for patients.  
 
Figure 1.2. Generation of flow-mediated dilation. The increase in blood flow 
activates endothelial nitric oxide synthase (eNOS), which converts L-arginine to 
nitric oxide (NO). NO diffuses into smooth muscle cells and activates soluble 
guanylate cyclase (sGC) resulting in the conversion of GTP to cGMP, which leads 
to the relaxation of the smooth muscle and subsequent vasodilation.  
 
Although the investigation on the association between brachial FMD and cardiovascular 
risk has been difficult due to confounding factors and discrepancies in the technical 
aspects of the FMD measurement across labs, there is ample evidence indicating that the 
brachial FMD is not only associated with conventional cardiovascular risk factors but 
also with future cardiovascular events (Matsuzawa et al., 2017; Ras et al., 2013; Green 
et al., 2011). More specifically, a meta-analysis study by Inaba et al. (2010) demonstrates 
that a 1% decrease in FMD is associated with a 13% increase in the risk of future 
cardiovascular events. Although this should be interpreted with caution given significant 
heterogeneity between studies, the brachial FMD has been recognised as an independent 
predictor of future cardiovascular incidents and processes independent prognostic value 
for future CVDs. For example, brachial FMD and brachial artery diameter have been 
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documented to be significant predictors of CVD events in older adults after adjustment 
for age, gender and CVD risk factors (Yeboah et al., 2007). Importantly, the association 
between brachial FMD and cardiovascular risk may differ in individuals according to the 
baseline cardiovascular risk. More specifically, a large meta-regression analysis of 399 
populations (211 selected articles) suggests a strong inverse association between brachial 
FMD and cardiovascular risk (assessed by the Framingham risk score) in low-risk 
populations and less strong associations in intermediate-risk and high-risk populations, 
independent of brachial artery diameter and technical differences in the FMD 
measurement (Witte et al., 2005). This meta-analysis indicates that the magnitude of the 
association between brachial FMD and cardiovascular risk decreases as the risk increases. 
In addition, brachial FMD has been reported to be less reproducible in subjects with CVD, 
with larger coefficients of variation compared with healthy controls (van Mil et al., 2016; 
Craiem et al., 2007). 
 
Given its non-invasive nature and better reproducibility and sensitivity than other non-
invasive techniques (Donald et al., 2006), FMD has been widely adopted worldwide for 
assessment of endothelial function. However, there are disadvantages to this technique 
that are worth noting. Despite its seemingly simple appearance, FMD has been 
recognised to be technically challenging, which requires at least 100 supervised practice 
scans to be competent and regular practice (100 scans per year) to maintain competence 
(Corretti et al., 2002). Given that performing FMD has a significant learning curve, it 
typically requires several months to attain competence, depending both on the technical 
skill of the operator and the frequency of practice scans. As a hands-on technique, it also 
requires repeated practice with an experienced individual who can elucidate how to 
acquire the optimal image of the brachial artery and lumen interface for detection of the 
artery diameter and the pulsed-wave Doppler velocity through manual techniques. In 
addition, the FMD data analysis also requires good understanding of the technique and 
the principle of the software used for analysis, especially in the selection of the region of 
interest for data analysis. Inter-individual variations in the FMD data analysis have been 
observed (Woodman et al., 2001) and therefore caution should be taken in order to obtain 
accurate data analysis. Taken together, FMD requires considerable amount of training 
and its reproducibility is highly operator dependent (Vogel et al., 2000).  
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Hence, other non-invasive techniques such as finger plethysmography and peripheral 
arterial tonometry, have been adopted as simpler and cheaper alternative methods for 
assessment of endothelial function, reflecting downstream hyperaemic response induced 
by occlusion of the brachial artery (Kuvin et al., 2003). An optimal technique for 
assessment of endothelial function should be inexpensive, non-invasive and reproducible. 
However, it is worth noting that there is no perfect technique and all the techniques 
available for evaluation of endothelial function have advantages and disadvantages, as 
reviewed by Deanfield et al. (2007).  
 
1.2.2 Nitric oxide and its roles in cardiovascular health 
Among all the mediators produced by endothelial cells, NO is a key vasodilator (Palmer 
et al., 1987) and plays multiple roles in cardiovascular protection, including regulation 
of myocardial contractility, maintaining endothelial integrity, inhibiting inflammation, 
platelet aggregation and vascular smooth muscle cell proliferation (Loscalzo and Welch, 
1995). Given these biological functions, NO is a crucial component in the vascular 
protection and the endogenous defence against atherosclerosis. However, it is worth 
noting eNOS plays distinct roles in normal endothelial function and endothelial 
dysfunction. 
 
Specifically, NO is produced by a variety of cells, including endothelial cells, neurons, 
platelets and neutrophils (Loscalzo and Welch, 1995). Nitic oxide synthesis by 
endothelial nitric oxide synthase (eNOS) is illustrated in Figure 1.3. In healthy 
endothelial cells, in response to various stimuli (such as shear stress, vascular endothelial 
growth factor (VEGF), bradykinin, insulin, oestrogen), eNOS dimers are rapidly 
phosphorylated at serine 1177 site, resulting in electrons transferred from nicotinamide 
adenine dinucleotide phosphate (NADPH) to flavin adenine dinucleotide (FAD) and to 
flavin mononucleotide (FMN)  in the reductase domain of a monomer of eNOS, and then 
to the oxygenase domain of the other monomer, where electrons interact with 
tetrahydrobiopterin (BH4) and the haem iron to catalyse the reaction of oxygen with L-
arginine, producing NO and citrulline (Alderton et al., 2001). Importantly, monomers of 
eNOS are unable to bind BH4 or L-arginine, and therefore are unable to catalyse NO 
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production. However, in the presence of CVD risk factors (such as hypertension, 
hypercholesterolemia, elevated inflammation and diabetes), excessive amounts of 
superoxide reacts with NO to form peroxynitrite, thereby reducing NO bioavailability 
and diminishing its vascular protection. Worse still, peroxynitrite leads to eNOS 
uncoupling and enzyme dysfunction (Förstermann and Münzel, 2006; Landmesser et al., 
2003a). Specifically, BH4 is highly sensitive to oxidation to BH2 by peroxynitrite. When 
BH4 is limited, eNOS becomes uncoupled and electrons derived from NADPH are passed 
to oxygen rather than L-arginine, thereby producing superoxide instead of NO, which is 
referred to as eNOS uncoupling (Stuehr et al., 2001). In addition, hydrogen peroxide is 
produced if the substrate L-arginine is deficient (Förstermann and Münzel, 2006). Thus 
eNOS is transformed from a protective enzyme producing NO to a detrimental enzyme 
contributing to oxidative stress in dysfunctional endothelial cells. Taken together, the key 
roles of eNOS in endothelial function and dysfunction make this enzyme crucial to 
endothelial homeostasis (Deanfield et al., 2007). 
 
Figure 1.3.  Basic structure of eNOS dimer with a zinc-thiolate cluster at the dimer 
interface and NO synthesis in endothelial cells. Upon activation of eNOS dimers, 
electrons are transferred from NADPH to FAD and to FMN in the reductase 
domain of eNOS, and subsequently to BH4 and the haem iron in the oxygenase 
domain of eNOS to catalyse the reaction of oxygen with L-arginine, resulting in the 
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production of NO and citrulline. Uncoupled eNOS is unable to bind BH4 or L-
arginine, therefore is unable to catalyse NO synthesis. Modified from (Förstermann 
and Münzel, 2006). 
 
Accelerated degradation of NO by ROS is believed to be the major mechanism for 
reducing NO bioavailability in CVDs (Behrendt and Ganz, 2002; Harrison, 1997). 
Accumulating evidence indicates that reduced NO bioavailability is closely associated 
with endothelial dysfunction (Sena et al., 2013; Green, 2005), which is not only the 
primary aetiology of atherosclerosis but also the earliest identifiable event in the 
development of atherosclerotic cardiovascular disease. Hence the measurement of 
endothelial function and NO bioavailability is of great importance.  
 
Only low levels (in the pico- to nanomolar range) of NO are generated from eNOS 
(Moncada et al., 1991) and it is rapidly metabolized to nitrite and nitrate before being 
excreted in the urine (Moncada and Higgs, 2006; Schechter and Gladwin, 2003). The 
low cellular production of NO and its short half-life (4 s) make its direct measurement 
difficult. Therefore, NO-dependent FMD is often used as an alternative, representing in 
vivo NO bioavailability. It is assumed that a small FMD is an indication of low NO 
bioavailability and increased CVD risk (Inaba et al., 2010). Given the fundamental role 
of NO in mediating endothelial function, impairment of vasodilation in response to shear 
stress due to limited endothelium-derived NO is often used as a measure of endothelial 
dysfunction (Deanfield et al., 2007).  
1.3 Flavonoids and cardiovascular health 
Given the growing evidence of the potential benefits of flavonoids on cardiovascular 
health from epidemiological studies (Kim and Je, 2017; Knekt et al., 2002), research 
interest in flavonoids from dietary sources has been increasing. Flavonoids are 
polyphenolic compounds that exist prevalently in plants, produced as secondary 
metabolites with multiple functions in protecting plants from harmful environmental 
conditions through their antioxidant properties (Agati et al., 2012) and regulating 
transcription of genes for growth and development (Peer et al., 2004). In addition, many 
flavonoids are responsible for the colours of flowers, fruits and leaves (Harborne and 
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Williams, 2000). Polyphenols encompass a wider variety of compounds, divided into 
flavonoids, phenolic acids, stilbenes and lignans, based on their structural differences 
(Manach et al., 2004). The focus of this thesis is on flavonoids, especially citrus 
flavonoids, and their effects on endothelial function and cardiovascular health.  
 
Figure 1.4.  The basic structure and numbering pattern of flavonoids (Cook and 
Samman, 1996).  
 
More than 7000 flavonoids have been identified (Beecher, 2003), sharing a C6–C3–C6 
structure with two aromatic rings linked together by a three-carbon unit, as shown in 
Figure 1.4. Based on the connection of the B ring to the C ring and the degree of oxidation 
of the C ring, flavonoids are divided into subclasses encompassing flavanones, flavonols, 
flavanols, flavones, anthocyanidins and isoflavones (Beecher, 2003). In addition, the 
basic structure of flavonoids allows a multitude of substitution patterns in the benzene 
rings A and B within each subclass of flavonoids, for example phenolic hydroxyls, O-
sugars, methoxy groups, sulphates and glucuronides.  
 
1.3.1 Dietary sources and intake of flavonoids 
Fruit and beverages (fruit juice, coffee, tea, red wine) are found to be most abundant in 
flavonoids, followed by vegetables, dry legumes and cereals (Scalbert and Williamson, 
2000). The majority of flavonoids occur in nature as glycosides and other conjugates, 
with flavanols as an exception which occur in the form of aglycones (Beecher, 2003). 
Representative flavonoids in different subclasses and their respective major dietary 
sources are summarised in Table 1.1.  
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Table 1.1. Flavonoid subclasses with representatives and dietary sources. 
Subclass  Representative aglycones Major dietary sources 
Flavanone Hesperetin; naringenin Citrus fruits 
Flavonol Quercetin; myricetin; kaempferol  Tea, apples and onions 
Flavanol Catechins; procyanidins Tea, cocoa and red wine 
Flavone Apigenin; luteolin Cereals and herbs 
Anthocyanidin Peonidin; cyanidin Berries 
Isoflavone Genistein; daidzein Soybeans 
Apart from catechins, most flavonoids exist as glycosides in nature. 
 
The main dietary source of flavanones is citrus fruits, which also contain other subclasses 
of flavonoids such as flavones, flavonols, and anthocyanins (the last exclusively in blood 
oranges). The genus Citrus encompasses several orange types, including sweet oranges 
(four subclasses-common, navel, Valencia, and blood), sour oranges, tangerines, lemons, 
tangors, tangelos and grapefruit. Flavanones usually occur in the form of glycosides, with 
rutinosides (6-O-α-L-rhamnosyl-D-glucosides) or neohesperidosides (2-O-α-L-
rhamnosyl-D-glucosides) attached at position C7. The differences in the sugar moieties 
of the flavanone glycosides in sweet and sour oranges lead to distinct tastes. Specifically, 
hesperidin and narirutin with the sugar rutinose have a neutral taste and are relatively 
high in sweet oranges, tangerines, lemons and limes, whereas neohesperidin and naringin 
with the sugar neohesperidose possess a bitter taste and are abundant in sour oranges and 
grapefruits.  
 
Hesperidin is the predominant flavanone in sweet oranges (C. sinensis), followed by 
narirutin, whereas neohesperidin and naringin predominate in sour oranges (C. 
aurantium) (Peterson et al., 2006). Citrus flavonoids in pure blond and blood orange juice 
are shown in Table 1.2, with data from Phenol-Explorer (Rothwell et al., 2013). 
Similarly, hesperidin is the predominant flavanone in orange juice with the content of 
18-42.8 mg/100 ml in not-from-concentrate orange juice, followed by narirutin ranging 
from 2.95 to 5.41 mg/100 ml (Vanamala et al., 2006). Although nobiletin and tangeretin 
are minor in orange juice (Table 1.2), they are more abundant in citrus fruit peels with 
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the content of 5.89 ± 0.58 mg/g solid extract and 6.41 ± 1.03 mg/g solid extract 
respectively (Huang and Ho, 2010). Naringin is the primary flavanone in grapefruit juice 
with the content of 23.5- 37.2 mg/100 ml in not-from-concentrate grapefruit juice, 
followed by narirutin ranging from 9.1 to 11.7 mg/100 ml (Vanamala et al., 2006). 
Notably, citrus flavanone content is affected by the growing location, season, the 
maturity of the fruit (Albach et al., 1981). In terms of the distribution of flavanones in 
citrus fruits, flavanones are ubiquitous, especially abundant in the peel and seeds. As an 
example, the albedo and peel of pummelo (Citrus maxima) are found to be more 
abundant in naringin than the flesh, with naringin contents of 3910 µg/g and 220 µg/g, 
respectively (Yusof et al., 1990). Furthermore, total flavanone content in the whole fruit 
may be up to 5 times as much as that in a glass of orange juice (Manach et al., 2004). 
Given that citrus peels and seeds rich in flavanones are not used to produce orange juice, 
utilisation of these by-products has attracted increasing research interest (Sharma et al., 
2017; Ghasemi et al., 2009).  
 
Table 1.2. Citrus flavonoids in blond and blood orange juice (OJ) (pure juice) 
(mg/100 mL).  
 Hesperidin Narirutin Didymin Nobiletin Tangeretin 
Blond OJ 25.85 ± 12.16 5.36 ± 3.05 5.93 ± 0.33 0.07 ± 0.08 0.02 ± 0.01 
Blood OJ 43.61 ± 17.98 4.8 ± 1.28 2.43 ± 1.27 0.34 ± 0.02 0.04 ± 0.01 
Data from Phenol-Explorer (Rothwell et al., 2013). 
 
As shown in Figure 1.5, hesperetin and naringenin share similar structures with a 
saturated C ring whereas there is a double bond at 2-3 position at the C ring of nobiletin 
and tangeretin, with multiple methoxy groups at both A and B rings. The differing 
structures of these compounds contribute to their differential effects as detailed in 
Chapter 2.  
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Figure 1.5. Structures of hesperetin (A),  naringenin (B), nobiletin (C), tangeretin 
(D) and resveratrol (E).  
 
With regards to dietary sources of other flavonoids, quercetin, a flavonol, is the most 
ubiquitous flavonoid in the human diet and has been most intensively researched. It 
occurs prevalently in plant foods with particular abundance in onions (0.3 mg/g fresh 
weight) (Hertog et al., 1992) and tea (10–25 mg/L) (Hertog et al., 1993). The main 
flavanols are catechins. They are abundant in tea and the four major catechins in tea are 
(−)-epicatechin (EC), (−)-epicatechingallate (ECG), (−)-epigallocatechin (EGC) and (−)-
epigallocatechingallate (EGCG) (Balentine et al., 1997). Due to the differences in the 
manufacturing process, there is a huge difference in the catechin content in different 
kinds of tea. In green tea, catechins account for 77.1% of the total polyphenols whereas 
catechins account for 3.3% of the total polyphenols in black tea (Del Rio et al., 2004). 
During fermentation, the catechins are converted to theaflavins and thearubigins in black 
tea. Proanthocyanidins (PAs) are oligomeric and polymeric flavanols and exist 
ubiquitously in plants. According to the study conducted by Gu et al. (2004), the average 
daily intake of PAs in the U.S. population ( >2 y old) was estimated to be 57.7 mg/person, 
with monomers, dimers, trimers, and those above trimers account for 7.1, 11.2, 7.8, and 
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73.9% of total PAs, respectively. The main dietary sources of PAs in the American diet 
are apples (32.0%), chocolate (17.9%) and grapes (17.8%) (Gu et al., 2004). Flavones 
consist chiefly of glycosides of luteolin and apigenin. The main food sources of flavones 
are parsley (240–1850 mg/kg fresh weight) and celery (with apigenin contents of 20-140 
mg/kg fresh weight) (Manach et al., 2004). The occurrence of isoflavones is mainly 
restricted to soybean products, with approximately 1 mg of genistein and daidzein per 
gram of dry bean (Reinli and Block, 1996). There are three types of isoflavones in four 
chemical forms in soybean: the aglycones daidzein, genistein and glycitein; the 
acetylglucosides 6”-O-acetyldaidzin, 6”-O-acetylgenistin and 6”-O-acetylglycitin; and 
the malonylglucosides 6”-O-malonyldaidzin, 6”-O-malonylgenistin and 6”-O-
malonylglycitin (Kudou et al., 1991). 
 
It should be noted that the accurate quantification of dietary flavonoid intake has been 
difficult given the complexity and structural diversity of flavonoids occurring in foods 
with large variability, their prevalence in a large number of dietary sources and different 
analytical methods used for quantification (Erdman et al., 2007). In addition, the current 
methods using food records and food composition tables for the estimation of flavonoid 
intake fail to take those into account and therefore are not accurate. Despite those 
challenges and limitations, previous studies have conducted some investigations on 
dietary intake of flavonoids. The total intake of dietary polyphenols in Western 
populations who consume several servings of fruits and vegetables per day has been 
reported to be approximately 1-2 g/day, with flavonoids accounting for two thirds and 
phenolic acid accounting for one third (Rothwell et al., 2012; Scalbert and Williamson, 
2000). It is worth noting that this proportion depends on foods and beverages consumed 
and may vary substantially from individual to individual, due to their dietary habits and 
food preferences. For example, heavy coffee consumers are likely to consume more 
phenolic acids than flavonoids (Clifford, 1999).  
 
Taken together, given that citrus fruits and juices are highly consumed worldwide 
(Sebastian et al., 2017; Zamora-Ros et al., 2011; Johannot and Somerset, 2006), citrus 
flavonoids are among the most consumed dietary flavonoids, accounting for a large 
proportion of the total daily intake of flavonoids (Tomás‐Barberán and Clifford, 2000). 
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Therefore, research on citrus flavonoids and their effects on health is of significant 
relevance.  
 
1.3.2 Bioavailability of flavonoids 
Bioavailability has various definitions depending on the field of study. In nutritional 
research, the definition of bioavailability is “the rate and extent to which the active 
ingredient or active moiety is absorbed from a drug product and becomes available at the 
site of action”, according to U.S. Food and Drug Administration (FDA). Accessing 
bioavailability of flavonoids involves determination of their absorption, distribution, 
metabolism and excretion (ADME) (Thilakarathna and Rupasinghe, 2013). The 
understanding of the bioavailability of flavonoid is of great significance to evaluate their 
biological activities and effects on cardiovascular health. It was initially assumed that the 
bioavailability of flavonoids was generally low, due to their complex structures, usually 
conjugated to sugar moieties (Bravo, 1998). However, with increasing understanding of 
flavonoid absorption and metabolism, recent evidence suggest that flavonoids, especially 
flavanones and anthocyanins, are more bioavailable than previously reported (Kay et al., 
2017; Walle, 2004). Following ingestion, flavonoid aglycones are absorbed by intestinal 
enterocytes (Scalbert and Williamson, 2000) whereas glycosides undergo phase I 
deglycosylation and may be hydrolysed by lactase phlorizin hydrolase (LPH) in the brush 
border of the  small intestine (Day et al., 2003), releasing corresponding aglycones, 
which are less hydrophilic and can be easily absorbed by intestinal enterocytes. 
Alternatively, glucosides can be transported into the epithelial cells, possibly via the 
active sodium-dependent glucose transporter (SGLT-1) (Gee et al., 2000). Hydrolysis of 
glucosides is then mediated by cytosolic β-glucosidase (CBG) within epithelial cells, 
releasing the respective aglycones. Subsequently, aglycones may diffuse into the hepatic 
portal vein (Day et al., 2003) or undergo phase II metabolism in the intestinal enterocytes, 
resulting in sulfates, glucuronides, and/or methylated metabolites, via the action of 
sulfotransferases (SULT), uridine-5’-diphosphate glucuronosyltransferases (UDP-GT), 
catechol-O-methyltransferases (COMT), respectively (Scalbert and Williamson, 2000). 
Thereafter, these metabolites are transported to hepatocytes in the liver, where they may 
undergo  further phase II metabolism (Perez‐Vizcaino et al., 2012), before being 
distributed to the tissues or eliminated by the kidney via urine excretion.  
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In addition, unabsorbed flavonoids and flavonoid metabolites are carried to the colon, 
where substantial deconjugation occurs. Specifically, the colonic microbiota break down 
the conjugation, releasing the aglycones, which are either absorbed or undergo ring 
fission and fermentation resulting in smaller compounds, such as phenolic acids and  
phenylacetic acids (Serra et al., 2012). These products may be absorbed by the colon 
(Déprez et al., 2000), a portion of which circulate to the liver and undergo phase II 
metabolism, before being excreted in faeces (Monagas et al., 2010).  
 
Large variability has been observed in the bioavailability between different flavonoids 
(Manach et al., 2005) and between individuals (Fuhr and Kummert, 1995). Numerous 
factors contribute to this variability, including the chemical structure of flavonoids 
(Manach et al., 2004), food matrix (Bohn, 2014), endogenous factors such as digestive 
enzymes and microbiota (Scalbert and Williamson, 2000). With regards to the 
bioavailability of flavanones, the findings of Pereira-Caro et al. (2014) suggest that 
hesperidin and narirutin from orange juice are highly bioavailable. Specifically, when 
their metabolites and catabolites are both taken into account, a recovery over 37% of 
intake (nearly 100% with hippuric acid taken into calculation) has been estimated.  
 
1.3.3 Cardiovascular protection by flavonoids 
Numerus epidemiological studies have demonstrated an inverse association between the 
consumption of flavonoid-rich foods and the risk of CVD (Steinhaus et al., 2017; Cassidy 
et al., 2016; Landberg et al., 2011). Citrus flavonoids are of particular interest given that 
citrus fruits and  juices are highly consumed worldwide and flavanones are highly 
bioavailable, as discussed in section 1.3.1 and 1.3.2. In addition, only a few flavonoid-
rich products such as green tea (Babu et al., 2008; Tipoe et al., 2007), cocoa and dark 
chocolate (Magrone et al., 2017; Basu et al., 2015), have been more extensively 
researched, with more convincing clinical data suggesting their benefits for 
cardiovascular health including lowering blood pressure (Negishi et al., 2004) and LDL 
cholesterol (Maron et al., 2003) as well as improving endothelial function (Loffredo et 
al., 2017). In contrast, evidence from randomised controlled crossover trials on citrus 
products (as shown in Table 1.3 and 1.4) suggest the effect of citrus flavonoids on 
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cardiovascular health is still inconclusive and not fully understood, therefore warrants 
more investigation.  
 
Following increasing evidence from epidemiological studies indicating that the intake of 
flavonoids may have possible cardiovascular health benefits, a large number of in vitro 
and in vivo studies been conducted to elucidate the mechanisms by which flavonoids 
potentially improve cardiovascular health. Over decades, flavonoids have simply been 
assumed as antioxidants (Pietta, 2000) and numerous in vitro studies have been 
performed to investigate their role in scavenging radicals, using supraphysiological 
concentrations of flavonoids (Rice-Evans et al., 1996), overlooking the complexity of 
flavonoid metabolism. However, it is unlikely that the antioxidant capacity of flavonoids 
is the only mechanism for their benefits on cardiovascular health given that complex 
flavonoid metabolism may decrease the antioxidant capacity of their metabolites, such 
as sulfate or glucuronide conjugates (Turner et al., 2004; Moon et al., 2001). A previous 
study by Andriambeloson et al. (1997) has demonstrated that the endothelium-dependent 
relaxation in the rat aorta, induced by polyphenols from red wine, is not due to their 
superoxide scavenging activity, but to the induction of NO synthesis by polyphenols. In 
recent years, with increasing recognition of the pivotal roles of the endothelium and NO, 
the effect of flavonoids on endothelial function has been under active investigation.  
 
Flavonoids have been reported to exert favourable effects on endothelial function by 
different mechanisms, some of which are illustrated in Figure 1.6. For example, quercetin 
upregulates NO production by inducing phosphorylation of eNOS at serine 1179 (Li et 
al., 2012). (–)-epicatechin scavenges superoxide and its O-methylated metabolites 
downregulate endothelial NADPH oxidase activity (Steffen et al., 2007). Furthermore, 
resveratrol upregulates the expression of ROS detoxifying and antioxidant genes such as 
NAD(P)H:quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), gamma 
glutamyl cysteinyl synthetase (GCLC), through the activation of nuclear factor-E2-
related factor 2 (Nrf2) (Ungvari et al., 2010). Therefore, flavonoids preserve BH4, a key 
factor for eNOS coupling by reducing ROS such as peroxynitrite (Papageorgiou et al., 
2013). Preventing BH4 from oxidation is of great significance, given that in presence of 
oxidative stress, BH4 is oxidised by peroxynitrite, leading to eNOS uncoupling, which 
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results in production of ROS insteand of NO, contributing to oxidative stress and 
endothelial dysfunction (Landmesser et al., 2003b).  
 
 
Figure 1.6. Mechanisms involved in pathological artery with increased NADPH 
expression, resulting in an upregulation of reactive oxygen species (ROS), which 
leads to a reduction in NO and relaxation as well as an increase in the contraction 
of the smooth muscle cells. Flavonoids are reported to inhibit NADPH oxidase and 
reduce ROS, thereby preserving BH4  and contributing to NO production. cGMP, 
cyclic guanosine monophosphate; ET-1, endothelin 1; TXA2, thromboxane A2.  
 
In addition, intakes of flavanones have been inversely associated with plasma 
inflammatory biomarkers in healthy subjects (Landberg et al., 2011), the effect of citrus 
product consumption on inflammatory biomarkers is of great significance and warrants 
further in vivo and in vitro investigation, given that inflammation and endothelial 
dysfunction are considered to be important contributors to the development of 
atherosclerosis (Deanfield et al., 2007; Friedman et al., 2005).  
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Specifically, randomised controlled trials (RCT) investigating the effect of citrus 
products on cardiovascular risk biomarkers following short- or long-term consumption 
are summarised in Table 1.3. The inclusion criteria are: a crossover study design; with a 
control drink  matched for sugar content of tested juice, or a double-blinded design for a 
placebo and citrus extracts; outcomes include at least one of the following: endothelial 
function, blood pressure, lipid profile, inflammatory biomarkers (or antioxidant status).  
 
As shown in Table 1.3, there is conflicting evidence regarding the short- or long-term 
consumption of citrus products on endothelial function, mostly measured by FMD. 
Several factors may have contributed to this discrepancy. Firstly, variations in the 
characteristics of the subjects inevitably lead to mixed results: ethnicity, male or female, 
premenopausal or post menopausal women,  normal-weight or overweight, with or 
without the presence of CVD risk factors. To our knowledge, ethnicity has not been 
controlled for in previous studies. However, ethnicity-associated differences have been 
observed in the enzymes involved in the metabolism of polyphenols, such as LPH 
(Maskarinec et al., 1998). In addition, given that dietary nitrate also contributes to 
circulating NO through the nitrate-nitrite-NO pathway (Lundberg et al., 2008), 
differences in dietary nitrate metabolisms due to different ALDH2  phenotypes in Asian 
populations and Caucasians (Thomasson et al., 1991; Shibuya and Yoshida, 1988) also 
give rise to variations in circulating NO and the resultant NO-dependent endothelial 
function as measured by FMD. Furthermore, previous studies involving premenopausal 
women have not controlled for the confounding effect of oestrogen, which increases NO 
production in endothelial cells, mediated partially through oestrogen receptor-α (Muller-
Delp et al., 2003), thereby rendering the FMD results questionable. Therefore, further 
studies controlling for these confounding factors are warranted to minimise confounding 
effects, thereby investigating effects of citrus products on endothelial function (the 
primary outcome of this thesis). Secondly, the composition of the juice ingested (high or 
low contents of flavonoids, fibre and sugar) (Reshef et al., 2005) may have also played a 
role in the outcomes. Other factors such as juice compliance, food matrix, physical 
activity may have resulted in variations in endothelial function.  
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From reviewing previous studies on citrus products, evidence regarding blood orange 
juice consumption is much less than that on blond orange juice. To our knowledge, only 
one published crossover study by Buscemi et al. (2012) suggests short-term (1 week) 
consumption of blood orange juice significantly increases endothelial function as 
measured by FMD, as shown in Table 1.3. However, there are several limitations to this 
previous study, such as lack of controlling for confounding factors and another baseline 
measurement at the beginning of the second intervention arm. In addition, effects 
regarding blood orange juice consumption on endothelial function and other CVD risk 
factors for longer than 1 week are still unknown and warrant further investigation.
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Table 1.3. Summary of crossover randomised controlled trials investigating the effects of short- or long- term consumption of citrus 
products on CVD risk biomarkers. 
Study Intervention arms Duration  Subjects Results 
(Constans et al., 2015) OJ (600 ml/d) 4 wk Hypercholesterolemic men FMD: - 
 CD (vitamin C controlled)  (n=25, 50-60 y) sICAM-1, sVCAM-1, sE-selectin: - 
    Lipid profile: - 
    Antioxidant status: ↑ 
    ROS:  ↓ 
(Habauzit et al., 2015) GFJ (340 ml/d) 6 mo Healthy postmenopausal women FMD: - 
 CD (vitamin C controlled)  (n=48,  50–65 y) BP: - 
    Inflammation: - 
    PWV: ↓ 
(Asgary and Keshvari, 2013) Natural OJ (NOJ) (500 ml/day) 4 wk Healthy subjects DBP&SBP: ↓ in COJ 
 Commercial OJ (COJ)    (n=22, 18-59 y)  
(Buscemi et al., 2012) ROJ (500 ml/d)   1 wk Subjects with CVD risk factors FMD:  ↑ 2.2% 
 CD  (n=19, 19–67 y) hsCRP, IL-6, TNF-α: ↓ 
(Morand et al., 2011) CD+ hesperidin (CDH) (500 ml/d) 4 wk Healthy, overweight men  Microvascular reactivity: - 
 OJ   (n=24, 50-65 y) SBP: - ; DBP: ↓ in CDH & OJ 
 CD+placebo (CDP)    Lipid profile:- 
 (Rizza et al., 2011) Hesperidin (500 mg/d) 3 wk Subjects with metabolic syndrome FMD: ↑ 2.57%  
 Placebo   (n=24, 21-65 y) BP: - 
    Lipid profile: TC: ↓;HDL: ↑; LDL&TG:- 
    Inflammation: hsCRP, SAA, sE-selectin all ↓ 
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Study Intervention arms Duration  Subjects Results 
(Reshef et al., 2005) HF citrus juice  5 wk 12 patients with hypertension DBP:  ↓ 
 LF citrus juice   (n=12, 52.1±10.1 y)  
BP=blood pressure, CD=control drink, CVD=cardiovascular disease, DBP= diastolic blood pressure, FMD= flow mediated dilation, GFJ=grapefruit juice, 
HDL=high-density lipoprotein, HF=high flavonoid, hsCRP= high-sensitivity C-reactive protein, LDL= low-density lipoprotein, IL-6= interleukin 6, LF=low 
flavonoid, OJ=orange juice, PWV= pulse wave velocity, ROJ=red orange juice, ROS= reactive oxygen species, SAA= serum amyloid A, SBP= systolic blood 
pressure, sE-selectin=soluble E-selectin, sICAM-1=soluble intercellular adhesion molecule-1, sVCAM-1=soluble vascular cell adhesion molecule-1, TC=total 
cholesterol, TG= triglycerides, TNF-α= tumour  necrosis factor-α, ↑=significant increase, ↓=significant decrease, - =no significant changes.  
 
 
 
 
 
 
 
 
 
 
 
 
- 23 - 
 
Regarding acute effects of citrus products on cardiovascular risk biomarkers, the 
characteristics of some RCTs are summarised in Table 1.4, based on the same inclusion 
criteria: a crossover study design; with a control drink matched for sugar content of tested 
juice, or a double-blinded design for a placebo and citrus extracts; outcomes include at 
least one of the following: endothelial function, blood pressure, lipid profile, 
inflammatory biomarkers or antioxidant status. Interestingly, a variety of approaches 
have been used for the evaluation of endothelial function following citrus product 
consumption in a acute manner, such as FMD (Rendeiro et al., 2016), RH-PAT (Schär 
et al., 2015), laser Doppler flowmetry and iontophoresis (Morand et al., 2011), resulting 
in conflicting evidence, which may in part be due to differing sensitivity and 
reproducibility of the approaches used. Hence, evidence for acute effects of citrus 
products is still inconclusive and further investigations are needed.  
 
Although some clinical studies suggest that the intake of citrus products may improve 
endothelial function and contribute to antioxidant status, the molecular mechanisms by 
which citrus flavonoids exert these effects have not been fully elucidated. However, 
previous in vitro studies on these mechanisms are limited and have incubated cells in 
supraphysiological concentrations of flavonoids (Appeldoorn et al., 2009; Liu et al., 
2008). Hence, more in vitro studies investigating effects of different citrus flavonoids at 
physiological concentrations are needed in order to decipher how they modulate gene 
expression relevant to NO production and antioxidant status in human endothelial cells. 
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 Table 1.4. Summary of crossover randomised controlled trials investigating the acute effect of citrus product consumption on CVD risk 
biomarkers. 
Study Intervention arms Time point Subjects Results 
(Rendeiro et al., 2016) OJ (128.88 mg TF)+ HFM 2, 5, 7 h Healthy men  FMD:  ↑ (7 h); ↓ (CD) 
 FROJ (272.14 mg TF) + HFM  (n=28, 30–65 y) Plasma nitrite:  ↓ (CD) 
 Whole orange (452.8 mg TF) + HFM  Plasma nitrate: ↓ 
 CD + HFM   RXNO species: -  
(Schär et al., 2015) OJ (767 ml) 5 h Men with CVD risk factors  RH-PAT: - 
  Hesperidin+Vitamin C    (n=16, 51–69 y) BP: - 
  CD (match for Vitamin C)     Arterial stiffness: - 
        Cardiac autonomic function: - 
        Platelet activation: - 
        
NADPH oxidase gene expression: 
- 
(Morand et al., 2011) CD+ hesperidin (CDH) (500 ml) 6 h Healthy, overweight men  Microvascular reactivity: ↑  
 OJ   (n=24, 50-65 y) (CDH&OJ)   
 CD+placebo (CDP)     
(Bui et al., 2006) Bitter orange extract (900 mg) every h until 6 h Young healthy subjects SBP: ↑ (1-5 h) 
  Placebo   (n=13, 22-29 y) DBP: ↑ (4,5 h)  
        HR: ↑ (2-5 h) 
(Min et al., 2005) Bitter orange extract (450 mg) 1, 3, 5, 8 h Healthy subjects QTc interval: - 
 Placebo  (n=36, >18 y) BP: - 
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BP=blood pressure, CD=control drink, CVD= cardiovascular disease, DBP= diastolic blood pressure,  FMD= flow mediated dilation, FROJ=flavanone-rich 
orange juice, HFM=high-fat meal, HR=heart rate, NADPH= nicotinamide adenine dinucleotide phosphate, OJ=orange juice, PH-PAT= reactive hyperemia-
peripheral arterial tonometry, QTc=QT interval corrected for heart rate, RXNO= nitros(yl)ated species, SBP= systolic blood pressure, TF=total flavanones, 
↑=significant increase, ↓=significant decrease, - =no significant changes. 
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1.4 Outline of this thesis 
The present literature review describes current understanding on cardiovascular health, 
evaluation of endothelial function, multiple roles of NO and its synthesis, dietary sources 
and intake of flavonoids, metabolism and bioavailability of flavonoids and their potential 
cardiovascular protective effects and possible mechanisms. In addition, based on current 
in vitro and in vivo data, remaining limitations to be addressed in future research have 
been discussed and some of these research gaps were addressed to some extent in the 
present work. 
 
In summary, CVD is the leading cause of death worldwide, causing great economic loss 
and diminishing life quality. As one of modifiable factors of CVD, foods or beverages 
rich in flavonoids have been associated with reduced rick of CVD. Given that citrus fruits 
and juices are highly consumed worldwide and are highly bioavailable, yet less studied, 
the effect of citrus flavonoids on cardiovascular health are of great importance.  
 
Indeed, some epidemiological studies have suggested an inverse association between the 
intake of citrus products and risk of CVD. However, evidence from in vitro and in vivo 
human studies is still lacking and conflicting, therefore the possible underlying 
mechanisms by which flavanones may exert beneficial effects on endothelial function 
and antioxidant status remain poorly understood.  
 
Therefore, in order to investigate effects of citrus flavonoids on cardiovascular health 
and address some limitations of previous studies, the objectives of this thesis are as 
follows:  
1. To investigate the effects of selected citrus flavonoids on endothelial NO 
production at transcription and protein levels as well as gene expression relevant 
to antioxidant status in human endothelial cells (Chapter 2). 
2. To determine and compare flavanone content in commercial orange juices 
including blond orange juice and blood orange juice (Chapter 3).  
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3. To investigate the acute effect of flavanone-rich blond orange juice on vascular 
function, specifically on cardiac electrical activity, blood pressure, vascular 
compliance, peripheral blood flow, pulse transit time and pulse wave velocity 
(Chapter 3). 
4. To investigate the effects of flavanone-rich blood orange juice on endothelial 
function (FMD), blood pressure, lipid profile, inflammation, in healthy 
overweight/obese men and premenopausal women of European origin with 
consideration of female hormonal cycle (Chapter 4).  
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Chapter 2 Effects of citrus flavonoids on the basal expression of 
vascular biomarkers in human endothelial cells 
2.1 Abstract 
Epidemiological studies have indicated that the consumption of citrus fruit is inversely 
associated with the risk of cardiovascular disease (CVD). Although clinical studies 
suggest that the intake of citrus flavonoids might improve endothelial cell function and 
reduce blood pressure, the molecular mechanisms by which different citrus flavonoids 
contribute to cardiovascular health have not been fully elucidated. The aim of this study 
therefore was to investigate the potential of selected citrus flavonoids to modulate gene 
expression relevant to nitric oxide (NO) production and antioxidant status in endothelial 
cells. 
 
Confluent human endothelial cells (EA.hy926 hybrid cell line) were incubated with 
increasing concentrations of hesperetin, naringenin, tangeretin and nobiletin for 18 h. 
Cell viability was measured by neutral red assay. Expression of endothelial NO synthase 
(eNOS) and endothelin 1 (ET-1) as well as expression of genes associated with 
antioxidant and cytoprotective function (gamma glutamyl cysteinyl synthetase, GCLC 
and heme oxygenase-1, HO-1) were determined by quantitative real time PCR. eNOS 
protein expression in response to different citrus flavonoids was determined by western 
blot. NO production from EA.hy926 in response to selected citrus flavonoids was also 
evaluated.  
 
The results demonstrate that incubation of EA.hy926 cells with nobiletin resulted in 
significant augmentation of NO production through dose-dependent induction of NOS3 
mRNA and protein expression, significant reduction of ET-1 mRNA expression and 
significant induction of HO-1 and GCLC in a dose-dependent manner. Tangeretin also 
significantly upregulated NOS3 mRNA and protein levels. Present data indicate that 
selected citrus flavonoids favourably modulate gene expression in endothelial cells, 
which could in part contribute to the health effects associated with citrus product 
consumption. 
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2.2 Introduction 
Epidemiological studies have demonstrated an inverse association between the 
consumption of citrus fruit and the risk of cardiovascular disease (CVD) (Landberg et 
al., 2011; Knekt et al., 2002). Some randomised controlled trials (RCT) have indicated 
that the consumption of citrus juice improves endothelial function acutely (Rendeiro et 
al., 2016) and chronically (Rizza et al., 2011), as measured by flow mediated dilation 
(FMD), which is nitric oxide (NO) dependent. However, molecular mechanisms by 
which citrus flavonoids contribute to cardiovascular health have not been fully 
elucidated. Previous in vitro studies have treated endothelia cells with flavonoids at 
supraphysiological concentrations, therefore lacking clinical relevance (Kay, 2010; 
Appeldoorn et al., 2009; Liu et al., 2008). Effect of citrus flavonoids at physiological 
concentrations on endothelial cells, hence, warrants investigation.  
 
As reviewed in Chapter 1, NO is the major vasodilator produced by endothelial cells and 
plays a pivotal role in the regulation of vascular homeostasis by inducing vasodilation as 
well as inhibiting inflammation, platelet aggregation and smooth muscle proliferation 
(Andriantsitohaina et al., 2012; Deanfield et al., 2007). Accumulated evidence indicates 
that reduced NO bioavailability is closely associated with endothelial dysfunction, which 
is not only the primary etiology of atherosclerosis but also the earliest identifiable event 
in the process of atherosclerotic cardiovascular disease development (Kawashima and 
Yokoyama, 2004; Oemar et al., 1998). In healthy endothelial cells, NO is produced from 
L-arginine in the presence of oxygen by endothelial nitric oxide synthase (eNOS) with 
cofactors such as tetrahydrobiopterin (BH4). However, when the redox balance between 
oxidants and antioxidants is disrupted and oxidants outweigh antioxidants, oxidative 
stress is produced. Consequently, excessive amounts of superoxide reacts with NO to 
form peroxynitrite, not only reducing NO bioavailability but also leading to uncoupling 
of eNOS. Specifically, BH4 is oxidised to BH2 by peroxynitrite, resulting in eNOS 
uncoupling (Stuehr et al., 2001). Consequently, electrons derived from NADPH are 
passed to oxygen rather than L-arginine, thereby producing superoxide instead of NO by 
eNOS. Prolonged eNOS uncoupling contributes to oxidative stress and leads to 
endothelial dysfunction (Förstermann and Münzel, 2006; Landmesser et al., 2003a). 
Given the crucial role of NO in both normal endothelial function and endothelial 
 
 
- 30 - 
 
dysfunction, the effect of citrus flavonoids on eNOS expression is of particular interest. 
Only hesperetin and naringenin have been studied for their effect on eNOS expression. 
Specifically, incubation with hesperetin (12.5-100 µM) for 24 h dose dependently 
induced NO production (measured as nitrite) in human umbilical vein endothelial cells 
(HUVECs), whereas no significant changes were observed after treatment with 
naringenin under the same conditions (Liu et al., 2008). The effect of other citrus 
flavonoids at lower concentrations has yet to be explored.  
 
Elevated vasoconstrictor endothelin 1 (ET-1) plasma concentrations are associated with 
hypertension and heart failure (Schiffrin, 2001; Yoshibayashi et al., 1991). ET-1 has been 
reported to downregulate eNOS promoter activity and protein levels through inducing  
hydrogen peroxide mediated by endothelin A receptor (Wedgwood and Black, 2005). 
Moreover, ET-1 upregulated superoxide anions in HUVECs (Duerrschmidt et al., 2000), 
thereby inducing oxidative stress and reducing NO bioavailability. There is, however, a 
paucity of data regarding effect of citrus flavonoids on ET-1 expression. Moreover, 
endothelial function is modulated by the balance between eNOS and ET-1, both 
influenced by cellular inflammation/oxidative stress. 
 
It has been recognised that oxidative stress and vascular inflammation are closely 
associated with endothelial dysfunction and vascular damage (Siti et al., 2015). Part of 
the pathophysiology of CVD, especially  hypertension and atherosclerosis, is attributed 
to mild chronic vascular inflammation (Touyz, 2005; Libby et al., 2002). Furthermore, 
excessive oxidative stress can turn eNOS from a protective enzyme producing NO to a 
detrimental enzyme producing superoxide and contributing to oxidative stress. 
Therefore, redox balance in endothelial cells is of great importance. Several genes 
contribute to maintaining redox balance. Specifically, the increase in heme oxygenase-1 
(HO-1) is associated with a decrease in intracellular pro-oxidants and an increase in 
bilirubin and carbon monoxide with anti-apoptotic and anti-inflammatory properties in 
cells (Chen et al., 2010; Szabo et al., 2004). Moreover, HO-1 induction protects eNOS 
expression from oxidized low-density lipoprotein (oxLDL) and tumour necrosis factor-
α (TNF-α) via cellular bilirubin degraded from haem (Kawamura et al., 2005). In 
addition, the glutathione (GSH) antioxidant system plays a vital role in maintaining 
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cellular redox balance and protecting against oxidative injury (Hayes and McLellan, 
1999). The upregulation of gamma glutamyl cysteinyl synthetase (GCLC) as a subunit 
of the first rate-limiting enzyme for GSH synthesis, also contributes to cellular 
antioxidant defence and cell protection against oxidative stress.  
 
The aim of this chapter, therefore, was to investigate the potential of selected citrus 
flavonoids to modulate gene expression relevant to NO production and antioxidant status 
in endothelial cells. 
2.3 Materials and methods 
2.3.1 Chemicals and reagents 
Hesperetin, naringenin, phorbol-12-myristate-13-acetate (PMA), Nω-nitro-L-arginine 
methyl ester hydrochloride (L-NAME) were obtained from Sigma-Aldrich (Dorset, UK). 
Nobiletin, tangeretin, genistein, resveratrol were purchased from Extrasynthase (Genay, 
France). 
 
Dulbecco's phosphate-buffered saline (DPBS) without calcium and magnesium, T75 
flasks, 6-well plates, PCR single tubes (free of DNA, DNase/RNase and PCR inhibitor) 
were purchased from Fisher Scientific (Loughborough, UK). Dulbecco’s modified 
Eagle’s medium (DMEM), L-glutamine, penicillin-streptomycin, Trypsin-EDTA were 
obtained from Lonza (Slough, UK). All other chemicals and reagents were obtained from 
Sigma-Aldrich unless specified otherwise. 
 
2.3.2 Treatment with flavonoids 
Stock solutions of all compounds were prepared in 100% dimethyl sulfoxide (DMSO) at 
100 mM in aliquots, with the exception of tangeretin (at 25 mM due to its limited 
solubility in DMSO), and stored at -20°C. Working solutions were diluted from stock 
solutions to specific concentrations immediately prior to treatment.  
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Cell viability and compound cytotoxicity were determined by the neutral red (NR) uptake 
assay. Thereafter, optimisation of NOS3 induction was conducted using positive controls 
PMA (Li et al., 1998) and resveratrol (Appeldoorn et al., 2009). Subsequent experiments 
were conducted under optimised conditions for NOS3 induction. Following incubating 
confluent human endothelial cells (EA.hy926 hybrid cell line) with increasing 
concentrations of hesperetin, naringenin, tangeretin and nobiletin for 18 h, expression of 
NOS3, ET-1, HO-1, GCLC were determined using quantitative real time PCR. eNOS 
protein expression in response to different citrus flavonoids was determined by western 
blot. NO production from EA.hy926 in response to selected citrus flavonoids was also 
evaluated using DAN assay and DAF-2 assay.  
 
Specifically, EA.hy926 cells were seeded into 12-well plates at 1x105 cells/ml and left 
to grow overnight to reach 90% confluence. After media removal, cells were incubated 
with flavonoids at different concentrations (1, 10, 25, 50, 100 µM) for 18 h, with PMA 
(10 nM ) as a positive control and L-NAME (20 nM) as a negative control for NOS3 
induction.  
 
2.3.3 Cell culture 
2.3.3.1 Thawing frozen cells 
Human endothelial cells EA.hy926 (ATCC® CRL-2922™), derived from the fusion of 
human umbilical vein endothelial cells and the permanent human cell line A549 (Edgell 
et al., 1983), were obtained from ATCC (Middlesex, UK) and stored in liquid nitrogen 
until required. Cells were thawed by placing the vial in a 37 ºC water bath with gentle 
agitation. Caution was taken to keep the cap and O-ring of the vial out of water to avoid 
contamination. The vial contents were transferred to a centrifuge tube containing 9 ml of 
pre-warmed complete media (Dulbecco’s modified Eagle’s medium with 1000 mg/L 
glucose, 2 mM L-glutamine, 10% fetal bovine serum and 1% penicillin and streptomycin) 
under aseptic conditions as soon as the vial contents were thawed, followed by 
centrifugation at 125 x g for 5 min. The supernatant was removed by an aspirator and the 
cell pellet was re-suspended with pre-warmed complete media and dispensed into a T75 
culture flask. The flask was then incubated in a humidified atmosphere with 5% CO2 at 
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37ºC overnight. The cells were checked using an inverted microscope after 24 h and 
medium was  replaced to remove non-adherent cells.  
 
2.3.3.2 Cultivation of EA.hy926 cells 
EA.hy926 cells were grown in complete media (Dulbecco’s modified Eagle’s medium 
with 2 mM L-glutamine, 1 mM sodium pyruvate, 10% fetal bovine serum and 1% 
penicillin and streptomycin) in a humidified atmosphere with 5% CO2 at 37ºC.  Medium 
was  changed every two to three days. Cells were subcultured to the next passage when 
cells were in log-phase growth before confluence was reached. Basically, after removal 
of the media, cells were gently washed by DPBS to remove any remaining serum, 
calcium and magnesium which inhibit enzymatic dissociation. Subsequently, 3 ml of pre-
warmed Trypsin-EDTA solution was added to a T75 flask, followed by an incubation at 
37 ºC for 5 min to facilitate enzymatic dissociation. Dispersal of cells was checked under 
an inverted microscope before 6 ml of complete medium was  added to the T75 flask to 
deactivate the enzymatic dissociation by Trypsin-EDTA. Cells were transferred to a 
centrifuge tube by gentle pipetting, followed by centrifugation at 125 x g for 5 min. 
Supernatant was removed by an aspirator. Cells were then re-suspended in fresh 
complete media in desired split ratios.   
 
2.3.3.3 Cell counting 
Cell counting was conducted using a haemocytometer (Neubauer Improved counting 
chamber, Assistent, Sondheim v. d. Rhön, Germany). Cells in suspension were obtained 
as described in 2.3.3.2. Both the upper and lower chambers were filled with 10 µl of cell 
suspension. Counting of the cells was conducted in the large central squares containing 
25 medium squares in the upper and lower chambers. The average of cell numbers in the 
upper and lower chambers was calculated and multiplied by 104 as an estimation of the 
number of cells per ml.  
 
2.3.3.4 Freezing cells 
Early passages of EA.hy926 cells were frozen and preserved for long-term storage. 
Specifically, a pellet of viable cells was obtained as described in 2.3.3.2. Subsequently, 
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cells were re-suspended in recommended freezing media (70% complete media, 20% 
fetal bovine serum, 10% DMSO) at a concentration of approximately 1x106 cells/ml 
before being transferred to sterile cryovials. These cryovials were placed in a freezing 
container which allowed slowly freezing cells by reducing the temperature at the optimal 
rate for cell preservation (approximately 1 ºC per minute) and left in a -80 ºC freezer 
overnight, before being stored in liquid nitrogen and a -80 ºC freezer.  
 
2.3.4 Cell viability 
Cell viability and compound cytotoxicity were determined by the neutral red (NR) uptake 
assay (Borenfreund and Puerner, 1985), and the principle is based on the ability of viable 
cells to accumulate neutral red in lysosomes. NR assay has been recognised to be more 
cost efficient and more sensitive, with less interference compared with other methods 
using tetrazolium salts (Repetto et al., 2008).  
 
The NR stock solution was made from 40 mg neutral red dye dissolved in 10 ml DPBS, 
stored at room temperature and protected from light. NR working solution (40 µg/ml) 
was prepared one day before treatment, 1:100 diluted from NR stock solution in phenol 
red-free, serum-free media. For each experiment, each 24-well plate was seeded at 1x105 
cells per ml in complete media. After 24 h, cells reached 90% confluence and the medium 
was  removed by an aspirator. Varying concentrations (0, 25, 50, 100 µM) of compounds 
in phenol red-free and serum-free medium was added to each well in triplicate, followed 
by an incubation at 37°C for 18 h. Controls included a blank control (medium without 
flavonoids) and a vehicle control (medium containing 0.4% DMSO which was the 
highest concentration of DMSO used in this chapter). Subsequently, medium was  
removed and 1 ml NR-working solution was added to each well, followed by an 
incubation at 37°C for 2 h. The NR working solution was then removed and the cells 
were washed gently with DPBS, followed by the addition of 1 ml NR destain solution 
(50% ethanol, 49% deionized H20, 1% glacial acid) to each well. The plate was then 
placed on a plate shaker and shaken rapidly for 15 min. The solution in each well was 
pipetted up and down to form a homogeneous solution and 200 µl of this solution was 
added to each well of a 96-well plate in duplicate. The absorbance was measured at 540 
nm by a plate reader (Thermo Fisher Scientific, Loughborough, UK), with NR destain 
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solution without cells as a reference. Viability of treated cells was calculated as percent 
relative to the blank control (untreated cells).  
 
2.3.5 Optimisation of NOS3 induction 
NOS3 was the primary outcome of the present study. Optimisation of NOS3 induction 
was conducted at the beginning by testing effects of different incubation periods (6 h and 
18 h) and different components in the media (glucose and FBS), with resveratrol 
(Appeldoorn et al., 2009) and PMA (Li et al., 1998) as positive controls. Expressions of 
two housekeeping genes, GAPDH and ACTB, were compared. The more stably 
expressed housekeeper gene was selected for all the subsequent experiments.  
 
2.3.6 RNA isolation and real time qPCR 
Cell culture medium was removed and cells were washed gently with DPBS. Total RNA 
was extracted from EA.hy926 cells using a commercially available reagent TRIsure 
(Bioline, London, UK) according to the manufacturer’s instructions. Confluent cells in 
12-well plates after treatment were lysed by 600 µl of TRIsure, which protected the 
integrity of RNA during lysis due to the RNase inhibitory property of TRIsure reagent. 
Repeated pipetting was performed to facilitate cell lysis and homogenisation, followed 
by an incubation at room temperature for 5 min. Homogenised samples were then 
transferred to 1.5 ml tubes and 120 µl of chloroform was added to each tube. Samples 
were shaken vigorously by vortex for 15 s and then incubated for 3 min at room 
temperature before they were centrifuged at 12,000 x g for 15 min at 4ºC. The aqueous 
phase (upper phase) was transferred into new Eppendorf tubes. RNA was precipitated by 
the addition of 300 µl of ice cold isopropanol per sample. The mixture was incubated for 
10 min at room temperature and centrifuged at 12000 x g for 10 min at 4ºC, followed by 
the removal of the supernatants. The pellet was washed with 800 µl of 75% ethanol. 
Samples were vortexed and centrifuged at 7500 x g for 5 min at 4ºC. Supernatants were 
discarded and the pellet was air-dried for 5-10 min. RNA was re-dissolved in 30 µl of 
DEPC-treated water and stored at -80°C. Total RNA quantity was measured using 
NanoDrop2000 micro-volume spectrophotometer, with purity assessed by A260/280.  
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Reverse transcription of RNA to cDNA was conducted using Script TM cDNA synthesis 
kit (Bio-Rad, Hertfordshire, UK):1 µg total RNA template was used for cDNA synthesis, 
with the addition of 4 µl of 5x iScript reaction mix containing oligo (dT) and random 
hexamer primers, 1 µl of iScript reverse transcriptase pre-blended with RNase inhibitor 
and nuclease-free water to make a total volume of 20 µl. The mixture was incubated for 
5 min at 25ºC, then for 30 min at 42ºC and finally for 10 min at 85ºC. cDNA samples 
were diluted 1/20 with DEPC-treated water and stored at -20ºC.  
 
Diluted cDNA samples (4 µl ) in duplicate were mixed with 16 µl of SYBR™ Green 
master mix (Bioline, London, UK) containing 5 µl of DEPC-treated water, 10 µl of 2x 
SensiMix Buffer (Bioline, London, UK), 0.5 µl of forward primer and 0.5 µl of reserve 
primer. Standard tools were used to design primers (Table 2.1) as previously described 
(Boesch-Saadatmandi et al., 2012), which were then synthesised by Eurofins Genomics 
(Ebersberg, Germany). Real time qPCR was conducted using StepOne Real-Time PCR 
system (ThermoFisher, Warrington, UK). Started with an enzyme activation step for 10 
min at 95ºC, reactions underwent 40 cycles of denaturation for 15 s at 95ºC, annealing 
for 15 s at specific annealing temperature for target genes (usually 57-60ºC), and 
extension for 15 s at 72ºC. Threshold cycle (Ct) was measured and target gene expression 
was normalised to ACTB (housekeeping gene), expressed as fold change relative to 
control (cells without treatment).  
Table 2.1. Primers of target genes for RT-qPCR (Sequence (5’-3’)). 
Gene Forward primer  Reverse primer 
hsACTB AGAGCTACGAGCTGCCTGAC AGCACTGTGTTGGCGTACAG 
hsGAPDH CCATCTTCCAGGAGCGAGAT TGCTGATGATCTTGAGGCTG 
hsNOS3 GCAGCCTCACTCCTGTTTTC GGTCTTCTTCCTGGTGATGC 
hsHMOX1 CTTCTTCACCTTCCCCAACA AGCTCCTGCAACTCCTCAAA 
hsGCLC CAATGGGAAGGAAGGTGTGT GCGATAAACTCCCTCATCCA 
hsEDN1 GATGCCAATGTGCTAGCCAA GCTGTTTCTCATGGTCTCCG 
 
2.3.7 Protein preparation and quantification 
EA.hy926 cells were seeded in large petri dishes at 1.5x105 cells/ml and cultured to 90% 
confluence. After media removal, cells were incubated for 24 h in fresh complete media 
with hesperetin, naringenin, nobiletin, tangeretin at 50 μM, and 10 nM PMA and 50 μM 
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apigenin were used as positive controls. After media removal and DPBS wash, 200 µl of 
RIPA buffer (150 mM sodium chloride, 1% Triton X-100, 0.5% sodium deoxycholate, 
0.1% sodium dodecyl sulphate (SDS), 50 mM Tris-HCl (pH 8.0), 1/100 proteinase 
inhibitor cocktail) was added to lyse cells. Cell lysates were transferred to Eppendorf 
tubes and incubated on ice for 30 min, followed by centrifugation at 12,000 x g at 4ºC 
for 30 min. Supernatants in aliquots were stored at -80ºC for further analysis.  
 
Protein concentrations of cell lysates were quantified using Pierce BCA Protein Assay 
Kit (Thermo Fisher Scientific, Loughborough, UK). The principle of BCA method is 
based on proteins’ capacity to convert Cu+2 to Cu+1 in an alkaline medium, followed by 
the highly selective colorimetric detection of the complex formed by Cu+1 and 
bicinchoninic acid. Standards of BSA protein (0-2000 µg/ml) were prepared. Working 
reagent was freshly made from a mixture of BCA reagent A and B (A: B = 50:1) 
immediately prior to use.  
 
Measurements were conducted in triplicate: 10 µl of standards and samples were pipetted 
to each well, followed by the addition of 200 µl of working reagent per well. The mixture 
was incubated for 30 min at 37°C and the absorbance was measured at 570 nm using a 
plate reader (Thermo Fisher Scientific, Loughborough, UK). Influence of lysis buffer 
was tested by diluting the lysis buffer with PBS (1/1000, 1/100, 1/10 and undiluted), 
followed by protein quantification as mentioned.  
 
2.3.8 Western blot 
Protein samples (20 µg) were mixed with 5xLaemmli buffer and denatured at 95°C for 
5 min. Subsequently, protein samples were separated on a 10% SDS–polyacrylamide gel 
(Bio-Rad Laboratories, Hamel Hempstead, UK) in 1xTBS buffer (1/10 diluted from 10x 
TBS: 60.6 g Tris and 87.6 g sodium chloride in 1 L ultrapure water, pH adjusted by HCl 
to 7.6) and transferred onto PVDF membranes (Bio-Rad Laboratories, Hamel Hempstead, 
UK), which were blocked in 5% non-fat milk powder in TBS-Tween-20 buffer (100 ml 
of 10x TBS and 500 µl of Tween-20 filled with ultrapure water to 1 L). PVDF 
membranes were then incubated with corresponding primary antibodies (eNOS and β-
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actin in 1:1000 dilution) for 2 h, followed by three washes with TBST buffer. Membranes 
were incubated with corresponding anti-rabbit second antibodies and precision prot 
streptactin-HRP (both in 1:10000 dilution) for 1 h. Target protein bands were visualised 
with Pierce enhanced chemiluminescence (ECL) Western Blotting Substrates (Thermo 
Fisher Scientific, Loughborough, UK) and exposed by ChemiDoc system (Bio-Rad, 
Hertfordshire, UK). Quantifications were performed with densitometric analysis by 
Image Lab software. Protein bands were normalised to β-actin band.  
 
2.3.9 Measurement of nitric oxide 
Nitric oxide produced by EA.hy926 cells following 18-h incubation with different 
compounds was measured by the following two assays.  
 
2.3.9.1 2,3-diaminonaphthalene (DAN) assay 
Confluent EA.hy926 cells in 12-well plates were incubated for 18 h with different 
compounds in DMEM (phenol red free and FBS free). 20 μl of medium was  taken from 
each well for measurement of NO production (total nitrate and nitrite) by a nitrate/nitrite 
fluorometric assay kit from Cayman (Michigan, USA). The principle of this assay is 
based on the conversion of nitrate to nitrite by nitrate reductase, followed by the 
quantification of nitrite using a fluorometric assay. Briefly, the reaction between nitrite 
and 2,3-diaminonaphthalene (DAN) in an acidic solution forms a highly fluorescent 
product 1(H)-naphthotriazole, the detection of which is enhanced by NaOH.  
 
Stock solution of nitrate (200 μM) was made from 0.1 ml of reconstituted Nitrate 
Standard and 0.9 ml of Assay Buffer (AB). Nitrate standards were prepared immediately 
prior to use. The measurement was conducted in duplicate. 60 µl of nitrate standards 
were added to 20 µl of assay buffer; 20 µl of samples were added to 60 µl assay buffer. 
The mixture of 20 µl media and 60 µl assay buffer was used as control. 10 μl of the 
Enzyme Cofactor Mixture and 10 μl of the Nitrate Reductase Mixture were added to each 
well. The plate was then covered with film and incubated for 1 h at room temperature. 
Thereafter 10 μl of DAN Reagent was added to each well and the plate was incubated 
for 10 min followed by the addition of 20 μl of NaOH to each well. Fluorometric 
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measurement was conducted using an excitation wavelength of 355 nm and an emission 
wavelength of 410 nm with a plate reader (Tecan SPARK 10M, Männedorf, Switzerland). 
 
2.3.9.2 4,5-diaminofluorescein (DAF-2) assay 
The principle of this assay is based on the reaction of low fluorescence 4,5-
diaminofluorescein (DAF-2) with NO in the presence of dioxygen to produce highly 
fluorescent DAF-2T (Kojima et al., 1998). The protocol was modified from previous 
studies (Elíes et al., 2011; Räthel et al., 2003). EA.hy926 cells were seeded in 96-well 
plates and grown to confluence, followed by 18-hour incubation with different 
compounds in DMEM (phenol red free and FBS free). Cells were washed with DPBS, 
following the removal of cell culture media. Cells were then incubated with L-arginine 
(100 µM) in DPBS for 10 min. DAF-2 (0.1 µM) was added and cells were incubated in 
the dark for 5 min thereafter. Then fluorescence was measured at room temperature with 
excitation wavelength at 485 nm and emission wavelength at 520 nm with a plate reader 
(Tecan SPARK 10M, Männedorf, Switzerland). Auto-fluorescence of DAF-2 (measured 
in wells without cells) was subtracted from the total fluorescence in all the wells. 
Measurements were conducted in duplicate. 
 
2.3.10  Statistical analysis 
Results from 3 independent passages were expressed as mean ± standard deviation. 
Statistical analysis was conducted using Statistical Package for the Social Sciences 
(SPSS, version 24, IBM Corporation, USA). Treatment effects were analysed by one-
way analysis of variance (ANOVA) followed by post-hoc test of Dunnett's (comparing 
multiple treatments to a single control). P < 0.05 was considered as statistically 
significant.  
2.4 Results 
2.4.1 Effect on cell viability 
EA.hy926 cells were incubated with increasing concentrations of flavonoids (0, 25, 50, 
100 µM) or 0.4% of DMSO (the highest concentration used in serial dilutions) for 18 h.  
Cell viability or compound toxicity is presented in Figure 2.1. Resveratrol was used as a 
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positive control compound in the optimisation of NOS3 induction and was found to be 
toxic to cells at 100 µM. Similarly, cell viability was significantly reduced after the 
incubation with nobiletin and tangeretin at 50 and 100 µM. No significant difference was 
observed between DMSO treated group (98.78±3.13%) and untreated group (100±2.1%) 
(p=0.71), therefore DMSO used in experiments at 0.4% or lower, was not considered  to 
have a negative effect on cell viability. Likewise, positive control PMA at 10 nM and 
negative control L-NAME at 20 nM were not toxic to EA.hy926 cells (87±5.3%, p=0.81 
and 91± 2.4%, p=0.68, respectively).  
 
Figure 2.1. Effect of resveratrol, naringenin, hesperetin, nobiletin and tangeretin on 
cell viability of EA.hy926 cells. Cell viability was determined using neutral red 
uptake assay after incubation with different flavonoids (0, 25, 50 ,100 µM) for 18 h 
(RES: resveratrol, NAR: naringenin, HES: hesperetin, NOB: nobiletin, TAN: 
tangeretin). Data of three independent experiments are presented as mean ± SD.  
*indicates significant differences between treatment group and untreated control 
group (p<0.05).  
 
2.4.2 Optimisation of NOS3 induction  
Based on the more consistent mRNA levels of ACTB throughout the experiments 
compared to GAPDH, ACTB was used as the housekeeping gene. Hence, mRNA 
expression of target genes was normalised to corresponding ACTB mRNA levels in all 
the following experiments.  
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PMA was used as a positive control for NOS3 mRNA induction. The effect of different 
concentrations of PMA (0-1000 nM) on NOS3 mRNA expression was determined 
(Figure 2.2). NOS3 mRNA levels were augmented by PMA in a concentration-dependent 
manner from 0 to 10 nM, followed by a decrease at 100 and 1000 nM. Therefore, PMA 
at 10 nM was used as a positive control in subsequent experiments.  
 
Figure 2.2. Effect of increasing concentrations of PMA on NOS3 mRNA levels. 
NOS3 mRNA expression after 18 h incubation with PMA at 0-1000 nM, normalised 
to ACTB mRNA expression. Data of three independent experiments are presented 
as mean ± SD.  *indicates significant differences between treatment group and 
untreated control group at p<0.05; **indicates significant difference at p<0.01.  
 
Incubation of EA.hy926 cells with PMA (positive control, 10 nM) for 6 and 18 h induced 
NOS3 mRNA levels similarly (2.8-fold vs. 3.2-fold) (Figure 2.3), however, resveratrol 
induced NOS3 much stronger following 18 h. Hence, an incubation period of 18 h was 
conducted for subsequent experiments.  
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Figure 2.3. Effect of incubation periods on NOS3 mRNA levels. NOS3 mRNA levels 
after 6 h and 18 h incubation with PMA at 10 nM and resveratrol (RES) at 25, 50 
µM, normalised to ACTB mRNA expression. Data of three independent 
experiments are presented as mean ± SD.  *indicates significant differences between 
treatment group and untreated control group at p<0.05; **indicates significant 
difference at p<0.01.  
 
Baseline NOS3 mRNA levels were not affected by the high glucose content in the media 
whereas fetal bovine serum (FBS) supplementation resulted in a significant upregulation 
of NOS3 mRNA by around 1.6-fold (Figure 2.4). This increase might be due to oestrogen 
present in the serum that contributed to NOS3 induction. To minimise confounding 
effects and optimise NOS3 induction, 18 h incubation with flavonoids in low glucose 
media with 5% FBS was used for subsequent experiments.  
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Figure 2.4. Effect of fetal bovine serum (FBS) and glucose on NOS3 mRNA levels. 
NOS3 mRNA expression following 18 h incubation in low-glucose (5.5 mM) or high-
glucose (25 mM) media, with or without addition of fetal bovine serum (FBS 10%), 
normalised to ACTB mRNA expression. Data of three independent experiments are 
presented as mean ± SD.  *indicates significant differences between high glucose 
groups (with and without FBS). 
 
2.4.3 Effect on NOS3 mRNA expression 
Effect of nobiletin, tangeretin, naringenin and hesperetin on NOS3 mRNA expression 
was investigated at increasing concentrations following incubation for 18 h. A dose- 
dependent increase was observed in the upregulation of NOS3 by nobiletin (Figure 2.5A) 
from 1 µM to 25 µM and followed by a plateau of NOS3 mRNA induction by nobiletin 
from 25 µM to 50  µM. Nobiletin was found to be more potent in inducing NOS3 mRNA 
expression at 25 µM, compared to resveratrol which only resulted in a significant 
induction of NOS3 at 50 µM (Figure 2.3). Similarly, a dose-dependent increase in NOS3 
mRNA expression was also induced by tangeretin at lower concentrations (from 1 to 25 
µM), with a significant upregulation at 25 µM (p<0.05), as shown in Figure 2.5B. A 
reduction in NOS3 mRNA was observed at 50 µM, probably due to toxicity of tangeretin 
to cells at this concentration.  
 
 
 
- 44 - 
 
 
 
 
- 45 - 
 
Figure 2.5. Effect of nobiletin (A), tangeretin (B), hesperetin (C) and naringenin (C) 
on NOS3 mRNA levels. NOS3 mRNA levels after incubation with nobiletin, 
tangeretin, hesperetin and naringenin at 0-50 µM for 18 h, normalised to ACTB 
mRNA expression. Data of three independent experiments are presented as mean ± 
SD.  *indicates significant differences between treatment group and untreated 
control group at p<0.05; **indicates significant difference at p<0.01. 
As shown in Figure 2.5C, incubation with hesperetin and naringenin at 0-50 µM did not 
result in significant changes in NOS3 mRNA levels. A 1.24 fold increase in NOS3 
mRNA expression was only observed following incubation with hesperetin at 50 µM 
(p=0.08).  
 
2.4.4 Effect of nobiletin on ET-1 mRNA expression 
As shown in section 2.4.3, nobiletin was the most potent compound in NOS3 mRNA 
upregulation among the flavanones investigated. Hence, the effect of nobiletin on ET-1 
mRNA levels was also investigated. As shown in Figure 2.6, nobiletin decreased mRNA 
expression of ET-1 in a concentration-dependent fashion, with a 35% reduction at 25 µM 
(p<0.05) and a 45% reduction at 50 µM (p<0.05). 
 
Figure 2.6. Effect of nobiletin on ET-1 mRNA levels. ET-1 mRNA expression after 
18 h incubation with nobiletin at 0-50 µM, normalised to ACTB mRNA expression. 
Data of three independent experiments are presented as mean ± SD.  *indicates 
significant differences between treatment group and untreated control group at 
p<0.05. 
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2.4.5 Effect on eNOS protein expression  
Nobiletin, tangeretin, naringenin, hesperetin and apigenin at 25 µM were investigated for 
their effect on eNOS protein following incubation for 24 h, with PMA as a positive 
control. Housekeeping protein β-actin was used as an internal control. As illustrated in 
Figure 2.7, eNOS protein was upregulated by nobiletin by 1.23 fold whereas tangeretin 
significantly upregulated eNOS protein expression by 1.67 fold under the investigated 
conditions. No significant changes in eNOS protein were observed by other flavonoids.  
 
 
 
 
 
 
Figure 2.7. Effect of PMA, nobiletin, apigenin, hesperetin, naringenin and 
tangeretin on eNOS protein levels. eNOS protein expression after 24 h incubation 
with nobiletin (NOB), tangeretin (TAN), hesperetin (HES) and naringenin (NAR), 
apigenin (API) at 25 µM, with PMA (10 nM) used as a positive control. Data were 
normalised to β-actin protein expression. Data of three independent experiments 
are presented as mean ± SD. Different letters represent significant difference 
(p<0.05).  
 
eNOS 
β-Actin 
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2.4.6 Effect on nitric oxide production  
2.4.6.1 DAN assay 
As nobiletin and tangeretin markedly upregulated NOS3 mRNA levels (section 2.4.3) 
and eNOS protein expression (section 2.4.5), their effect on NO production from 
EA.hy926 cells was further investigated. NO release from EA.hy926 was measured as 
the sum of nitrite and nitrate, which is commonly used for NO quantification. Nitrate 
standard curve for quantification of total nitrate following the conversion of nitrite to 
nitrate is shown in Figure 2.8.  
 
Figure 2.8. Nitrate standard curve. A serial dilutions of nitrate standards were 
freshly prepared and converted to nitrite utilizing nitrate reductase. Following the 
addition of DAN and NaOH, samples were measured at an excitation wavelength of 
355 nm and an emission wavelength of 410 nm. 
 
PMA was used as a positive control for NO production from EA.hy926 cells. Effect of 
increasing concentrations of PMA (0-1000 nM) on total nitrate and nitrite was 
determined (Figure 2.9). In contrast with NOS3 mRNA induction data, PMA at lower 
concentrations (0.1-100 nM) upregulated NO production similarly (by 1.32-1.46 fold) 
but only at 1000 nM augmented total nitrate and nitrite significantly.  
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Figure 2.9. Effect of PMA on NO production from EA.hy926 cells. NO was 
measured as total nitrate and nitrite after 18 h incubation with PMA at increasing 
concentrations (0-1000 nM). Data were expressed as fold change of control. 
Measurement was conducted in duplicate and presented as mean ± SD. **indicates 
significant differences between treatment group and untreated control group at 
p<0.01.  
 
As shown in Figure 2.10, no significant changes were observed in total nitrate and nitrite 
following incubation with L-NAME and PMA (p=0.62 and p=0.36, respectively). 
Similarly, total nitrate and nitrite levels did not change following incubation with 
nobiletin and tangeretin at 1-25 µM (P>0.05).  
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Figure 2.10. Effect of nobiletin and tangeretin on NO production from EA.hy926 
cells. NO was measured as total nitrate and nitrite after 18 h incubation with 
nobiletin (NOB) and tangeretin (TAN) at 1-25 µM, with L-NAME (20 nM) and 
PMA (10 nM) as negative and positive controls. Data were expressed as fold change 
of control. Data of three independent experiments are presented as mean ± SD. 
 
2.4.6.2 DAF-2 assay 
As shown in Figure 2.11, NO produced by EA.hy926 cells detected by DAF-2 was 
significantly augmented by nobiletin in a concentration-dependent fashion, from 1.6 fold 
increase at 10 µM to 7 fold increase at 50 µM.  Resveratrol was used as a positive control 
for NO induction with a 1.6 fold upregulation at 25 µM whereas nobiletin at 25 µM 
resulted in a 4.98 fold increase in NO release. Therefore, nobiletin appeared to be more 
potent in inducting NO than resveratrol (both at 25 µM).  
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Figure 2.11. DAF-2 detected NO release from EA.hy926 cells after 18 h incubation 
with nobiletin (NOB) at 10-50 µM, with resveratrol (RES) (25 µM) as a positive 
control. Data were expressed as fold change of control. Data of three independent 
experiments are presented as mean ± SD. 
 
2.4.7 Effect on antioxidant status related genes  
Citrus flavonoids were also investigated for their effect on HMOX1 and GCLC mRNA 
expression. In contrast to tangeretin, hesperetin and naringenin, nobiletin significantly 
increased HMOX1 and GCLC mRNA expression at 25 and 50 µM (Figure 2.12 and 
2.13).  
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Figure 2.12. Effect of nobiletin, tangeretin, hesperetin, naringenin on HOMX1 
mRNA levels after 18 h incubation. HMOX1 mRNA expression after 18 h 
incubation with nobiletin (NOB), tangeretin (TAN),  hesperetin (HES) and 
naringenin (NAR) at 0-50 µM, normalised to ACTB mRNA expression. Data of 
three independent experiments are presented as mean ± SD.  *indicates significant 
differences between treatment group and untreated control group at p<0.05. 
 
 
Figure 2.13. Effect of nobiletin, tangeretin, hesperetin, naringenin on GCLC mRNA 
levels after 18 h incubation. GCLC mRNA expression after 18 h incubation with 
nobiletin (NOB), tangeretin (TAN),  hesperetin (HES) and naringenin (NAR) at 0-
50 µM,  normalised to ACTB mRNA expression. Data of three independent 
experiments are presented as mean ± SD.  *indicates significant differences between 
treatment group and untreated control group at p<0.05. 
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2.5 Discussion 
Higher habitual intake of flavanones has been associated with a lower risk of ischemic 
stroke (Cassidy et al., 2016) and coronary heart disease (Mink et al., 2007) evidenced by 
epidemiological studies. Some RCTs have demonstrated that the consumption of citrus 
juice or extracts leads to improved endothelial function (Rendeiro et al., 2016; Buscemi 
et al., 2012; Morand et al., 2011), reduced blood pressure (Morand et al., 2011; Reshef 
et al., 2005), elevated antioxidant status (Constans et al., 2015) and reduction in vascular 
and systemic inflammatory markers (Buscemi et al., 2012; Rizza et al., 2011). In contrast, 
other RCTs have indicated the consumption of citrus products do not alter endothelial 
function (Constans et al., 2015; Habauzit et al., 2015), blood pressure (Habauzit et al., 
2015; Rizza et al., 2011), and inflammatory markers (Constans et al., 2015; Habauzit et 
al., 2015). Hence, how citrus flavonoids modulate these markers is not conclusive and 
the underlying mechanisms have yet to be elucidated.  
  
Given the key role of NO in maintaining normal endothelial function, inhibiting 
inflammation and platelet aggregation, how citrus flavonoids regulate its synthesis 
therefore is crucial to cardiovascular health. However, only hesperetin and naringenin 
have been tested for their effect on NO production at supraphysiological concentrations. 
In the present work, the potential of selected citrus flavonoids on eNOS expression were 
explored at physiological concentrations. In addition, redox status plays a key role in cell 
metabolism, apoptosis and proliferation, contributing to the pathophysiology of a number 
of chronic diseases, including CVD and cancer (Matés et al., 2008). Furthermore, redox 
status is also crucial to eNOS coupling (Landmesser et al., 2004), thereby determining 
whether NO or superoxide is produced by eNOS. Therefore, in the present work the 
effect of selected citrus flavonoids on the expression of antioxidant status related genes 
was investigated in EA.hy926 cells, which is one of the most widely used and 
characterised endothelial cell lines, with many endothelium-specific phenotypes (Unger 
et al., 2002). In the present study, effects of citrus flavonoids on transcription of genes 
related to vasomotor, antioxidant and cytoprotective function were investigated. 
Induction of eNOS protein expression by citrus flavonoids and NO production by 
nobiletin and tangeretin were also evaluated.  
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2.5.1 Modulation of endothelial cell function 
The effect of naringenin and hesperetin on eNOS expression has been more investigated 
than other citrus flavonoids. Treatment with hesperetin (12.5-100 µM) for 24 h increased 
NO production (measured as nitrite) in human umbilical vein endothelial cells 
(HUVECs) in a concentration-dependent manner, whereas no significant changes were 
observed after treatment with naringenin under the same conditions (Liu et al., 2008). 
Similarly, the present study also demonstrated that hesperetin appeared to be more potent 
in increasing NOS3 mRNA levels in EA.hy926 cells than naringenin (at 50 µM for 18 
h). In the previous study by Liu et al. (2008), treatment with hesperetin (50 µM, 25 h) 
also upregulated eNOS protein expression in HUVECs whereas naringenin showed no 
effect. In contrast, incubation with hesperetin and naringenin at 25 µM for 18 h on eNOS 
protein expression resulted in no significant changes in eNOS protein expression in 
EA.hy926 cells in the present study, suggesting cell type- and/or time point-associated 
differences. Hesperetin and its plasma metabolite 7-O-β-D-glucuronide exert 
vasoprotective function through the inhibition of superoxide anion production via 
NADPH oxidase activity in HUVECs (Takumi et al., 2012).  
 
Nobiletin and tangeretin, polymethoxyflavones (PMFs) from citrus fruit peels, have been 
reported to exert anti-inflammatory and anti-tumour effects (Ho and Kuo, 2014; Li et al., 
2009; Yoshimizu et al., 2004). Their effect on eNOS transcription and protein expression 
in endothelial cells has yet to be elucidated. In the present study, nobiletin promoted NO 
production (detected using DAF-2) in EA.hy926 cells via augmentation of eNOS 
expression at mRNA level and protein level. Similarly, eNOS transcription and protein 
expression were also upregulated by tangeretin. Nobiletin and tangeretin were found to 
be more potent in inducing eNOS mRNA expression than hesperetin and naringenin, 
probably due to the presence of double bond at 2-3 postion at the C ring, which has been 
associated with an increase in eNOS mRNA expression (Martínez-Fernández et al., 
2015). Arguably, this might be due to the reduction potential of double bond.  
 
It should be noted that changes in eNOS mRNA and protein levels might not necessarily 
lead to changes in NO. Specifically, phosphorylation and activation of eNOS, Ca2+ 
concentrations,  redox status in endothelial cells, eNOS coupling as dimers are crucial to 
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NO production (Fleming and Busse, 2003). Cellular NO is produced at low levels in 
endothelial cells (picomoles to nanomoles) (Moncada, 1992). The short half-life of NO 
makes its measurement very difficult. In the present study, NO production was measured 
using two different assays, DAN and DAF-2. NO production was measured as total 
nitrate and nitrite using DAN assay. However, total nitrate and nitrite may not be a good 
reflection of NO produced by the endothelial cells. There is a growing body of evidence 
that plasma nitrite reflects NO-dependent endothelial function/dysfunction (Rendeiro et 
al., 2016; Kleinbongard et al., 2006). In contrast, the detection of NO was specific using 
DAF-2 assay, given that NO reacted with DAF-2 in the presence of dioxygen, producing 
highly fluorescent DAF-2T. In addition, it appeared that DAF-2 assay was more sensitive 
whereas the interference from the media in NO measurement was large in DAN assay: 
only PMA at 1000 nM induced a significant increase in NO detected by DAN. Taken 
together, DAF-2 assay may be more suitable for detection of low levels of NO released 
from EA.hy926 cells and can reflect changes in NO production more accurately. 
Resveratrol (0.1 -100 µM) is documented to be potent in upregulation of NOS3 mRNA 
expression in HUVECs (Nicholson et al., 2008) and in EA.hy926 cells (Appeldoorn et 
al., 2009). In the present study, nobiletin was found to be more potent in augmenting 
NOS3 mRNA expression than resveratrol at 25 µM in EA.hy926 cells.  
 
In the present study, EA.hy926 cells were cultured in low-glucose media. Exposure to 
high glucose (22.2 mM) for 5 days resulted in increased levels of NOS3 gene expression, 
protein expression, and NO production (measured as nitrite) in human aortic endothelial 
cells (Cosentino et al., 1997). It should be noted that in this previous study O2
− production 
was also markedly increased (by more than threefold) after prolonged exposure to high 
glucose, whereas the increase in nitrite was only 40%. Despite the increase in nitrite, this 
imbalance between nitrite and O2
− is associated with endothelial dysfunction.  
 
Pretreatment with hesperidin (1-100 µM) for 30 min inhibited ET-1 release from strain-
stimulated HUVEC (Chiou et al., 2008). In a study by Martínez-Fernández et al. (2015), 
hesperetin and naringenin at 1 µM significantly inhibited ET-1 mRNA expression in 
H2O2-treated HUVECs whereas no effect was observed on NOS3 mRNA expression. 
The present study demonstrated that nobiletin (1-50 µM) concentration-dependently 
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upregulated NOS3 expression and also suppressed ET-1 mRNA expression, which may 
contribute to the improvement of endothelial function.  
 
2.5.2 Modulation of cytoprotection  
Hesperidin, the β-7-rutinoside of hesperetin, concentration-dependently (20-80 µM) 
augmented HO-1 mRNA expression, protecting Hepatic L02 Cells from hydrogen 
peroxide-stimulated cell damage (Chen et al., 2010). The induction of HO-1 was also 
enhanced by hesperetin from 25 µM to 50 µM (by 19.5%) in the present study. 
Naringenin was found to upregulate HO-1 mRNA and protein levels in rat vascular 
smooth muscle cells (VSMCs) in a concentration-dependent fashion (25-100 µM), 
thereby inhibiting VSMCs proliferation and migration (Chen et al., 2012). In agreement 
with previous studies, the induction of HO-1 was also upregulated by naringenin from 
25 µM to 50 µM (by 20%) in the present study.  
 
Induction of HO-1 in endothelial cells by nobiletin and tangeretin has not been previously 
investigated. In the present study, HO-1 transcription was increased similarly (by 18.7%) 
by tangeretin at 25 µM followed by a decrease in HO-1 to the baseline level treated with 
tangeretin at 50 µM. In contrast, HO-1 was significantly upregulated by nobiletin at 25 
µM (by 2.98 fold) and at 50 µM (by 2.6 fold), making nobiletin the most potent citrus 
flavonoid in HO-1 induction among the citrus flavonoids investigated in this study.  
 
Expression of GCLC contributes to antioxidant and detoxification function (Dickinson 
and Forman, 2002). There is, however, a notable paucity of studies investigating effect 
of citrus flavonoids on GCLC expression. The present study indicates the effect of 
nobiletin is most pronounced on GCLC induction. The structures of nobiletin and 
tangeretin are identical except for the presence of a methoxy group at 5’ position at B 
ring in nobiletin, which in part contributed to its induction of HO-1 and GCLC mRNA 
levels. Other citrus flavonoids which did not show a significant effect in this study might 
improve cardiovascular health by different mechanisms such as inhibition of ROS-
forming enzymes (such as NADPH oxidase, xanthine oxidase and lipoxygenases), 
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platelet aggregation (Beretz et al., 1982) and leukocyte adhesion, which have been 
observed by some flavonoids.  
 
2.5.3 Conclusions 
Taken together, these findings indicate citrus flavonoids, especially nobiletin, exert 
vasoprotective effects, at least in part through upregulation of NO evidenced by induction 
of eNOS transcription and protein levels. Augmentation of mRNA expression of genes 
associated with antioxidant and cytoprotective function also contributes to these 
vasoprotective effects by citrus flavonoids. Under the conditions investigated, nobiletin 
seems to be the most potent compound to induce NOS3 and therefore potentially increase 
NO levels as well as enhance cell protective enzymes. The mechanisms by which other 
citrus flavonoids might improve endothelial function warrant futhter investigation. 
 
2.5.4 Limitations and future work 
The present study has provided novel insight into how citrus flavonoids modulate 
vascular function at molecular, transcriptional and protein levels. However, there were 
some limitations to this work. Flavonoids go through complex metabolism producing 
sulfate and glucuronide metabolites and gut-derived phenolic compounds (Pereira-Caro 
et al., 2014; Roowi et al., 2009). Future studies should investigate effects of these 
compounds at physiological concentrations on the expression of vascular biomarkers in 
human endothelial cells on basal expression as well as under stressor stimulated 
conditions. 
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Chapter 3 Acute effects of orange juice on vascular function  
3.1 Abstract 
Cardiovascular diseases (CVD) represent one of the leading causes of mortality 
worldwide. Epidemiological studies have indicated that the consumption of citrus 
products is inversely associated with the risk of CVD. However, clinical evidence 
regarding effects of orange juice on vascular function are limited and conflicting. The 
aims of this chapter were to compare the citrus flavonoid contents in a range of 
commercially available blond and blood orange juices and to investigate in a preliminary 
study the acute effects of orange juice consumption on vascular function using 
plethysmography.  
 
The major citrus flavanones in commercially available blond and blood orange juices 
were identified and quantified by LCMS. Healthy adult subjects (n=13) were recruited 
for this study. Measurements were conducted prior to and following flavanone-rich blond 
orange juice consumption. All subjects were instrumented to record cardiac electrical 
activity via a 3-lead ECG, peripheral pulse amplitude via infra-red plethysmography and 
the finger pulse signal recorded via a pulse transducer. Data were recorded during 
baseline for 10 min, occlusion of forearm blood flow for 5 min and recovery post cuff 
deflation for 10 min. Cardiac electrical activity, vascular compliance, peripheral blood 
flow, pulse transit time and pulse wave velocity were calculated from recorded signals.  
 
The present results demonstrate substantial variations in the flavanone contents of 
commercial orange juices. An increase in vascular compliance was observed during 
reactive hyperaemia post orange juice consumption, indicating improved vascular 
function, however this increase was not significant. Other vascular related markers were 
not acutely altered 2 h following consumption of orange juice under the investigated 
conditions.  
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3.1  Introduction 
Given that cardiovascular diseases (CVD) are the leading cause of death in both men and 
women worldwide (World Health Organization, 2017), there is an increasing interest in 
research on modifiable lifestyle factors like physical activity (Francois and Little, 2017; 
Harris et al., 2014) and diet (Shivappa et al., 2017; Ros et al., 2014). Growing evidence 
from epidemiological studies has demonstrated an inverse association between 
polyphenol-rich foods and the risk of CVD (Steinhaus et al., 2017; Tresserra-Rimbau et 
al., 2016; Tresserra-Rimbau et al., 2014). In support of this, numerous animal studies 
have suggested favourable effects of polyphenol-rich foods on vascular function and 
inhibition of insulin resistance and inflammation (Anhê et al., 2015; Boesch-
Saadatmandi et al., 2012). Likewise, in vitro cell mechanistic studies have also indicated 
promising positive effects of polyphenols on genes associated with endothelial function 
and antioxidant status as detailed in Chapter 2 and also in the literature (Kamiloglu et al., 
2017; Boesch-Saadatmandi et al., 2009). In addition, randomised controlled trials (RCT) 
have been conducted to investigate the impact of polyphenol-rich foods on 
cardiovascular health (Lockyer et al., 2017; Salden et al., 2016; Egert et al., 2010), 
however, with conflicting results.  
 
Compared with some flavonoids (for example, chocolate and cocoa, green tea) that have 
been more extensively studied with convincing favourable effects observed, the effects 
of citrus products on cardiovascular health are still inconclusive, however, are of 
significant relevance as citrus products, especially orange juice, are highly consumed 
worldwide. Furthermore, recent studies have suggested that flavanones, exclusively from 
citrus products, demonstrate the highest bioavailability among flavonoids (Pereira-Caro 
et al., 2014; Manach et al., 2005).  
 
Although numerous epidemiological studies have suggested that higher habitual intakes 
of citrus fruits are associated with a lower risk of CVD in women (Landberg et al., 2011) 
and men (Cassidy et al., 2016), clinical data regarding the acute effect of orange juice 
consumption on vascular function have been inconclusive. Specifically, a recent study 
by Rendeiro et al. (2016) suggests the efficacy of orange juices with flavanone content 
ranging from 128.88 to 452.8 mg/240 mL in attenuating postprandial impaired 
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endothelial function, induced by high-fat double meal. In contrast, no acute vascular 
effects were observed after orange juice consumption despite the presence of circulating 
flavanone and phenolic metabolites (Schär et al., 2015). Acute effects of orange juice 
therefore still warrant more investigation.  
 
Vascular function can be evaluated by a variety of approaches such as flow mediated 
dilation (FMD), reactive hyperemia-peripheral arterial tonometry (RH-PAT), laser 
Doppler flowmetry, acetylcholine iontophoresis and finger plethysmography. The term 
plethysmograph is derived from two Greek words “plethysmos” meaning “to increase” 
and “graph” meaning “write” (Alnaeb et al., 2007).  Finger plethysmography provides 
non-invasive, continuous measurement of pressure via infrared light. As the arterial pulse 
expands and contracts the microvasculature, changes in pulsatile blood flow from the 
finger are recorded via an infrared photoelectric sensor. The waveform acquired by this 
technique represents pulsatile peripheral blood flow and indicates both peripheral and 
central hemodynamics (Dennis, 2013). The digital volume pulse (DVP) acquired by this 
technique is a waveform that estimates pulse wave velocity (PWV), which is an indicator 
for arterial stiffness, predicting CVD risk (Theilade et al., 2013). In addition, vascular 
compliance calculated from this technique has also been used as an indicator of 
cardiovascular health (Alsop and Hauton, 2016). As shown to be reliable and 
reproducible (Gunarathne et al., 2008; Thijssen et al., 2005), finger plethysmography is 
used in this study to evaluate the effect of orange juice on vascular function.  
 
Furthermore, information on flavanone contents in commercial orange juices, especially 
the comparison of blond orange juice and blood orange juice, is limited. In addition, 
Chapter 2 demonstrates favourable effects of flavanones on gene expression relevant to 
nitric oxide (NO) production and antioxidant status in endothelial cells. The aims of this 
study therefore were to determine and compare total flavanone contents in selected 
commercial citrus products, including blond orange juice and blood orange juice, and to 
select an orange juice for a preliminary study to investigate its acute effect on vascular 
function (cardiac electrical activity, blood pressure, vascular compliance, peripheral 
blood flow, pulse transit time and pulse wave velocity). 
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3.2 Materials and methods 
3.2.1 Materials 
Flavonoid standards (hesperidin and narirutin) and internal standard genistein were 
purchased from Extrasynthase (Genay, France). Methanol (LCMS grade), acetonitrile 
(LCMS grade) and formic acid were purchased from Sigma Aldrich (Poole, UK). Water 
was purified using a Millipore, Millipore UK Ltd (Merck, UK). Tested orange juices 
were purchased from Morrisons, Tesco, Waitrose, Leeds, UK. Information on citrus 
products is shown in Table 3.1. Buxton still mineral water (Buxton, UK), low in nitrate 
(<0.1 mg/L) was purchased from Tesco, Leeds, UK.  
 
Table 3.1. Analysed commercially available citrus products. 
Code Product name Product type Product labelled contents 
1 
Tropicana Orange Juice 
With Extra Juicy Bits  Blond orange juice 
100% orange juice with juicy 
bits 
    
2 
Tropicana Orange Juice 
Smooth  Blond orange juice 100% smooth orange juice 
    
3 
Morrisons Orange Juice 
with Bits  Blond orange juice 
100% orange juice from 
concentrate  
    
4 
Morrisons Orange Juice 
Smooth  Blond orange juice 
100% orange juice from 
concentrate  
    
5 
Tesco 100% Pure 
Squeezed Orange Juice 
With Bits Blond orange juice 
100% orange juice with juicy 
bits 
    
6 
Tesco 100% Pure Orange 
Juice Smooth Blond orange juice 100% smooth orange juice 
    
7 
Innocent Sicilian Blood 
Orange Juice Blood orange juice 
100% blood orange juice 
from Sicilian oranges 
    
8 
Waitrose 1 Sicilian blood 
orange juice  Blood orange juice 
100% blood orange juice 
from Sicilian oranges 
    
9 
Tropicana Sanguinello 
Blood Orange Juice  Blood orange juice 100% blood orange juice 
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3.2.2 Extraction and quantification of citrus flavonoids   
3.2.2.1 Extraction of citrus flavonoids from orange juice 
Nine commercially available orange juices (Table 3.2) were analysed to determine citrus 
flavonoid content. According to the previous work by Chebrolu et al. (2011), 
optimization of extraction conditions (solvent, juice to solvent ratio, centrifuge speed and 
temperature, extraction cycles) of flavanones was conducted. The polarity of the solvent 
has a major effect on extraction: dimethyl sulfoxide (DMSO) > acetonitrile (ACN) > 
methanol (MeOH) >ethanol (EtOH). However, samples for LCMS analysis cannot be 
prepared in DMSO. ACN and MeOH were used as extraction solvents. After 
centrifugation (5 min at 5000 x g, 20°C), there were two phases in the supernatant in the 
samples extracted by ACN and this was consistent with that in the previous work by 
Chebrolu et al (2011). Therefore MeOH was selected as the solvent for extraction.  
 
Orange juice (1 ml) in triplicate was mixed with 100% MeOH (2 ml). The mixture was 
vortexed for 2 min and then centrifuged (5 min at 5000 x g, 20°C).  The supernatant was 
removed into a new tube and 2 ml of MeOH was added to the remaining pellet. The 
extraction was conducted for three times. Supernatants from three times were combined 
and vortexed. Internal standard genistein (final concentration of 5 µg/ml) was added to 
all the samples and standards and then the mixture was filtered (0.2 µM PTFE filter) prior 
to LCMS analysis.  
 
Table 3.2. Composition of tested orange juice according to the label (/100 ml). 
Product 
code  
Energy 
(kcal) 
Carbohydrates  
(g) 
Sugars (g) 
Vitamin C 
(mg) 
Fibre (g) 
1 42 8.6 8.6 34 0.8 
2 43 8.9 8.9 33 0.6 
3 42 9.2 9.2 20 0.1 
4 42 9.2 9.2 20 0.1 
5 44 10.1 8.1 30 0.1 
6 45 10 10 30 0.1 
7 47 11 9.5 42 N/A 
8 47 10.9 9.1 24 0.2 
9 52 10.4 10.4 47 0.8 
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3.2.2.2 LCMS analysis   
The method was adapted from a previous method (Sweidan, 2015). LCMS 2020 from 
Shimadzu was used for detection. Separation was carried out using a C18 Zorbax column 
(4.6 x 50 mm; internal diameter 1.8 µm, Agilent, Berkshire, UK). A gradient of water-
formic acid (solvent A; 100:0.1, v: v) and acetonitrile-formic acid (solvent B; 100:0.1, v: 
v) was applied with a total flow rate and column temperature of 0.5 ml/min and 30ºC, 
respectively. The gradient is shown in Table 3.3. Injection volume was 10 µL. The DAD 
scanned from 190 to 800 nm. In SIM and negative mode, specific detection was carried 
out at 269, 579, 609 (m/z), for detection of genistein, narirutin and hesperidin, 
respectively. Blank water samples were run in regular intervals, at the beginning, after 
the standards, between samples and at the end of the sequence. Standards of narirutin and 
hesperidin were also analysed for quantification of narirutin and hesperidin, respectively.  
 
Table 3.3. LCMS gradient. 
Time (min) % of mobile phase B 
0 5 
5 10 
20 40 
25 95 
28 95 
29 5 
33 5 
 
3.2.3 Subjects of human study 
Given that some made-from-concentrate orange juices contain added sugars whereas not-
made-from-concentrate orange juice contains naturally occurring sugars in citrus fruits, 
following determination of flavanone contents in nine orange juices, the blond not-from-
concentrate orange juice with highest flavanone content was then selected for a 
preliminary study to ascertain its acute effects on vascular function. The effects of blood 
orange juice on vascular function were investigated in Chapter 4.  
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The study was reviewed by the ethical committee of the University of Leeds Faculty of 
Mathematics and Physical Sciences and Engineering (Ethics Reference Number: MEEC 
14-028), in accordance with ethical principles of the Declaration of Helsinki of 1975 as 
revised in 2013. Subjects were recruited from the University of Leeds through word of 
mouth. Interested subjects were informed of all aspects of the study and what it involved. 
The eligibility was confirmed verbally. Potential subjects were given at least 48 h to 
consider the participation and to ask any questions.  
 
Female and male adults aged between 20 and 50 years who were generally fit and 
healthy, free from diabetes, liver, cardiac or kidney disease were recruited for the study. 
Smokers and anyone taking dietary supplement were excluded. Thirteen subjects 
provided written informed consent prior to commencement of the study. 
 
3.2.4 Experimental protocol  
Given that exercise has been reported to improve vasodilation during reactive 
hyperaemia in healthy adults (Clarkson et al., 1999), subjects were asked to stay fasted 
and restrain from exercise for 12 h before measurements in the morning. On the study 
day, participants arrived at the human study room around 9.00 am. Anthropometric 
measurements including body mass and height were performed upon arrival.  
 
As 15% of dietary nitrate is from drinking water and also exerts vascular effects (Lidder 
and Webb, 2013), participants were then asked to drink low-nitrate water (Table 3.4) (4 
ml/kg body mass). Meanwhile, the information of the study and the procedures of their 
involvement were explained to participants. Compliance with overnight fast and length 
of sleep the night before were ascertained before measurements, given that sleep has a 
significant influence on blood pressure, heart rate and sympathetic nervous system 
activity (Gangwisch et al., 2006).  
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Table 3.4. Characteristics of Buxton still natural mineral water. 
 Typical analysis (mg/L) 
Calcium 55 
Magnesium 19 
Potassium 1 
Sodium 24 
Bicarbonate 248 
Chloride 37 
Sulphate 13 
Nitrate <0.1 
Dry Residue at 180°C 280 
pH at Source 7.4 
 
After participants rested for 15 min, systolic blood pressure, diastolic blood pressure and 
heart rate were measured in triplicate by a blood pressure monitor (Omron BP760, 
Omron Healthcare UK Ltd., Milton Keynes, UK). Specifically, systolic and diastolic 
blood pressures were measured in overnight fasted subjects in a quiet, temperature-
controlled room (22°C ± 1°C), the subject was in a seated position for at least 15 min to 
reach a cardiovascular steady state prior to the measurement. The cuff was placed on the 
left upper-arm at the same level as the heart, with the blue stripe aligned with the middle 
finger. The subject was instructed not to speak during the measurement, which was 
conducted three times with 2-minute intervals. The averages of three recordings were 
calculated. 
 
The set-up of the measurement of peripheral vascular function is illustrated in Figure 3.1. 
Participants were seated in a comfortable position and instrumented to record cardiac 
electrical activity via a 3-lead ECG module (Bio-Amp, ADInstruments, Oxford, UK) 
with adhesive electrodes attached to the skin of the right shoulder, the left forearm and 
one ankle. A sphygmomanometer cuff was put on the right forearm of the participant. 
Changes in tissue blood volume, caused by the arterial pulse expanding and contracting 
the microvasculature, were detected by an infrared (at the wavelength of 950 nm) 
photoelectric sensor ( MLT-1020PPG, ADInstruments, Oxford, UK) attached to the right 
thumb by a velcro strap. Caution was taken to make the strap firm on the finger without 
restricting blood flow. The amplitude of the infrared photoelectric sensor is in proportion 
to blood volume in the capillary bed detected by the sensor. The finger pulse signal was 
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detected by a pulse transducer (TN1012/ST) using a piezo-electric element that develops 
a voltage in response to an applied force on the active surface of the transducer. Powerlab 
(4/35, ADInstruments, Oxford, UK) was used to record ECG and peripheral pulse 
amplitude. Optimal settings for the channel of ECG recording were as follows: range 2 
mV, low pass 1000 Hz (to reduce high frequency noise), mains filter on, sampling rate 
1000/s. Optimal settings of peripheral pulse amplitude via infra-red plethysmography 
were as follows: range 50 mV, AC coupling on, sampling rate 1000/s. Optimal settings 
of pulse signal recorded at the index finger were as follows: range 500 mV, low pass 
1000 Hz (to reduce high frequency noise), sampling rate 1000/s. Cardiac electrical 
activity and peripheral pulse amplitude were recorded for 10 min followed by occlusion 
of the blood flow for 5 min via inflating a sphygmomanometer cuff to 50 mm Hg above 
systolic blood pressure of the participant to occlude arterial inflow. Cardiac electrical 
activity and peripheral pulse amplitude were continuously recorded during this period 
until 10 min after the release of the blood pressure cuff. During the experiment, 
participants were spontaneously breathing.  
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Figure 3.1. Set-up for the measurement of peripheral vascular function: cardiac 
electrical activity via a 3-lead ECG, peripheral pulse amplitude via infra-red 
plethysmography attached to the right thumb and the finger pulse signal recorded 
via a pulse transducer attached to the right fourth finger (the ring finger). 
 
After the initial measurements, participants were asked to drink orange juice (Table 3.5) 
(4 ml/kg body mass) and refrain from any food for 2 h and then come back to repeat the 
measurements. 
Table 3.5. Characteristics of orange juice used for the preliminary human study.  
Typical Values 100ml contains 
Energy 186kJ (44kcal) 
Fat <0.1g 
Saturates <0.1g 
Carbohydrate 10.1g 
Sugars 8.1g 
Fibre <0.1g 
Protein 0.8g 
Salt <0.01g 
Vitamin C 30.0mg (38% of NRV) 
Information from the label of Tesco 100% pure squeezed orange juice with bits. 
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3.2.5 Data analysis  
LabChart software (LabChart 8.0, ADInstruments, Oxford, UK) was used for data 
recording and analysis. Figure 3.2 is a screenshot of cardiac electrical activity (channel 
1), peripheral pulse amplitude (channel 2), the finger pulse signal (channel 3) and 
transformed heart rate data (channel 4). It should be noted that plethysmography signals 
(channel 2) are inverted, with a higher signal representing lower light transmission due 
to increased tissue blood flow during systole.  
 
 
Figure 3.2. LabChart software (LabChart 8.0, ADInstruments) for recording and 
analysing cardiac electrical activity via a 3-lead ECG (channel 1), peripheral pulse 
amplitude detected via infra-red plethysmography (channel 2) and the finger pulse 
signal detected via a pulse transducer (channel 3). Channel 4 was transformed from 
signals in channel 1 for calculation of heart rate. Signals were shown at a scale of 
5:1.  
 
Relative flow (as A in the Figure 3.3) was calculated as the differences in the voltages 
between the foot and the peak of the pulse pressure waveform measured by an infrared 
photoelectric sensor on the thumb. As illustrated in Figure 3.3, vascular compliance was 
calculated as the ratio of the magnitude of the dicrotic notch (B) to total amplitude (A) 
(A/B *100%) from pulse pressure waveform as an indicator of vascular function 
(Chowienczyk et al., 1999). Compliance and blood flow was calculated in triplicate every 
2 min during baseline, every 10 s during the first minute after cuff deflation, every 15 s 
during the second minute and every 2 min until 10 min after cuff deflation.  
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Figure 3.3. Pulse amplitude recorded via infra-red plethysmography attached to the 
thumb. The total amplitude (A) and the dicrotic notch (B) were calculated and the 
pulse amplitude ratio of B to A *100 was calculated as vascular compliance. Mean 
compliance was made from 3 consecutive pulse waveforms.  
As shown in Figure 3.4, pulse transit time (PTT) was calculated as the time difference 
between ECG R-wave peak and the peak of pulse pressure waveform measured by a 
pulse transducer at the fingertip. Pulse wave velocity (PWV) was calculated according 
to the following formula (Davies and Struthers, 2003), with BDC as body correlation 
factor being 0.5 when calculating peripheral pulse wave at the finger for adults (Gesche 
et al., 2012):  
PWV(cm/ms) = 
BDC ×height (cm)
PTT (ms) 
 
 
Figure 3.4. Calculation of pulse transit time (PTT). A: cardiac electrical activity via 
a 3-lead ECG. B: the finger pulse signal detected via a pulse transducer. Pulse 
transit time was calculated as the time difference between the R-wave peak of ECG 
and the peak of finger pulse waveform. Mean PTT was made from 3 consecutive 
calculations. Signals were shown at a scale of 5:1. 
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As illustrated in Figure 3.5, peripheral pulse amplitude and the finger pulse signal were 
continuously recorded during baseline for 10 min, and then an occlusion of forearm blood 
flow (the experiment arm) for 5 min and recovery for 10 min. As shown in the Figure 
3.5., peripheral pulse amplitude and the finger pulse signal were negligible during 
occlusion, followed by an increase in the amplitude upon cuff deflation. In addition, 
peripheral pulse amplitude was also recorded on the contralateral arm at the beginning 
of the study, used as a control for the concurrent endothelium-independent changes in 
vascular tone. 
 
Figure 3.5. Peripheral pulse amplitude and the finger pulse signal continuously 
recorded during the experiment. A: Peripheral pulse amplitude detected via infra-
red plethysmography on the experiment hand during baseline (10 min), occlusion 
(5 min) and recovery (10 min). B: Peripheral pulse amplitude simultaneously 
detected on the contralateral arm, used as a control for the concurrence of 
endothelium-independent changes in vascular tone. C: The finger pulse signal via a 
pulse transducer simultaneously detected on the experiment hand. Signals were 
shown at a scale of 2000:1.  
 
3.2.6 Statistical analysis  
Based on previous data, at least 12 subjects were required to investigate the effect of 
orange juice on peripheral vascular function measured by plethysmography (Alsop and 
Hauton, 2016). 
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Statistical analysis was conducted using Statistical Package for the Social Sciences 
(SPSS, version 24, IBM Corporation, USA). Data were tested for normality using 
Shapiro-Wilk test. Markers before and after orange juice consumption were analysed by 
analysis of variance (ANOVA), with treatment and time as within-subject factors or two-
tailed t-tests (for blood pressure). The flavanone contents in different juices were 
analysed using one-way ANOVA, with post hoc Tukey’s test. P < 0.05 was considered 
as statistically significant. 
 
3.3 Results 
3.3.1 Citrus flavonoid content in different citrus products  
Flavanones are the predominant flavonoinds in orange varieties. Two flavanones, 
hesperidin and narirutin, were identified and quantified in the citrus products analysed. 
As shown in Figures 3.6, standard curves were constructed of pure citrus flavonoid 
compounds, for quantification of citrus flavonoids in unknown samples. Identification of 
citrus flavonoids were based on the corresponding retention times and the MS spectra of 
pure standards and spiking of selected samples with authentic standards. Genistein was 
used as an internal standard and the results indicated there was no retention time shift 
from sample to sample. Specifically, narirutin, hesperidin and genistein eluted at 12.5, 
13.3, 18.5 min, respectively (Figure 3.7).  
 
Figure 3.6. Standard curve of hesperidin (A) and narirutin (B). A: specific detection 
was carried out at 609 (m/z) at 13.3 min using LCMS for hesperidin. B: specific 
detection was carried out at 579 (m/z) at 12.5 min using LCMS for narirutin. 
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Figure 3.7. A typical LCMS chromatogram of citrus flavonoids in orange juice after 
extraction by methanol. N is narirutin, H is hesperidin and G is genistein; specific 
detection of these compounds was conducted at 12.5, 13.3, 18.5 min, at 579, 609, 269 
m/z, respectively.  
 
Nine brands of orange juice, including blond and blood orange juice, were analysed for 
their flavanone contents. After extraction by methanol, hesperidin was found to be the 
most abundant flavanone in all juice samples ranging from 60.7 ± 0.5 to 82.1 ± 2.4 
mg/100 ml in blond orange juice and ranging from 58.6 ± 3.0 to 80.2 ± 2.7 mg/100 ml in 
blood orange juice, followed by narirutin ranging from 13.0 ± 1.5 to 20.4  ± 0.7 mg/100 
ml in blond orange juice and ranging from 5.1 ± 1.2 to 9.5 ± 0.1 mg/100 ml in blood 
orange juice. As shown in Table 3.6, the concentrations of hesperidin, narirutin and total 
flavanones in the orange juice from Morrisons (both with bits and smooth from 
concentrate) were found to be the highest among all the juices tested, followed by those 
in the blood orange juice from Innocent. In contrast, hesperidin, narirutin and total 
flavanones were found to be least abundant in the blood orange juice from Waitrose. 
Regarding the impact of orange juice manufacturing process on flavanone content, 
smooth orange juices and the corresponding orange juices with bits were found to be 
comparable in hesperidin and narirutin levels. In addition, the narirutin-to-hesperidin 
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ratio for blond orange juice and blood orange juice ranged from 0.17 to 0.25 and from 
0.08 to 0.12, respectively. In addition, hesperidin contents in blond orange juice and 
blood orange juice were comparable (71.7 ± 9.8 mg/100 ml and 69.8 ± 9.6 mg/100 ml, 
respectively). In contrast, narirutin was found to be more abundant in blond orange juice 
than blood orange juice (15.5 ± 4.5 mg/100 ml and 6.8 ± 2.2 mg/100 ml, respectively). 
Furthermore, the flavanone contents of orange juices with bits and smooth were 
comparable.  
 
Table 3.6. Flavanone contents in nine commercially available brands of orange juice 
(mg/100 ml). 
Code  Product  
Hesperidin Narirutin 
Total 
flavanones 
1 Tropicana (with bits) 66.3 ± 3.1c 10.6 ± 0.7bc 76.9 ± 3.8cd 
2 Tropicana (smooth)  60.7 ± 0.5c 13.0 ± 1.5b 73.7  ± 1.3cd 
3 Morrisons (with bits)  80.6 ± 1.4ab 20.2  ± 1.4a 100.8 ± 2.0a 
4 Morrisons (smooth)  82.1 ± 2.4ab 20.4  ± 0.7a 102.5 ± 3.1a 
5 Tesco (with bits) 69.1 ± 2.6abc 12.6  ± 0.5b 81.7 ± 2.9bc 
6 Tesco (smooth)  68.4 ± 3.2abc 12.2 ± 0.9b 80.6 ± 3.4bc 
7 Innocent (blood orange juice) 80.2 ± 2.7ab 9.5 ± 0.1bc 89.7 ± 2.6abc 
8 Waitrose (blood  orange juice) 58.6 ± 3.0c 5.1 ± 1.2c 63.7 ± 2.6d 
9 Tropicana (blood orange juice) 70.7 ± 1.7bc 5.8 ± 1.5c 76.5 ± 0.4cd 
Means within the column without the same letter (a, b, c, d) are significantly different (P <0.05; one-way 
ANOVA with post hoc Tukey’s  test). 
 
3.3.2 Baseline subject characteristics 
The baseline characteristics of subjects in the present study are presented in Table 3.7. 
Thirteen healthy subjects (body mass index 25.7 ± 3.3 kg/m2, aged 22-43 y) were enrolled 
in the study,including seven premenopausal women and six men. Although male subjects 
were relatively younger than female subjects (28.3 ± 4.8 and 32.3 ± 5.4 y, respectively), 
the BMIs of both genders were similar (26.1 ± 3.1 and 25.4 ± 3.8 kg/m2, respectively). 
Moreover, the subjects were normotensive with average blood pressures of 111.9 mmHg 
(systolic) and 71.7 mmHg (diastolic). The average heart rate was 76.9 ± 12.7 bpm at 
baseline. 
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Table 3.7.  Baseline characterisation of subjects. 
 Mean ± SD Range 
Age (y) 30.5 ± 5.4 22-43 
Subjects (n) 13 M=6 / F=7 
BMI (kg/m2) 25.7 ± 3.3 20.2-31.4 
Systolic blood pressure (mm Hg) 111.9 ± 8.3 99.5-124.5 
Diastolic blood pressure (mm Hg) 71.7 ± 9.2 58.0-90.0 
Heart rate (bpm) 76.9 ± 12.7 57.7-111.0 
 
3.3.3 Effect on cardiac electrical activity and blood pressure 
Heart rate was calculated as 30 s averages every 2 min for 10 min during baseline, every 
1 min for 5 min during cuff occlusion and every 2 min for 10 min post cuff release. As 
illustrated in Figure 3.8, heart rate during occlusion significantly decreased under both 
conditions (p<0.05). No significant changes in heart rate were observed prior to and 2 h 
following orange juice consumption (p=0.25), indicating no significant alterations in the 
sympathetic nervous system tone.  
 
 
Figure 3.8. Cardiac electrical activity expressed as heart rate during baseline, cuff 
occlusion and recovery. Data represent mean ± SD (n=13). Heart rate during 
occlusion (t=12, 13 min) significantly decreased compared with baseline and 
recovery levels, in both pre and post orange juice consumption conditions (p<0.05).  
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As shown in Table 3.8, no changes were observed in diastolic blood pressure prior to and 
at 2 h following the consumption of orange juice (p=0.5) while a 3% reduction in systolic 
blood pressure was observed (p= 0.08).   
 
Table 3.8. Blood pressure prior to and at 2 h following consumption of orange juice.  
 Pre Post 
Systolic blood pressure (mm Hg) 111.9 ± 8.3 108.6 ± 9.1 
Diastolic blood pressure (mm Hg) 71.7 ± 9.2 71.4 ± 8.5 
Data are mean ± SD (n=13).   
 
3.3.4 Effect on peripheral blood flow  
As shown in Figure 3.9 relative flow during baseline slightly decreased at 2 h post orange 
juice consumption. Relative flow was negligible in the fingertip during cuff occlusion, 
followed by an increase post cuff deflation and recovery to baseline thereafter (Figure 
3.10). Specifically, relative flow significantly augmented at 40 s post cuff deflation 
compared with baseline relative flow prior to orange juice consumption.  
 
Figure 3.9. Relative flow data during baseline, calculated from peripheral pulse 
amplitude in triplicate pre and post orange juice consumption. Data represent mean 
± SD (n=13). No significant differences were observed.   
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Figure 3.10. Relative flow data post cuff deflation, calculated from peripheral pulse 
amplitude in triplicate pre and post orange juice consumption. Data represent mean 
± SD (n=13).  
 
3.3.5 Effect on vascular compliance 
Vascular compliance was measured as pulse amplitude ratio. As shown in Figure 3.11, 
no changes were observed in pulse amplitude ratios during baseline prior to and 
following orange juice. Pulse amplitude ratio was 0 during cuff occlusion and increased 
to 100% upon cuff release, followed by a gradual decrease to a plateau. Specifically, 
during the first 20 s following cuff deflation pulse amplitude ratio significantly increased 
compared with baseline level prior to orange juice consumption (Figure 3.12). Similarly, 
pulse amplitude ratio was significantly augmented during the first 20 s post cuff deflation 
compared with baseline level following orange juice consumption. In contrast, pulse 
amplitude ratio was elevated post cuff deflation following orange juice consumption 
compared with that prior to orange juice consumption.  
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Figure 3.11. Vascular compliance at baseline, expressed as mean of three 
consecutive values of pulse amplitude ratio (%) pre and post orange juice 
consumption. Data represent mean ± SD (n=13). 
 
Figure 3.12. Vascular compliance post cuff deflation, expressed as mean of three 
consecutive values of pulse amplitude ratio (%), pre and post orange juice 
consumption. Data represent mean ± SD (n=13).  
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Delta of vascular compliance during baseline and post cuff release was calculated, as 
shown in Figure 3.13 and 3.14. Although there was an increase in the mean of vascular 
compliance following orange juice consumption during baseline and post cuff release, 
no significant changes were observed (p>0.05).  
 
 
Figure 3.13. Delta of vascular compliance following orange juice consumption 
during baseline data recording. Data represent mean ± SD (n=13). 
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Figure 3.14. Delta of vascular compliance following orange juice consumption post 
cuff release. Data represent mean ± SD (n=13). 
 
3.3.6 Effects on pulse transit time and pulse wave velocity 
As illustrated in Figure 3.15, no significant differences were observed in pulse transit 
time at baseline pre and post orange juice consumption, with averages of pulse transit 
time as 256.1 ± 2.4 and 255.7 ± 2.7 ms, respectively. Given that pulse amplitude was 
negligible during cuff occlusion, pulse transit time could not be calculated. Upon cuff 
deflation, pulse transit time slightly elevated then gradually returned to baseline value 
(Figure 3.16). No significant differences were observed in pulse transit time following 
cuff deflation. 
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Figure 3.15. Pulse transit time during baseline, calculated by subtracting the ECG 
R-wave peak time from the peak time of pulse pressure waveform. Data represent 
mean ± SD (n=13). 
 
Figure 3.16. Pulse transit time post cuff deflation, calculated by subtracting the 
ECG R-wave peak time from the peak time of pulse pressure waveform. Data 
represent mean ± SD (n=13). 
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In addition, negative correlations were found between systolic blood pressure and pulse 
transit time prior to and following orange juice ingestion (r=-0.185 and r=-0.088, 
respectively). Moreover, no significant changes were observed in pulse wave velocity 
during baseline (Figure 3.17) and post cuff deflation (Figure 3.18) prior to and following 
orange juice consumption.  
 
Figure 3.17. Pulse wave velocity during baseline, calculated from height and pulse 
transit time. Data represent mean ± SD (n=13). 
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Figure 3.18. Pulse wave velocity post cuff deflation, calculated from height and 
pulse transit time. Data represent mean ± SD (n=13). 
 
3.4 Discussion 
In the present study, flavanone contents of nine commercial orange juices were 
determined. The blond not-from-concentrate orange juice with the highest flavanone 
content was then selected for a preliminary study to investigate the acute effects of 
flavanone-rich orange juice in healthy subjects on cardiac electric activity, blood 
pressure, peripheral blood flow, vascular compliance and pulse wave velocity prior to 
and at 2 h following consumption. The present study demonstrated substantial variations 
in flavanone content of commercially available orange juice, which in part might have 
contributed to the conflicting results in previous studies regarding changes in health 
outcomes following orange juice intake in an acute or chronic manner. Although 
elevation of plasma flavanone metabolites have been observed at 2-7 h following orange 
juice consumption in healthy subjects (Rendeiro et al., 2016), the present study suggested 
that flavanone-rich blond orange juice did not significantly improve cardiac electrical 
activity, blood pressure, vascular compliance, peripheral blood flow, pulse transit time 
and pulse wave velocity in an acute manner, 2 h post ingestion of juice. 
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3.4.1 Comparison of flavanone content in orange juices 
Over 60 flavonoids have been identified in citrus fruits, including 4 types of flavonoids 
(flavanones, flavonols, flavones and anthocyanins) (Benavente-García et al., 1997; 
Horowitz and Gentili, 1977). The flavonoids in citrus are usually in the form of 
glycosides, with the predominated flavonoids being flavanones (Lee et al., 1990). In 
keeping with previous studies (Aturki et al., 2004; Kawaii et al., 1999), hesperidin was 
found to be the most abundant flavonoid in orange juices analysed in the present study, 
followed by narirutin. The narirutin-to-hesperidin ratio has been proposed for quality 
control of commercial orange juice (Rouseff, 1988). The narirutin-to-hesperidin ratios of 
the studied blond and blood orange juices were in accordance with those reported in 
previous studies (Aturki et al., 2004; Rouseff, 1988). The levels of hesperidin in orange 
juice reported in the literature vary substantially, ranging from 35 to 70 mg/100 ml 
(Mears and Shenton, 1973). In the present study, flavanones were found to be slightly 
higher than those reported by Vanamala et al. (2006) ranging from 18.0 to 54.8 mg/100 
ml for hesperidin and ranging from 2.9 to 8.0 mg/100 ml for narirutin. Similarly, the 
concentrations of hesperidin and narirutin in blood orange juice were also found to be 
slightly higher than those reported by Kelebek et al. (2008) with hesperidin ranging from 
11.3 to 14.3 mg/100 ml and narirutin ranging from 2.9 to 3.3 mg/100 ml. This 
inconsistency might be due to variations in the flavanone content of the fruits, different 
techniques used to manufacture orange juice (squeezing, mild or standard pasteurisation, 
concentration and freezing), storage conditions and differences in the extraction and 
analytical methods of flavanones. Specifically, substantial variations in flavanone 
content of citrus fruits might be attributed to numerous factors: varietal variations,  
environmental and growing conditions, harvest seasons and degree of fruit maturity 
(Mears and Shenton, 1973). Differences in extraction solvent, solvent to juice ratio and 
extraction cycles are reported to result in considerable variations in flavanone extracted 
(Chebrolu et al., 2011). Specifically, the flavanone levels in the commercial orange juices 
in the present study were found to be generally higher than those reported by Sweidan 
(2015) on the same juice products including Tropicana orange juice and Morrisons 
orange juice. It should be noted there were several differences in the extraction methods: 
in the present study 100% methanol was used as the extraction solvent with a solvent-to-
juice ratio as 2:1 whereas 80% methanol was used with a solvent-to-juice ratio as 1:1 in 
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that previous study, suggesting higher concentrated methanol with a higher solvent-to-
juice was more effective in the extraction of flavanones from orange juice samples.  
 
Moreover, total flavanone content was found to be higher in made-from-concentrate 
orange juice in comparison to not-from-concentrate orange juice, in agreement with the 
foundlings of Vanamala et al. (2006). In support of this, total flavanones are reported to 
increase following concentration due to the precipitation of flavanones from the soluble 
faction (Gil-Izquierdo et al., 2002).  
  
3.4.2  Acute effect of orange juice on vascular function  
The measurement of peripheral vascular function provides important diagnostic and 
prognostic information on cardiovascular health and the risk of CVD (Brevetti et al., 
2003). In the present study, during each experiment arm, the increase in compliance upon 
cuff release validated the experiment, together with increased relative flow and 
unchanged heart rate, indicating the dilation of the blood vessel. Post juice consumption, 
heart rate, systolic blood pressure and relative flow reduced, whereas vascular 
compliance increased meanwhile pulse transit time and pulse wave velocity remained 
unchanged. The decrease in relative flow post juice consumption was consistent with a 
minor reduction in systolic blood pressure. Specifically, baseline compliance after 
drinking orange juice increased but not significantly. This increase might be due to the 
increase in insulin after drinking orange juice. Insulin has a vasodilatory role through 
induction of endothelial NO and therefore can alter vascular compliance (Cohen and 
Townsend, 2002). Notably, vascular compliance increased during reactive hyperaemia 
following orange juice consumption, with a concomitant reduction in systolic blood 
pressure, indicating protective effects in healthy subjects (Bahra et al., 2012). Although 
the increase in vascular compliance at 2 h post juice consumption was not statistically 
significant, it might still be clinically meaningful given that reduced vascular compliance 
has been associated with hypertension, atherosclerosis and diabetes mellitus (Izzo Jr and 
Shykoff, 2001; Glasser et al., 1997). It remains possible that a more pronounced increase 
in vascular compliance might be observed at a different time point or following 
prolonged consumption of orange juice.  
 
 
- 84 - 
 
  
Absolute pulse amplitude was increased after participants consumed chocolate and 
sandwich compared to that at the fasted state as control during baseline and recovery 
(Langer, 2012). In addition, it should be noted that there are several factors affecting the 
pulse wave magnitude. Vasodilation due to pharmacological factors (for example, 
nitroprusside), physiologic conditions (warming, sedation), or anaesthetic factors 
(regional sympathetic blocks) can lead to increase in waveform amplitude (Shelley, 
2007). Vasoconstriction resulting from pharmacological factors (phenylephrine, 
ephedrine) or physiologic factors (cold, surgical stress) can decrease waveform 
amplitude (Shelley, 2007). Therefore, the present study was conducted in a quiet, 
temperature-controlled room to minimise fluctuations in vascular tones.  
 
The findings regarding acute effect of orange juice on vascular function in the literature 
have been conflicting. Specifically, in the previous study by Schär et al. (2015), 
endothelial function in the microvasculature of the finger as measured by reactive 
hyperaemia-peripheral arterial tonometry (RH-PAT) (a similar technique as the present 
study), pulse wave velocity and central augmentation index as measures of central 
arterial stiffness, cardiac baroreflex sensitivity, platelet reactivity and NADPH oxidase 
gene expression were unchanged at 5 h post consumption of orange juice, compared with 
a control drink matched for vitamin C and sugars, despite elevated plasma concentrations 
of flavanone and phenolic metabolites in old men with increased cardiovascular disease 
risk. However, acute favourable effects of orange juice on vascular function in the 
postprandial state have been observed in studies using different techniques. Specifically, 
flavanone-rich juices were found to attenuate transit decline in endothelial function 
measured by flow-mediated dilation (FMD) induced by double meal high in fat, 
concomitant with increased plasma hesperetin and naringenin metabolites as well as 
plasma nitrite levels at 2 to 7 h post juice consumption in middle-aged healthy men, 
compared to a sugar-matched control drink (without vitamin C) (Rendeiro et al., 2016). 
In addition, a previous study by Morand et al. (2011) suggests that both orange juice and 
a sugar-matched control drink plus hesperidin significantly augmented postprandial 
microvascular endothelial reactivity measured by combined laser Doppler flowmetry 
(LDF) and iontophoresis, in relation to a sugar-matched control drink plus placebo, 
 
 
- 85 - 
 
assessed at baseline and 6 h post consumption in healthy overweight old men. In 
agreement with these positive effects by flavanones or flavanone-rich juice on vascular 
function observed in a postprandial state, several previous studies suggest other 
flavonoid-rich beverages have also improved endothelial function. For example, a 
previous postprandial study by Lorenz et al. (2007) demonstrates that endothelial 
function measured by FMD at 2 h post consumption of black tea rich in catechins and a 
standardised breakfast was significantly augmented in healthy postmenopausal women, 
in relation to baseline FMD, with water as a control drink. However, the improvement in 
FMD by black tea was completely inhibited by the addition of milk, probably due to the 
complexes formed between caseins in the milk and catechins in black tea, indicating the 
important influence of food matrix on vascular effects by flavonoids. Likewise, cocoa 
drink rich in flavan-3-ols significantly increased FMD in subjects with at least 1 
cardiovascular risk factor at 2 h post consumption, compared with baseline FMD whereas 
cocoa drink low in flavan-3-ols did not alter FMD (Heiss et al., 2003). Taken together, 
the disparity in previous literature pertaining to the acute impact of flavanone-rich orange 
juice might be explained by differences in participant profile (age, gender, BMI, healthy 
or at increased cardiovascular disease risk), inter-individual variations in polyphenol 
absorption and metabolism, different methods for assessment of vascular function (RH-
PAT, FMD, LDF) as the results may be subject to the sensitivity and reproducibility of 
the technique (Woo et al., 2014; Onkelinx et al., 2012; Dhindsa et al., 2008), 
measurement conducted in the fasted state or in the postprandial state, differential 
choices of the control drink (most studies matched for sugar content without equivalent 
vitamin C) and observation made at different time points.  
 
3.4.3 Comparison of different approaches for assessment of endothelial 
function  
In the literature, a variety of approaches have been used when investigation effects of 
flavonoid-rich foods/beverages on vascular function. Flow-mediated dilation was first 
introduced by Celermajer et al. (1992), using high-resolution ultrasound to examine the 
changes in diameters of the brachial and superficial femoral arteries caused by reactive 
hyperaemia following occlusion of the blood flow. It has then been widely adopted as a 
measure of endothelial function for its non-invasive manner. As reviewed in Chapter 1, 
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it is well accepted that FMD is technically challenging (Corretti et al., 2002) and the 
competence in performing FMD with good reproducibility requires substantial practice 
over several months. Furthermore, the variability in FMD is highly operator-dependent. 
In contrast, finger plethysmography used in the present study is easy to operate and 
recording of the data is operator-independent, together with a 3-lead ECG module and a 
pulse transducer, providing information on multiple outcomes such as vascular 
compliance, peripheral blood flow, cardiac electrical activity, pulse transit time and pulse 
wave velocity.  
 
Another widely used approach is RH-PAT, which can be used as an indication of atrial 
stiffness by calculation of the augmentation index (Matsui et al., 2004). In addition, 
measurements conducted on the contralateral arm can be used as a control for the 
concurrence of endothelium-independent changes in vascular tone, such as those caused 
by alterations in the autonomous nervous system tone (Hijmering et al., 2002). 
Furthermore, significant correlations have been observed between FMD and reactive 
hyperaemia index (RHI) measured by RH-PAT during the same episode of reactive 
hyperaemia, irrespective of gender and presence of cardiovascular diseases (Woo et al., 
2014; Kuvin et al., 2003). Although  RH-PAT is easier to perform and less operator-
dependent, also evaluating vascular endothelial function in a non-invasive manner, it is 
a widely held view that brachial artery FMD is a more sensitive method of assessing 
endothelial function and cardiovascular risk (Lind, 2013; Onkelinx et al., 2012). No 
changes in vascular function were observed via RH-PAT, despite potential biological 
significant concentrations of flavanone metabolites (Schär et al., 2015), highlighting the 
importance of the sensitivity of the approaches for measurement, which might in part 
explain the lack of effect in the present study.  
 
3.4.4 Conclusions 
The present study suggests substantial variations in the flavanone contents of commercial 
orange juices, which might have contributed to the conflicting results in the literature.  
The flavanone content ranges of commercial blond and blood orange juices were 
comparable. Made-from-concentrate orange juice was found to be more abundant in 
flavanones. Vascular functions were not acutely altered at 2 h following consumption of 
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a flavanone-rich orange juice in healthy subjects under the conditions investigated. 
However, it remains possible that favourable vascular effects of orange juice 
consumption can be observed using other techniques and/or after a more prolonged  
consumption.  
 
3.4.5 Limitations and future work  
Some limitations of the present study are worth noting. First, the lack of suitable control 
drink in the acute study. The effect of orange juice would become clearer if compared 
with a control drink with same sugar content to balance the influence from the sugars in 
the orange juice and therefore remove the effect from insulin on the vascular function. 
Second, the experiment time, set to 2 h in the current study, which was considered 
sufficient for this preliminary study. Changes in vascular function post juice consumption 
showed tendency for improvement in vascular function but were not significant. It 
remains possible that more pronounced changes would have been observed at other time 
points such as 5-7 h, during which the maximal plasma concentrations of flavanone 
metabolites have been observed (Manach et al., 2005). However, investigation in 
vascular function in a fasted state made it difficult to conduct measurement at 5-7 h when 
subjects need to stay fasted for longer hours. Finally, it appears that finger 
plethysmography for evaluation of endothelial function may not be sensitive enough for 
detection of small changes. Therefore, in the following Chapter 4, FMD was adopted for 
investigation regarding effects of flavanone-rich orange juice on endothelial function. In 
future studies, randomised controlled crossover intervention studies are needed to test 
the vascular effects of flavanone-rich orange juice with a control drink marched for sugar 
and vitamin C content, at various time points (0, 2, 5, 7 h) or after a long exposure 
(several weeks/months) in a more defined population regarding ethnicity, BMI, age. The 
mechanism by which flavanones modulate resultant FMD should be explored by 
determining concurrent plasma concentrations of nitrite, nitrate and nitroso species and 
correlations between FMD and these concentrations.  
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Chapter 4 Effects of blood orange juice on vascular function in 
healthy overweight/obese subjects 
4.1 Abstract 
Epidemiological studies have indicated that the consumption of citrus fruit is inversely 
associated with the risk of cardiovascular disease. Acute and chronic effects of citrus 
juice have been investigated intensively in recent years with mixed results, which might 
be due to a number of factors including body weight and health status, age and gender. 
In contrast to blond orange juice, little is known on the effects of daily consumption of 
blood orange juice on vascular function. The aim of this study therefore was to 
investigate the effects of blood orange juice consumption for 2 weeks (400 ml/day) 
compared with a control drink on vascular function and cardiovascular risk factors.  
 
Fifteen overweight/obese men and women (aged 20-45 years)  of European origin were 
enrolled in this randomized controlled crossover trial. Endothelial function (brachial 
artery flow-mediated dilation: FMD), blood pressure, anthropometric measures, lipid 
profile and hsCRP were evaluated before and after each intervention. Premenopausal 
women started the intervention on specific days of the menstrual cycle to minimise the 
fluctuations in oestrogen levels between four measurements of FMD, which were also 
monitored in serum samples. 
 
The results demonstrate a significant increase in FMD following consumption of blood 
orange juice (pre: 8.15% ± 2.92%, post: 10.16% ± 3.31%) compared with the control 
drink (pre: 8.11% ± 2.52%, post: 7.77% ± 2.43%) (time by treatment interaction: 
P=0.002). The impact of the juice on FMD did not differ with gender (p=0.922). Notably, 
this favourable effect on endothelial function was only observed in overweight subjects 
but not in obese subjects. Baseline blood pressure, lipid profile, high-sensitivity C rective 
protein (hsCRP) and endothelin 1 (ET-1) were generally within healthy ranges and were 
not affected by the intervention. Present data indicate that blood orange juice exerts 
favourable effects on endothelial function in healthy overweight men and premenopausal 
women of European origin, possibly due to the elevated NO bioavailability by flavonoids. 
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4.2 Introduction 
Numerous epidemiological studies have suggested that consumption of citrus fruit is 
inversely associated with the risk of cardiovascular diseases (CVD) (Cassidy et al., 2012; 
Knekt et al., 2002), inflammatory markers and endothelial dysfunction (Landberg et al., 
2011). There has been an increasing interest in the potential cardio-protective properties 
of flavanones in recent years. In vitro studies suggest flavanones induce endothelial nitric 
oxide synthase expression and the resultant nitric oxide (NO) production in endothelial 
cells (Rizza et al., 2011; Liu et al., 2008), and other genes associated with antioxidant 
and cytoprotective function as detailed in Chapter 2. However, randomized controlled 
trials on the chronic effect of blond orange juice (Constans et al., 2015; Asgary and 
Keshvari, 2013) and/or single compound hesperidin (Salden et al., 2016; Morand et al., 
2011) or naringin (Demonty et al., 2010; Jung et al., 2003) on cardiovascular health have 
shown mixed results. Numerous factors might have contributed to these discrepancies, 
including subject profile, inter-individual variations, compliance, use of different 
methods of analysis and controlling for confounding factors.  
 
In contrast with blond orange juice, effects of blood orange juice on cardiovascular health 
have been much less researched. Compared with blond orange juice, blood orange juice 
is reported to have higher concentrations of flavanones and hydroxycinnamic acids 
(Rapisarda et al., 1998), as well as anthocyanins which are responsible for the red colour, 
together with high amounts of vitamin C, making it a good source of bioavailable 
antioxidants (Riso et al., 2005). 
  
In terms of the subject profile of previous studies, the majority of previous studies have 
involved male subjects with increased cardiovascular risk (Constans et al., 2015; Morand 
et al., 2011) or postmenopausal women (Habauzit et al., 2015). Few studies have 
investigated the effects of polyphenol-rich food on endothelial function in 
premenopausal women and have not controlled for the confounding effect of oestrogen, 
which rendered the results questionable. Hence, little is known on the effects of citrus 
flavonoids in premenopausal women. Likewise, ethnicity has rarely been controlled for 
in previous studies. However, ethnicity-associated differences have been observed in the 
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metabolism of polyphenols (Maskarinec et al., 1998), possibly due to differences in the 
enzymes involved. For example, lactase phlorizin hydrolase (LPH) plays a pivotal role 
in the exclusive hydrolysis of some polyphenol glucosides before absorption (Day et al., 
2000). It is assumed that LPH deficiency occurs in 5% of European adults and 90% of 
African and Asian adults. In addition, dietary nitrate exerts important vascular affects 
through the nitrate-nitrite-NO pathway (Lundberg et al., 2008), mediated  partially by 
aldehyde dehydrogenase (ALDH2). Notably, there is high prevalence of ALDH2-
deficient phenotype among Asian populations (Chang et al., 2017; Thomasson et al., 
1991) whereas ALDH2 deficiency is believed to very uncommon in Caucasians 
(Brennan et al., 2004; Shibuya and Yoshida, 1988). Taken together, investigation on 
vascular effects of polyphenol-rich products in subjects across different ethnic groups 
will lead to considerable variations. Moreover, higher BMI is reported to be associated 
with a higher risk of coronary heart disease (CHD) in middle aged women after 
controlling for confounding factors such as age, smoking, menopausal status and parental 
history of CHD (Willett et al., 1995). Chronic low-level inflammation and impaired 
endothelial function have been observed in healthy obese subjects (Woo et al., 2004; 
Perticone et al., 2001). The observed endothelial dysfunction is associated with reduced 
NO bioavailability and imbalance between NO and endothelin-1 (ET-1) production 
(Caballero, 2003). Hence, overweight/obese subjects of European origin were recruited 
for the present study.  
 
In Chapter 3, acute effect of orange juice on vascular function was investigated using 
finger plethysmography. In this chapter, a more sensitive approach, flow-mediated 
dilation (FMD), was used for evaluation of endothelial function. It is assumed that a 
small FMD (as detailed in Chapter 1) is an indication of low NO bioavailability, 
associated with increased cardiovascular risk (Inaba et al., 2010). FMD, therefore, has 
been widely adopted to evaluate endothelial function. However, in previous studies 
confounding factors do not appear to be controlled for when assessing effects of citrus 
flavonoids on endothelial function using FMD. One of confounding factors is oestrogen 
in premenopausal women, based on the fact that oestrogen increases NO production in 
endothelial cells, mediated partially through oestrogen receptor-α (Muller-Delp et al., 
2003). The understanding of variations in endothelial function during the menstrual cycle 
is crucial to the study design of randomised controlled trials (RCT) investigating any 
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effects on premenopausal women and the data interpretation. Specifically, brachial artery 
FMD during late follicular phase has been documented to be significantly higher than 
that during other phases of the menstrual cycle in healthy premenopausal women 
(Adkisson et al., 2010; Williams et al., 2001), coincided with highest levels of oestradiol 
and plasma nitrite/nitrate, whereas no significant changes in FMD, oestradiol and plasma 
nitrite/nitrate were observed during early follicular phase, early luteal phase and late 
luteal phase (Adkisson et al., 2010). Therefore, controlling for menstrual cycle phase on 
the day of FMD testing in premenopausal women is imperative when investigating 
effects of other factors (such as food and exercise) on endothelial function. However, to 
our knowledge, menstrual phase on the day of FMD measurement has not been controlled 
for in previous studies investigating effects of citrus flavonoids on endothelial function 
in premenopausal women (Salden et al., 2016; Hashemi et al., 2015; Buscemi et al., 
2012). 
 
Both volunteer-related and methodology-related factors affect the reproducibility of 
brachial artery FMD (van Mil et al., 2016). More specifically, the reproducibility of FMD 
has been reported to be poorer in subjects with CVD, with larger coefficients of variation 
compared to healthy controls (van Mil et al., 2016, Craiem et al., 2007). Hypertension 
has a significant influence on the reproducibility of FMD (P < 0.001), independent of 
other factors (van Mil et al., 2016). Moreover, a meta-analysis by Witte et al. (2005) 
indicates that the association between FMD and cardiovascular risk is stronger in low-
risk individuals. In high-risk individuals, it should be noted that the brachial artery FMD 
might not reflect endothelial function accurately as the measured FMD might be distorted 
by stiffness in the arteries. In support of this, the  association between nitroglycerine-
induced dilation and cardiovascular risk is also stronger in individuals at low risk (Witte 
et al., 2005). Therefore, subjects with hypertension or CVD were excluded in the present 
study, to reduce the variability in FMD (the primary outcome of the present study), 
thereby reducing the likelihood of type I and II errors. 
 
The aim of this chapter, therefore, was to investigate the effects of flavanone-rich blood 
orange juice on endothelial function and cardiovascular risk factors in healthy 
overweight/obese men and premenopausal women of European origin.  
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4.3 Methods 
4.3.1 Subjects and study design 
The study was approved by Biological Sciences Faculty Research Ethics Committee, 
University of Leeds (Ethics Reference Number: BIOSCI 15-030), in accordance with 
ethical principles of the Declaration of Helsinki of 1975 as revised in 2013. Subjects were 
recruited through flyers, emails and a participant database with a similar subject profile 
generated through the EU funded Pathway-27 project (MEEC 15-015). Interested 
subjects were asked to contact the research team and were provided with a study 
information sheet detailing all aspects of the study and what it involved. The eligibility 
was confirmed following a short health and lifestyle questionnaire, conducted verbally 
or by email. Potential subjects were given at least 48 hours to consider the participation 
and to ask any questions.  
 
In total, 296 subjects responded to the advertisement, out of which, 272 male and female 
subjects, aged 20-60 years, were assessed for screening according to the following 
criteria: Caucasians (of European origin), generally healthy without any cardiovascular 
diseases, non-smokers, with BMI over 25 kg/m2, without use of medications or dietary 
supplements (vitamins, antioxidants), without lactose intolerance. Thirty subjects met 
these criteria however some failed to participate for the following reasons: time slots for 
the study clashed with their work, reluctance about venepuncture, and their unavailability 
to attend all four appointments. Sixteen subjects provided written informed consent prior 
to commencement of the study. One subject was excluded because of the use of 
medications during the intervention. Finally, fifteen subjects completed the study. The 
subject flow diagram is shown in Figure 4.1.  
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Figure 4.1. Flow diagram illustrating subject recruitment and study 
implementation.  
 
The aim of the present study was to evaluate the effects of daily consumption of blood 
orange juice on cardiovascular health in healthy overweight/obese subjects. For this 
purpose, the study design was a randomized, controlled, crossover trial. A simple 
randomisation was used to assign A and B to the two juices tested in the study. As a 
result, blood orange juice and orange juice drink were coded as drink A and B, 
respectively. Block randomisation was conducted to allocate drink sequences (starting 
with drink A or B) to subject codes which were assigned to subjects after enrolment. All 
the data were saved with subject codes and drink A or B so that the researchers who 
conducted sample processing and data analysis were blind to the study. Through two 2-
week periods, subjects were asked to daily consume 400 ml of drink A or B (200 ml with 
breakfast and dinner) in a randomised order, with a 1-week washout period between each 
treatment. Throughout the study, subjects were asked to maintain their lifestyle as usual, 
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including dietary routine and physical activity level. The time of each juice consumption 
was recorded by the subject in the citrus drink consumption record form which was 
returned to the researcher after 2-week consumption. During participation in the study, 
subjects were asked to maintain their dietary habits generally and refrain from high 
consumption of citrus foods and the consumption of flavonoid-rich beverages (such as 
coffee, tea, fruit juices and red wine), as suggested by other RCTs (Buscemi et al., 2012; 
Morand et al., 2011). 
 
Measurements were conducted prior to and following 2-week juice consumption. 
Subjects were instructed to stay fasted and restrain from exercise for 12 h before 
measurements in the morning. After the subject was supine and comfortable for 15 min 
to reach a cardiovascular steady state, blood pressure was measured in triplicate with 2-
minute intervals (as detailed in section 3.3.4). Endothelial function was evaluated via 
brachial artery FMD following the protocol described in detail in section 4.3.2. Each test 
for a given subject was performed at the same time of the day at the same imaged area 
of the brachial artery. Following brachial FMD measurement, venous blood samples 
(total volume: 14 ml) from antecubital vein were collected into vacutainers (Z Serum Sep 
Clot Activator tubes and K2E K2EDTA tubes, Greiner Bio-One, Austria) to produce 
serum and plasma. A urine sample (up to 50 ml) was collected at each visit. 
Anthropometric measures were also conducted before and after each intervention. 
 
Female subjects started the intervention on specific days of the menstrual cycle in order 
to avoid any measurements during the late follicular phase, thereby minimising the 
fluctuations in oestrogen levels, which were also monitored in serum samples. Regarding 
contraception for female subjects, there were three circumstances: subjects without it, 
subjects taking combined pills (oestrogen and progesterone), and subjects taking mini-
pills (progesterone-only). For those who were taking combined pills, they took the pill 
daily with a 7-day break during menses. All four appointments were arranged on the days 
when they took the combined pill, to control for confounding effect of the pill on FMD. 
For those who were taking mini-pill, as they were taking it daily without any breaks, the 
control for the experiment was the same as those without any contraceptive methods.  
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4.3.2 Assessment of brachial-artery endothelial function 
4.3.2.1 Ultrasound scan protocol 
The protocol for assessment of brachial-artery endothelial function via FMD in our lab 
(Harris et al., 2017; 2014) is in accordance with established guidelines (Thijssen et al., 
2011; Harris et al., 2010). Subjects were instructed to stay fasted and avoid exercise for 
12 h before the assessment. Examination of vascular function via duplex ultrasonography 
(Vivid E9 with XDclear, GE Healthcare, US) was conducted in the vascular laboratory 
which was quiet, dimly lit, and temperature-controlled (21±1°C) to minimise fluctuations 
in vascular tone. The subject was instructed to wear suitable clothes for the ultrasound 
scan without any restrictive clothing that might interfere with the blood flow to the arm, 
for the accurate measurement of FMD. The subject was in a supine position for 15 min 
to reach a cardiovascular steady state before extending the right arm in a comfortable 
position for the ultrasound scan of the brachial artery using a 7-MHz linear array probe 
(9L, GE Healthcare, USA). During the ultrasound examination, the subject was 
instructed to keep the examined arm as immobilised as possible. 
 
The brachial artery was examined above the antecubital fossa in the longitudinal plane 
via high resolution B-mode ultrasound to obtain the optimal image of the brachial artery 
and lumen interface. The probe was locked by a clamp to stay at the same position during 
the ultrasound scan and the clamp allowed micro movement of the probe if necessary. 
Subsequently, pulsed-wave Doppler was turned on for simultaneous acquisition of the 
brachial artery diameter and the pulsed-wave Doppler velocity signals. The insonation 
angle between the vessel orientation and the Doppler beam was kept as close to 60º as 
possible across all tests as a compromise for optimal data acquisition of B-mode 
ultrasound and pulsed-wave Doppler signals. The sample size (gate width) for detection 
of blood velocity was adjusted to be as wide as possible to cover the lumen without 
encompassing the arterial walls as recommended (Harris et al., 2010). The same sample 
size was maintained during the ultrasound scan and across repeated measures on the same 
subject.  
 
A rapid inflation and deflation pneumatic cuff was placed on the forearm distal to the 
imaged artery. Before cuff inflation, baseline image of the brachial artery was recorded 
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for 20 s with 15 images per second using a vascular imaging software (Vascular Imager, 
Medical Imaging Applications, Iowa, USA). The cuff was inflated to 220 mmHg and 
maintained at that pressure for 5 min. Post deflation image was recorded for 180 s starting 
from 30 s before cuff deflation. Figure 4.2 demonstrates the setup for brachial mediated-
dilation (FMD) measurement.  
 
 
Figure 4.2. Assessment of brachial flow-mediated dilation (FMD) with lower cuff 
placement distal to the imaged artery.  
 
4.3.2.2 Post-test analysis by software 
The brachial artery diameter and blood flow were detected off-line using Brachial 
Analyzer for Research (version 6, Medical Imaging Applications, Iowa, USA), which is 
currently considered as a reference method in FMD data analysis. This software provides 
continuous edge-detection for calculation of arterial diameter and blood flow, 
independent of investigator bias (Faita et al., 2011; Woodman et al., 2001).  
 
Automatic detection of the branchial arterial diameter relies on the change in the grey 
pixel of the image. The edge is detected by determining the part where the most 
significant change of the grey pixel intensity happens. After calibration, a region of 
interest was selected on the part of the artery with best-defined walls as shown in Figure 
4.3. Subsequently, the brachial artery diameter was automatically detected and the result 
was exported to a report (Microsoft Excel Worksheet 2013) for the calculation of FMD.  
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Figure 4.3. The image of the brachial artery with the selection of region of interest.  
 
Similarly, the blood flow analysis started with calibration and the selection of a region 
of interest which covered the pulsed-wave Doppler signals (Figure 4.4) before the 
automatic detection. The result was also exported to a report (Microsoft Excel Worksheet 
2013) for subsequent calculations.  
 
 
Figure 4.4. The image of the pulsed-wave Doppler signals with the selection of 
region of interest. 
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4.3.2.3 Calculation of FMD and shear rate 
The raw data calculated by Brachial Analyzer for Research are illustrated in Figure 4.5 
(baseline data) and Figure 4.6 (post deflation data). The average of resting brachial artery 
diameter was calculated from 300 images recorded prior to cuff inflation. 
 
Figure 4.5. Resting brachial artery diameter of a subject from the software 
(Brachial Analyzer for Research).  
 
Post deflation diameter data were smoothed by making moving averages of 3 consecutive 
diameters. The post deflation peak diameter was calculated from the maximum diameter 
of the moving averages. Absolute and relative FMD were calculated as follows: 
Absolute FMD (mm) = Peak diameter - resting diameter  
Relative FMD (%)  =
(Peak diameter – resting diameter)
Resting diameter 
× 100 
 
Figure 4.6. Analysis of brachial artery diameter of a subject recorded from 30 s 
prior to cuff deflation for 180 s, from the software (Brachial Analyzer for Research).  
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Although shear stress is the established stimulus for FMD response, accurate in vivo 
measurement of it is very difficult. As blood viscosity does not differ considerably 
between individuals or after interventions (Padilla et al., 2008), shear rate is often 
calculated as an indication of the stimulus for FMD. Velocity time integral (VTI) for 
blood flow was exported from the Brachial Analyzer for Research and the average VTI 
per second were calculated. The area under the shear rate curve (AUC) was calculated as 
(8 x VIT)/baseline diameter (Rakobowchuk et al., 2012). AUC to peak diameter was 
calculated as an indication of the stimulus for FMD as recommended (Thijssen et al., 
2011). Time to peak diameter was also calculated as the time period starting from 
deflation to the onset of the maximum diameter of the moving averages.  
 
FMD was not normalised to shear rate in this thesis as the validity of this approach is  
questionable in the literature (Thijssen et al., 2011; Atkinson et al., 2009). The accuracy 
of this approach depends on the relation between FMD and shear stress. It is only 
recommended when this relation is at least moderately strong, linear and consistent 
between subjects and groups, which is only observed in young subjects but not in other 
groups (Atkinson et al., 2009; Thijssen et al., 2009). Nonetheless, it is recommended in 
the expert-consensus guideline that shear rate should be calculated and considered as the 
stimulus for FMD; the relationship between FMD and shear rate should be investigated 
if necessary (Thijssen et al., 2011). It should also be noted that the magnitude of FMD is 
not determined by shear rate per se. Arguably, other factors like endothelial function to 
produce vasodilators in response to a given shear stress, characteristics of the vessel wall 
(Lehoux et al., 2006), function of the smooth muscles in response to vasodilators also 
contribute to the resultant FMD magnitude.  
 
4.3.2.4 Reliability and validity of brachial artery FMD measurement 
Although it has been reported that brachial artery FMD is more reproducible than other 
non-invasive techniques in evaluating endothelial function (Onkelinx et al., 2012), it is 
noteworthy that FMD is sensitive to methodology-related factors and subject-related 
factors.  
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Among methodology-related factors, the method to create shear stress has a crucial 
impact on the mechanisms of FMD. Distinct shear stress profiles created with different 
methods (reactive hyperaemia, hand warming, or infusion of vasodilator) yield varied 
mechanisms of the resultant dilation (Pyke and Tschakovsky, 2005). The duration and 
position of cuff occlusion both independently determine whether the dilation is NO-
dependent. More specifically, FMD in response to reactive hyperaemia created with the 
wrist occlusion for 5 min was significantly supressed by the infusion of the nitric oxide 
synthase (NOS) inhibitor NG-monomethyl-L-arginine (L-NMMA) whereas the dilation 
was not affected by L-NMMA after the wrist occlusion for 15 min (Mullen et al., 2001). 
Similarly, FMD response induced by reactive hyperaemia resulting from the distal 
occlusion was abolished while the response after proximal occlusion was only 
moderately attenuated (Doshi et al., 2001). Nitric oxide-dependent brachial artery FMD 
is assumed as an indication of in vivo NO bioavailability thereby reflecting vascular 
function. Hence, the distal occlusion for 5 min was adopted in the present study to create 
a reactive hyperaemia resulting in a primarily NO-dependent FMD. In addition, 
continuous measurement of brachial artery diameter across the cardiac cycle, data 
analysis using automatic edge-detection software, identifying the true peak diameter post 
deflation, and use of a probe clamp are documented to improve reproducibility (Greyling 
et al., 2016). Therefore, these methodology-related factors were controlled for according 
to the guidelines to improve the reliability of repeated FMD measurements.  
 
Regarding subject-related factors, age, hypertension and dyslipidemia were reported to 
significantly contribute to the variability of brachial artery FMD (van Mil et al., 2016). 
Even in healthy subjects, several factors still lead to variations in FMD: intake of 
polyphenols (Lekakis et al., 2005), vitamins (Title et al., 2000), caffeine (Papamichael et 
al., 2005), medications, high fat intake (Wei-Chuan et al., 2004), high sugar intake (Title 
et al., 2000), smoking (Celermajer et al., 1993), recent exercise (Clarkson et al., 1999), 
and menstrual phase (Williams et al., 2001). Moreover, FMD also demonstrates hourly 
variations (Järvisalo et al., 2006). Hence, these subject-related factors were controlled 
for when conducting FMD.  
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In order to access intra-reliability, repeated measures of FMD were conducted on 10 
healthy subjects with each individual examined during the same time of the day on two 
consecutive days. The coefficient of variation (CV; calculated as the standard deviation 
divided by the mean) of baseline brachial artery diameter was 0.4%. The CV of relative 
FMD was 6.12%, demonstrating good reproducibility. The 95% confidence interval (CI) 
for the difference in relative FMD between the means of repeated measures was -0.47% 
to 0.51%. The reproducibility of repeated FMD measures with a CV of 0-10% was 
considered as excellent in a meta-analysis study on the reproducibility of repeated FMD 
measures across different research centres worldwide (van Mil et al., 2016).  
 
4.3.3 Processing and analysis of biological samples 
Fasting blood samples were left at room temperate for 30 min to allow a clot to form. 
Serum was separated immediately following centrifugation (3000 x g for 10 min at 20°C). 
Plasma was also separated immediately following centrifugation (2000 x g for 10 min at 
4°C). Spot urine samples were centrifuged at 2000 x g at 4°C for 15 min. The supernatant 
of urine samples were filtered through a 0.22 µm CA-CN syringe filter  (Gilson Scientific 
Ltd, Bedfordshire, UK). Thereafter, aliquots of serum, plasma and urine samples were 
stored at -80°C prior to analysis.  Plasma ET-1 was analysed using QuantiGlo ELISA 
from R&D Systems (Abingdon, UK). Urine samples of 1 ml were freezed drid for future 
analysis of creatinine and metabolites of citrus flavonoids.  
 
Serum samples were sent to Research and Development (Blood Sciences, Leeds General 
Infirmary) for analysis of lipid profile, high sensitivity C-reactive protein (hsCRP) and 
oestradiol. Total cholesterol, HDL cholesterol (HDL-chol), triglycerides (TG) were 
measured by enzymatic assays (Siemens Healthcare Diagnostics Inc., Erlangen, 
Germany). Concentrations of LDL cholesterol (LDL-chol) were calculated with the 
Friedewald equation where all concentrations were in mmol/L ([LDL-chol] = [Total chol] 
- [HDL-chol] - ([TG]/2.2)). Inflammatory marker hsCRP was analysed using ADVIA 
Chemistry XPT System (Siemens Healthcare Diagnostics Inc., Erlangen, Germany). 
Oestradiol was measured using an immunoassay (Siemens Healthcare Diagnostics Inc., 
Erlangen, Germany).  
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4.3.4 Test drinks 
Three brands of blood orange juice are commercially available in the UK: Tropicana, 
Innocent and Waitrose. The flavanone content of these samples were analysed by LCMS 
(as detailed in section 3.3.2) and the juice with highest concentrations of flavanones was 
selected for the present study. Orange juice drink (Capri-Sun Orange Juice Drinks) with 
similar carbohydrate content was selected as the control drink and the flavanone content 
was also analysed by LCMS. The composition of test drinks are shown in Table 4.1. The 
juice for 2-week consumption was provided to each subject prior to the intervention and 
stored in their home refrigerators until consumption. 
 
Table 4.1. Composition of test drinks used in the human intervention study. 
 Innocent Capri-Sun 
Drink volume (ml/day) 400 400 
Energy (kcal) 188 164 
Carbohydrate (g) 44 40 
Sugar (g) 38 40 
Hesperidin (mg) 320.9a 25.1b 
Narirutin (mg) 38a 3.9b 
Different letters indicate significant differences in hesperidin and narirutin contents of test drinks 
(p<0.05). 
 
4.3.5 Statistical analysis 
To detect a 2.0 unit increase in %FMD (the primary outcome of the present study), 
assuming a standard deviation of 2.0 (based on reliability data), with 80% power and at 
the 5% significance level, a total sample size of 10 subjects was required to complete a 
two-treatment crossover study.  
 
Data are presented as mean ± standard deviation. Statistical analysis was conducted using 
Statistical Package for the Social Sciences (SPSS, version 24, IBM Corporation, USA). 
Data were tested for normality using Shapiro-Wilk test. Data at the end of each treatment 
were analysed using a linear mixed model for crossover trials, with age, BMI, baseline 
values as covariates, subjects nested within treatment sequence as the random effect, and 
gender, dietary treatment, treatment sequence, experimental period, the interaction 
between treatment and experimental period as fixed effects. The flavanone contents in 
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different juices were analysed using one-way ANOVA. Significance was defined at p < 
0.05. Pearson’s correlation analyses were conducted.  
4.4 Results 
4.4.1 Characteristics of test drinks 
Quantification of flavanone composition is detailed in Chapter 3. Hesperidin and 
narirutin were found to be the major flavanones in the blood orange juices analysed. The 
flavanone compositions of the three commercially available blood orange juices are 
displayed in Table 4.2. Hesperidin, narirutin and total flavanones in the blood orange 
juice from Innocent were significantly higher compared with the other two brands. 
Therefore, blood orange juice from Innocent was selected for the present study.  
Table 4.2. Flavanone contents in three commercial available brands of blood 
orange juice  (mg/100 ml). Data are mean ± SD (n=3). 
 Hesperidin Narirutin Total flavanones 
Innocent 80.2 ± 2.7a 9.5 ± 0.1a 89.7 ± 2.6a 
Waitrose 58.6 ± 3.0c 5.1 ± 1.2b 63.7 ± 2.6c 
Tropicana 70.7 ± 1.7b 5.8 ± 1.5b 76.5 ± 0.4b 
Means within the column without the same letter (a, b, c) are significantly different (P <0.05; one-way 
ANOVA with Tukey’s test). 
 
Compared with the flavanones in the blood orange juice (drink A), those in the orange 
juice drink (drink B) were negligible (Figure 4.7). Regarding intervention compliance, 
only two subjects missed drinking juice once during the 2-week consumption and all the 
other thirteen subjects kept drinking juice twice per day during two 2-week periods, 
according to the citrus drink consumption record forms.  
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Figure 4.7. LCMS chromatogram of citrus flavonoids extracted from blood orange 
juice (drink A) and orange juice drink (drink B). N is narirutin, H is hesperidin and 
G is internal standard genistein.   
 
4.4.2 Baseline subject characteristics 
The baseline clinical characteristics of subjects in the present study are summarised in 
Table 4.3. Fifteen overweight (body mass index 28.3 ± 3.1 kg/m2) subjects (aged 20-45 
y) were enrolled in the study, with ten premenopausal women and five men. The 
premenopausal women were relatively younger than the men (26.7± 4.7 y and 32.8 ± 8.1 
y, respectively), with a slightly lower BMI of 27.8 ± 2.5 kg/m2 compared with 29.3 ± 4.2 
kg/m2 of men. The subjects were normotensive with average blood pressures of 110 
mmHg over 91 mmHg. The averages of lipid profiles were generally within healthy range: 
total cholesterol < 5.2 mmol/L, HDL-cholesterol close to 1.6 mmol/L, LDL-cholesterol 
< 3.3 mmol/L, triglycerides < 1.7 mmol/L. The average of inflammatory marker hsCRP 
was < 3 mg/L, indicating low levels of inflammation in the studied subjects. Taken 
together, the subjects were generally healthy and at low risk of cardiovascular diseases. 
 
 
- 105 - 
 
Table 4.3. Baseline clinical characteristics of the study population (n = 15, F= 10, M 
=5). 
 Mean ± SD Range 
Age (y) 28.7 ± 6.5 20-45 
BMI (kg/m2) 28.3 ± 3.1 25.5-36.5 
Systolic blood pressure (mmHg) 110.0 ± 12.9 91.0-128.7 
Diastolic blood pressure (mmHg) 71.9 ± 9.5 59.3-92.3 
Total cholesterol (mmol/L) 4.7 ± 0.6 4.0-5.8 
HDL-cholesterol (mmol/L) 1.5 ± 0.5 0.8-2.1 
LDL-cholesterol (mmol/L) 2.6 ± 0.4 2.1-3.2 
Triglycerides (mmol/L) 1.3 ± 0.6 0.5-2.8 
hsCRP (mg/L) 0.9 ± 0.9 0.2-3.4 
 
No changes in diet and lifestyle to change weight were confirmed at each visit. Data from 
self-reported food records were imcomplete and not robust due to unclear portion sizes 
and poor compliance in recording, therefore are not shown. However,  as shown in Table 
4.4 unchanged body weight throughout the study may indicate there were no major 
changes in the diet and lifestyle. 
Table 4.4. Body weight pre and post 2-week consumption of blood orange juice  (A) 
and orange juice drink (B) in a randomised order (n=15). 
 PREA POSTA PREB POSTB 
Body weight (kg)  83.91 ± 9.53 84.21 ± 9.62 84.70 ± 9.45 84.34 ± 9.68 
 
4.4.3 Effects on brachial-artery endothelial function  
Individual variations were observed in baseline brachial artery diameter between 
subjects, ranging from 2.91 mm to 4.71 mm. Distinct differences in baseline brachial 
artery FMD were observed between subjects (4.14%-14.78%), as illustrated in Figure 
4.8. Baseline brachial artery FMD was significantly inversely associated with resting 
brachial artery diameter (r=-0.538, p=0.039). 
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Figure 4.8. The scatterplot of baseline brachial artery diameter (mm) and baseline 
brachial FMD (%) prior to any treatment (n=15).  
 
Resting brachial artery diameter did not change following the consumption of either juice, 
indicating no structural changes of the brachial artery (Table 4.5). The baseline brachial 
artery FMD values before the consumption of blood orange juice and orange juice drink 
were similar (8.15 ± 2.92% and 8.11 ± 2.52%, respectively), which may indicate good 
control of the experiment and no carryover effects.  
 
 
 
 
 
 
 
 
 
 
r=-0.538 
p=0.039 
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Table 4.5. Brachial artery endothelial function and endothelin 1 (ET-1) (mean ± 
SD) pre and post 2-week consumption of blood orange juice (A) and orange juice 
drink (B) in a randomised order. 
  PREA POSTA PREB POSTB 
Baseline 
diameter (mm) 
3.62 ± 0.56 3.64 ± 0.54 3.63 ± 0.57 3.62 ± 0.56 
AUCpeak 
(a.u.) 
55441.37 ± 57299.51 ± 57430.87 ±  56627.79 ± 
19120.73 22266.82 27386.07  21020.8 
Absolute FMD 
(mm) 
0.29 ± 0.08b  0.36 ± 0.09a 0.29 ± 0.07b 0.27 ± 0.07b 
Relative FMD 
(%) 
8.15 ± 2.92b 10.16 ± 3.31a 8.11 ± 2.52b 7.77 ± 2.43b 
Time to peak 
diameter (s) 
47.62 ± 13.55 47.48 ± 14.76 47.51 ± 17.05 46.52 ± 17.66 
ET-1 (pg/ml) 1.08 ± 0.18 1.05 ± 0.27 1.15 ± 0.22 1.09 ± 0.29 
Means within the row without the same letter (a, b) are significantly different (P <0.05): absolute and 
relative FMD significantly increased post 2-week consumption of drink A. All n=15 except for ET-1 
(n=10).  
 
The absolute FMD increased significantly after 2-week consumption of blood orange 
juice from 0.29 ± 0.08 mm to 0.36 ± 0.09 mm (time by treatment interaction: p=0.001) 
whereas no changes were observed after the consumption of orange juice drink (pre and 
post as 0.28 ± 0.07 mm and 0.27 ± 0.07 mm, respectively). Similarly, the relative FMD 
significantly increased from 8.15 ± 2.92% to 10.16 ± 3.31% after the consumption of 
blood orange juice with a significant time effect (p=0.017) and a significant treatment 
effect (p=0.001), while there were no changes after the consumption of orange juice drink 
(pre and post as 8.11 ± 2.52% and 7.77 ± 2.43%, respectively), as illustrated in Figure 
4.9. There were significant time by treatment interactions in both absolute and relative 
FMD (p=0.001 and p=0.002, respectively). The individual baseline relative FMD also 
had a significant effect on the relative FMD following the juice consumption (p<0.001).  
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Figure 4.9. Brachial artery relative FMD pre and post of 2-week consumption of 
blood orange juice (A) and orange juice drink (B) in a randomised order (n=15). 
Data are mean with SD. *indicates significant differences between pre and post 
consumption of blood orange juice (p<0.05).  
 
Notably, the increase in %FMD after blood orange juice consumption was found to be 
moderately inversely correlated with baseline brachial artery diameter (r=-0.309, 
p=0.263) (Figure 4.10). 
 
Figure 4.10. The change in relative FMD (%) after 2-week consumption of blood 
orange juice (A) and orange juice drink (B) in relation to baseline brachial 
diameter.  
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No significant changes were observed in the area under the shear rate curve to peak 
dilation (AUCpeak) as the occlusion to create reactive hyperaemia was controlled to 
remain the same throughout the study. However, a strong and significant correlation 
between AUCpeak and absolute FMD was only found after 2-week consumption of 
blood orange juice (r=0.603, p=0.017) whereas the correlations were weak and not 
significant before the consumption of blood orange juice (r=0.13, p=0.658), before the 
consumption of orange juice drink (r=0.229, p=0.411) and after the consumption of 
orange juice drink (r=0.259, p=0.352). Similarly, the correlation between AUCpeak and 
relative FMD was also strong and significant (r=0.626, p=0.013) while no significant 
correlations were found before the consumption of blood orange juice (r=0.273, p=0.345), 
before the consumption of orange juice drink (r=0.406, p=0.133) and after the 
consumption of orange juice drink (r=0.361, p=0.186). Taken together, it may suggest 
that the brachial artery responded better to the same stimulus after 2-week consumption 
of blood orange juice, indicating improved endothelial function. There were no 
significant changes in time from cuff deflation to peak diameter (p>0.05). Additionally, 
vasoconstrictor ET 1 did not change by the intervention as shown in Table 4.5.  
 
It is a widely held view that FMD is gender and age specific. Therefore, in the statistical 
analysis, the primary outcome of this study, %FMD was adjusted for age and gender. 
Age range of the subjects recruited in this study was controlled to minimise the 
confounding effect of age, in order to investigate the effect of blood orange juice. As a 
result, the statistical analysis showed that the effect of age on relative FMD (the primary 
outcome) in this study was not significant (p=0.619). The effect of the juices did not 
differ with gender in this study (p=0.922), indicating premenopausal women responded 
similarly to the juices as men.  
 
Interestingly, favourable effects of blood orange juice on endothelial function were only 
observed in overweight subjects (n=12) (relative FMD before and following blood 
orange juice consumption as 7.99% ± 3.23% and 10.49% ± 3.64%, respectively). In 
contrast, no changes were observed in obese subjects (n=3) following blood orange juice 
consumption (pre and post as 8.82% ± 1.29%, 8.84% ± 0.95%, respectively) (time by 
treatment interaction: p=0.278). Notably, there was a moderate inverse correlation 
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between BMI of the subjects and changes in relative FMD following 2-week 
consumption of blood orange juice (r=-0.416, p=0.123) (Figure 4.11 A). Likewise, 
changes in relative FMD following 2-week consumption of the control drink were 
inversely correlated with BMI of the subjects (r=-0.448, p=0.094) (Figure 4.11 B). Taken 
together, this may indicate that beneficial effects from blood orange juice consumption 
on endothelial function decreased with an increase in BMI.  
 
 
Figure 4.11. Delta of %FMD following 2-week consumption of blood orange juice 
(A) and the control drink (B) in relation to BMI of subjects.  
 
In addition, the effect of habitual consumption of citrus products on relative FMD 
changes after juice consumption was not significant (p=0.68).  
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4.4.4 Menstrual phase control 
No significant changes in endogenous oestradiol levels in premenopausal women were 
observed during the present study (p > 0.05) (Table 4.6).  
Table 4.6. Oestradiol in premenopausal women pre and post of 2-week 
consumption of blood orange juice (A) and orange juice drink (B) in a randomised 
order (n=8). 
 PREA POSTA PREB POSTB 
Oestradiol 
(pmol/L) 
326.50 ± 
269.95 
276.25 ± 
254.03 
266.50 ± 
164.89 
288.00 ± 
213.84 
 
4.4.5 Effect on blood pressure 
Systolic blood pressure and diastolic pressure did not change after either blood orange 
juice consumption or orange juice drink consumption, as shown in Table 4.7.  
Table 4.7. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) pre 
and post of 2-week consumption of blood orange juice (A) and orange juice drink 
(B) in a randomised order (n=15). 
 PREA POSTA PREB POSTB 
SBP (mmHg) 108.4 ± 11.5 108.0 ± 10.6 108.4 ± 11.3 107.9 ± 10.7 
DBP (mmHg) 70.9 ± 7.5 69.2 ± 7.3 71.6 ± 8.6 69.5 ± 8.1 
 
4.4.6 Effects on lipid profile and inflammation 
There were no significant changes in total cholesterol, HDL cholesterol, LDL cholesterol 
and hsCRP (p >0.05) (Table 4.8). It should be noted that these variables were generally 
within healthy ranges at baseline.  
Table 4.8. Lipid profile and hsCRP pre and post 2-week consumption of blood 
orange juice (A) and orange juice drink (B) in a randomised order (n=12). 
 
 PREA POSTA PREB POSTB 
Total cholesterol (mmol/L) 4.63 ± 0.6 4.68 ± 0.56 4.55 ± 0.57 4.54 ± 0.77 
HDL-c (mmol/L ) 1.53 ± 0.49 1.57 ± 0.57 1.59 ± 0.57 1.50 ± 0.49 
LDL-c (mmol/L) 2.62 ± 0.39 2.60 ± 0.23 2.39 ± 0.46 2.46 ± 0.46 
Triglycerides (mmol/L) 1.23 ± 0.77 1.28 ± 0.61 1.38 ± 0.68 1.28 ± 0.61 
hsCRP (mg/L)  0.59 ± 0.29 0.58 ± 0.35 0.87 ± 0.82 1.14 ± 1.47 
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4.5 Discussion 
Little is known regarding effects of blood orange juice on endothelial function in the 
literature. To our knowledge, the crossover study by Buscemi et al. (2012) is the only 
currently published study to investigate how blood orange juice consumption affects 
endothelial function as measured by FMD. This previous study demonstrated that 
consumption of blood orange juice for 1 week resulted in a significant increase in 
brachial artery FMD and a decrease in inflammatory markers (C-reactive protein, IL-6 
and TNF-α) in subjects with augmented cardiovascular risk (Buscemi et al., 2012). 
Noteworthy, there are several drawbacks in this study. First, baseline FMD was only 
measured once in this cross-over study, prior to any treatment. The lack of a second 
baseline FMD measurement before second juice consumption period, together with a 
relatively short period (3 days) as wash-out, may have resulted in poor control of the 
study. Hence, carry-over effects could not be ruled out and the drinking sequence might 
have had an effect on the outcome of this study. Second, subjects enrolled in this study 
were aged 19-67 years old across both genders. There was no control for the confounding 
effect of oestrogen in premenopausal women on the day of FMD measurement, therefore, 
naturally occurring variations in oestrogen in premenopausal women during the 17-day 
intervention may have contributed to the changes in FMD observed in the study. Exactly 
how much of the increase in FMD was related to cardio-protective properties of blood 
orange juice, therefore, is difficult to ascertain in this study. Taken together, caution 
should be warranted when interpreting these results.   
 
Evidence from previous clinical studies regarding effects of polyphenols on endothelial 
function in healthy subjects is inconclusive, which might be caused by insufficient 
control of confounding factors like oestrogen and ethnicity. The present study is the first 
study to take those factors into study design that showed significantly improved 
endothelial function in healthy subjects. The main finding were as follows: 2-week 
consumption of flavanone-rich blood orange juice significantly improved brachial artery 
FMD, thereby suggesting improved endothelial function, in both men and 
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premenopausal women; blood pressure, lipid profile and hsCRP were generally within 
healthy ranges and not affected by the intervention.  
 
4.5.1 Flavanone content 
In agreement with previous studies, hesperidin and narirutin were found to be the major 
flavonoids in orange juice (Vanamala et al., 2006; Mouly et al., 1998). The daily 
consumption of 358.9 mg total flavanones was ingested from 400 ml of blood orange 
juice. Extensive analysis of biological samples for the quantification of flavanone 
metabolites and gut-derived phenolic compounds was beyond the scope of the present 
study. Although the recovery of flavanones was not determined in the present study, the 
findings of Pereira-Caro et al. (2014) suggest that hesperidin and narirutin from orange 
juice are highly bioavailable, when their metabolites and catabolites are both taken into 
account, with a recovery of over 37% of intake (nearly 100% with hippuric acid taken 
into calculation). Similarly, anthocyanins from orange juice have been reported to be 
more bioavailable with a recovery of 44% when taking into consideration metabolites 
and catabolites in feces (Ferrars et al., 2014; Czank et al., 2013).  
 
4.5.2 Modulation of endothelial function by flavanones 
The baseline brachial artery FMD values prior to any treatment observed in the present 
study are in agreement with other values that have been reported in the literature. A 5-
minute ischemia distal to the examined brachial artery by high-resolution ultrasound is 
associated with 7.3% ± 3.2% FMD response in healthy adults (Thijssen et al., 2008). 
Baseline brachial artery FMD was significantly inversely associated with baseline 
brachial artery diameter (r= -0.538, p = 0.039) in the present study, in accord with earlier 
research by Celermajer et al. (1992) demonstrating a significant inverse association 
between the dilation of brachial artery in response to flow increases and baseline artery 
diameter in healthy subjects.  
 
Substantial variability in shear rate has been reported between individuals (Pyke and 
Tschakovsky, 2005). Reporting shear rate data and investigating their relationship 
with %FMD are crucial for accurate interpretation of %FMD and understanding the 
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mechanisms by which the dilation is elicited, as recommended in the guideline of 
accurate assessment of FMD (Thijssen et al., 2011). However, little is known on the shear 
rate in a food consumption intervention whereas only %FMD has been reported in the 
literature. The present study demonstrated that daily consumption of blood orange juice 
for 2 weeks resulted in a significant increase in brachial artery FMD while shear rate 
remained unchanged during the study, indicating the increase in FMD was not due to 
changes in shear rate. Moreover, strong and significant correlations between shear rate 
and FMD (both absolute and relative) were only found after blood orange juice 
consumption. In support of these findings, a significant correlation was only observed in 
younger adults (27±6 y), but not in older adults (58±4 y) (Thijssen et al., 2009), which 
may indicate a better preserved endothelial function in younger adults and progressive 
loss of endothelial function in the aging process. Taken together, consumption of blood 
orange juice may have contributed to improved endothelial function, thus more dilation 
was induced in response to unchanged shear rate. Furthermore, another novel finding of 
the current study is the differential responses of endothelial function to flavonoid-rich 
food consumption, depending on BMI of the subjects, which to our knowledge, have not 
been reported in previous studies. However, given the small sample size of the present 
study, caution should be taken when interpreting those data regarding the effects on obese 
subjects, which need to be confirmed in future larger cohorts.  
 
The confounding effect of oestrogen was controlled for in the present study resulting in 
no significant changes in the oestradiol levels in premenopausal women on the day of 
FMD measurement (before and after either juice consumption). Therefore, the increase 
in FMD after blood orange juice consumption was not due to changes in oestradiol levels.  
 
Given that vasoconstrictor ET-1 was not altered by the intervention, the significant 
increase in brachial artery FMD following blood orange juice daily consumption could 
be attributed to elevated vascular relaxation by high concentrations of flavonoids present 
in the juice. This favourable effect of blood orange juice on endothelial function accords 
with our previous in vitro study (Chapter 2), which showed that flavanones positively 
modulated gene expression relevant to NO production and antioxidant status in human 
endothelial cells. In support of these findings, consumption of blood orange juice for 21 
 
 
- 115 - 
 
days (600 ml/day) significantly increased plasma antioxidant concentrations (Riso et al., 
2005). Consumption of blackcurrant juice rich in polyphenols and vitamin C for 6 weeks 
(250 ml, 4 times per day) also resulted in significant increase in FMD in healthy adults 
(Khan et al., 2014).  
 
In contrast, a randomised parallel study by Salden et al. (2016) did not show any 
significant changes in FMD in healthy overweight individuals (aged 54±15 y, 50% 
female) after 6-week consumption of hesperidin 2S extract derived from citrus sinesis 
peel. It is noteworthy that the confounding effect of oestrogen in premenopausal women 
was not controlled for in this previous study. Whereas in a randomised crossover study 
by Rizza et al. (2011), 3-week consumption of hesperidin resulted in a significant 
increase in FMD from 8.24±0.88% to 10.26±1.19% (both mean ± SEM), to a similar 
extent as  the present study, but in subjects (aged 52±2 y) with metabolic syndrome. It 
should be noted that in this previous study, it was unlikely there was a confounding effect 
of oestrogen on the results given the age range of subjects. Other factors might have also 
contributed to the discrepancy between these two studies, including different subject 
profile, inter-individual variations, compliance and co-ingestion of food.  
 
Although the effect of age on %FMD was not significant in this study, it should be noted 
that there is a decline in %FMD in aging process: in healthy men, FMD is preserved until 
40 years of age before a gradual decline, compared with a steeper decline in healthy 
women after early 50s, as a result of aging-associated progressive endothelial 
dysfunction (Celermajer et al., 1994). Healthy subjects with relatively preserved brachial 
artery FMD were selected for this study. Time from cuff deflation to peak diameter was 
not affected by treatment in the present study, as this variable is more associated with 
age (Black et al., 2008), with an increase in aging process.  
 
Regarding the effects of flavonoid-rich food on endothelial function, a systematic review 
of RCTs demonstrated that consumption of flavonoid-rich products resulted in an 
increase in %FMD both acutely (2.33%) and chronically (0.73%), with a greater 
magnitude of %FMD increase in an acute manner (Kay et al., 2012). However, studies 
on flavanone-rich food were not covered in this systematic review due to lack of clinical 
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data on flavanone-rich food. Caution should be taken when interpreting the acute 
increase in %FMD after flavonoid-rich food consumption, as %FMD is not measured in 
a fasted state and therefore may not reflect changes in endothelial function truthfully. 
FMD as a measure of endothelial function should be measured in a fasted state, according 
to established guidelines for accurate assessment of FMD (Thijssen et al., 2011; Harris 
et al., 2010; Corretti et al., 2002).  
 
4.5.3 Modulation of blood pressure by flavanones 
Previous human clinical data have shown that chronic consumption of citrus juice 
(Asgary and Keshvari, 2013; Reshef et al., 2005) or hesperidin (Morand et al., 2011) 
result in a reduced blood pressure but this is not evidenced by other studies (Habauzit et 
al., 2015; Rizza et al., 2011). No significant changes in blood pressure were observed in 
the present study. A reduction in blood pressure after consumption of blood orange juice 
was not expected in the present study, given the baseline blood pressure values were 
relatively low (110.0 ± 12.9 mmHg systolic and 71.9 ± 9.5 mmHg diastolic).  
 
4.5.4 Modulation of lipid and inflammation by flavanones 
Plasma lipid concentrations are conventional cardiovascular risk factors. High-sensitivity 
CRP (hsCRP) as the prototypic marker of inflammation is often used as an independent 
risk marker for prediction of future cardiovascular diseases (Ridker et al., 2001). Chronic 
effects of flavanones from citrus juice or extract on these markers have been 
controversial in the literature, probably due to different compositions of juice or extract 
and differences in baseline levels of lipid and inflammation in the subjects. Specifically, 
effects of 500 ml daily consumption of blood orange juice for a longer term (12 weeks) 
moderately reduced total cholesterol and LDL cholesterol in healthy overweight or obese 
women whereas the effects on inflammatory markers varied according to grade of obesity, 
favourable effects only observed in subjects with BMI lower than 30 kg/m2 (Azzini et 
al., 2017). Similarly, in the present study favourable effects of blood orange juice 
consumption on relative FMD were also only observed in overweight subjects, with an 
absence of an effect in obese subjects. However, given the small sample size of the 
present study, further investigation on more subjects is needed. Taken together, it may 
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suggest cardiovascular protective effects of blood orange juice are more likely to occur 
in normal-weight and overweight subjects, but not in obese subjects.  
In agreement with these findings, a randomised parallel study by Dallas et al. (2014) 
demonstrated that consumption of blood orange derived extract for 12 weeks resulted in 
a reduction in inflammatory markers and oxidative stress in healthy overweight subjects. 
In contrast, a randomised parallel study suggested that 12-week consumption of orange 
juice (250 ml/day) in subjects with increased CVD risk resulted in a reduction in 
triacylglycerol concentrations in subjects with highest initial levels while lipid profile 
and inflammatory markers were not affected (Simpson et al., 2016). In contrast, chronic 
favourable effects on lipid profile and inflammation biomarkers were observed in normal 
weight and overweight subjects after daily consumption of 750 ml of orange juice for 8 
weeks (Dourado and Cesar, 2015).  
 
4.5.5 Conclusions 
The present study is the first study to show significantly improved endothelial function 
in healthy overweight but not obese men and premenopausal women of European origin 
from daily consumption of blood orange juice, compared to an orange juice drink with 
matched sugar content, with confounding effect of oestrogen levels controlled for. The 
increase in FMD was not due to a change in shear stimulus, the arterial structure, or ET-
1, indicating enhanced NO bioavailability by citrus flavonoids. This effect of blood 
orange juice did not differ with gender. Baseline blood pressure, lipid profile and 
inflammation of studied subjects were generally within healthy ranges and no changes 
were observed in the present study.  
 
Shear rate as the stimulus for FMD is crucial to the interpretation of FMD data and the 
understanding of endothelial function. However, it has rarely been discussed when 
investigating effects of polyphenols on endothelial function. In the present study, induced 
by unchanged shear rate, improved endothelial function was observed. This increase in 
FMD might be due to elevated NO bioavailability after blood orange juice consumption 
which is supported by our in vitro assay findings. 
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4.5.6 Limitations and future work 
There are several limitations to the present study. First, distinct differences in the colour 
and taste of the two juices made double-blind impossible. However, the two juices were 
coded in a randomised manner and these codes were used in all the labelling of biological 
samples and FMD data. The researchers who conducted the analysis of the biological 
samples and FMD data were blinded to which juice the subject had been consuming. In 
addition, it was considered unlikely that the outcomes of the present study (e.g., 
endothelial function, lipid profile, hsCRP) were influenced by subjects knowing which 
juice they were consuming. Second, although vitamin C content was not matched in the 
control drink, it is unlikely the observed enhancement in FMD was due to vitamin C 
present in the juice for the following reasons: clinical data suggest that doses of vitamin 
C up to 500 mg did not alter endothelial function, both acutely and chronically (Ashor et 
al., 2015) whereas vitamin C content in the blood orange juice ingested in the present 
study was only 84 mg per 200 ml consumption (168 mg daily with breakfast and dinner). 
In addition, given the short half life of vitamin C, it seems unlikely that vitamin C exerted 
any effect on the markers determined after a 12 h overnight fast. Finally, blood samples 
from three subjects were incomplete due to difficulties in venepuncture. These subjects 
were with higher BMI (29, 33, 36.5 kg/m2) compared with others enrolled in the study. 
The information on how consumption of blood orange juice modulated their lipid and 
inflammation profiles, therefore is lacking.  
 
Although the present data may encourage the consumption of blood orange juice, it 
should be noted that the favourable effects on endothelial function may not only be 
subject to the composition of the juice ingested (high or low contents of flavonoids, fibre 
and sugar), but also potentially subject to age, BMI, baseline inflammation levels of 
subjects. Randomised controlled intervention studies are needed to test the effects of long 
term consumption of blood orange juice on vascular function in larger number of  
individuals, as well as in other ethnic groups.  In addition, the novel finding in the 
differential responses of endothelial function to blood orange juice consumption 
depending on the BMI of the subjects is valuable for future RCTs and warrants further 
investigation in more subjects. It would also be interesting to see if  structural vascular 
changes occur after long term consumption of flavonoid-rich foods or beverages. 
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Although functional vascular changes (indicated by %FMD) induced by polyphenols 
have been intensively investigated in recent years, structural vascular changes by 
polyphenols have not been investigated in previous studies yet are of great importance 
in better understanding the mechanisms underlying chronic consumption of a certain 
food, before recommendations for the general population can be made.  
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Chapter 5  General discussion 
5.1 Overview of thesis 
The incidence of cardiovascular disease (CVD) is not only the leading cause of death 
worldwide, but is also increasing globally, especially in developing countries (World 
Health Organisation, 2016). Consequently, CVD causes huge economic loss and 
diminishes the quality of life. As a well known modifiable factor of CVD, a healthy diet 
is highly recommended as a balanced combination of  low levels of saturated fat, salt, 
sugar as well as abundant fibre and wholegrain foods, fruits and vegetables.  
 
In recent years, there has been increasing research on flavonoids, in light of an inverse 
association between flavonoid intake and the risk of CVD suggested by numerus 
epidemiological studies (Rienks et al., 2017; Tresserra-Rimbau et al., 2016). Among 
flavonoid-rich products, citrus fruits and juices are not only prevalently consumed 
worldwide, but also have high bioavailability, the consumption of which, therefore is of 
great significance. However, the effect of citrus products are actually less researched than 
other flavonoid-rich products such as green tea, soya, cocoa and dark chocolate. 
Furthermore, epidemiological studies have suggested that higher habitual intake of 
flavanones is significantly associated with a lower risk of ischemic stroke (Cassidy et al., 
2016) in healthy men and coronary heart disease in postmenopausal women (Mink et al., 
2007).  
 
However, results from in vivo human studies are conflicting. Additionally, in vitro 
studies investigating the mechanisms by which citrus flavonoids may exert beneficial 
effects on endothelial cells are limited. Therefore, the aim of this thesis was to investigate 
effects of citrus flavonoids on cardiovascular health, with a focus on endothelial function. 
 
The present data indicate brachial artery NO-dependent FMD was significantly increased 
following 2-week consumption of blood orange juice in healthy overweight subjects of 
European origin, whereas there were no significant changes in the brachial artery 
structure, shear stimulus, oestrogen levels or vasoconstrictor ET-1 (Chapter 4), 
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suggesting a functional improvement in endothelial function, likely due to elevated NO 
bioavailability by citrus flavonoids. This is in agreement with improved vascular 
compliance following orange juice consumption (Chapter 3) as well as enhanced NO 
production and elevated mRNA levels of eNOS and antioxidant genes induced by citrus 
flavonoids (as illustrated in Figure 5.1, data from Chapter 2). It should be noted that only 
nobiletin was tested for its effect on NO production by DAF-2 assay. It remains possible 
other citrus flavonoids and their metabolites may also exert favourable effects on NO 
production. Increased NO bioavailability might be due to ROS reducing capacity by 
citrus flavonoids to preserve BH4 as well as NO induction and increased antioxidant 
status by citrus flavonoids. 
 
 
Figure 5.1. Effects of citrus flavonoids on relaxation and contraction pathways. 
eNOS, endothelial nitric oxide synthase; ET-1, endothelin 1; GCLC, gamma 
glutamyl cysteinyl synthetase; HMOX1, heme oxygenase-1; NO, nitric oxide; NOB, 
nobiletin; ROS, reactive oxygen species; TAN, tangeretin; +, significant increase; -
, significant decrease.  
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Given the key role of NO in modulating vascular tone, inhibiting inflammation and 
platelet aggregation, how citrus flavonoids regulate its synthesis therefore is of great 
interest and was investigated in Chapter 2 in EA.hy926 cells. In addition, excessive 
amounts of superoxide not only reacts with NO, reducing its bioavailability, but also 
leads to eNOS uncoupling. As a result, eNOS is switched from producing NO to 
generating superoxide, contributing to oxidative stress in endothelial cells by this vicious 
cycle as detailed in Chapter 1. Hence, the effect of citrus flavonoids on gene expression 
related to antioxidant defence and cell protection against oxidative stress is also 
important, in order to maintain normal eNOS function and therefore normal endothelial 
function. Hesperetin, naringenin, nobiletin, tangeretin were tested for their potential  in 
regulating mRNA expression of NOS3, HOMX1 and GCLC. Most abundant in citrus 
peels, the effect of nobiletin on NO production and upregulation of the expression of 
cytoprotective genes was most potent among tested citrus flavonoids in the present work. 
In support of this novel finding, a randomised controlled parallel study by Hashemi et al. 
(2015) demonstrated that endothelial function as measured by FMD in overweight and 
obese participants (6-18 y) significantly increased following consumption of extracts of 
lemon and sour orange peels. Although hesperetin and naringenin were not effective in 
upregulating eNOS, HOMX1, GCLC expression in the present study, it remains possible 
their metabolites might exert favourable effects by upregulating the expression of these 
protective genes or by other mechanisms, given that hesperidin significantly improved 
microvascular reactivity acutely (6 h) and also led to a significant reduction in diastolic 
blood pressure post 4-week consumption in healthy overweight men (50-65 y) (Morand 
et al., 2011). Specifically, there are alternative mechanisms by which citrus flavonoids 
may exert beneficial effect on cardiovascular health such as downregulation of ROS-
forming enzymes and inhibition of platelet aggregation and leukocyte adhesion, which 
have been observed with some flavonoids and warrant further investigation on 
flavanones.  
 
Since in vitro findings may not reflect in vivo conditions truthfully, the effects of 
flavanones have been actively studied in animal models, which have suggested their 
beneficial effects on endothelial function (Herrera et al., 1996), lipid profile (Cho et al., 
2011), blood pressure (Ikemura et al., 2012) and platelet reactivity (Jin et al., 2007). 
However, evidence from human in vivo studies is limited and contradictory. Hence, 
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scientific evidence demonstrating a favourable impact of dietary flavanones on 
cardiovascular health in humans has not yet been established. Therefore, the effect of 
flavanone-rich juices on cardiovascular health was investigated in an acute manner 
(Chapter 3) and post regular consumption (Chapter 4).   
 
Regarding the selection of citrus product to test in vivo effects, flavanone-rich juice was 
selected instead of citrus supplement or extract, in light of their poor bioavailability. 
Specifically, plasma concentrations of flavanone aglycones and metabolites are 
significantly increased post orange juice consumption whereas the same dose of 
flavanones in the form of supplement results in only a negligible amount of flavanone 
aglycones and metabolites in a crossover study by Schär et al. (2015). Likewise, the lack 
of bioactive effect of other flavonoid supplement has been often reported in the literature 
in RCTs whereas in the same trial flavonoids in the form of foods or beverages exert 
significant effects on same subjects (Bondonno et al., 2017; Kerimi et al., 2017), 
highlighting the importance of food matrix on absorption and metabolism of flavonoids. 
For selection of a flavanone-rich orange juice, the flavanone content of nine commercial 
orange juice, including blond and blood orange juice, were determined in Chapter 3. The 
flavanone composition of orange juice was generally in agreement with previous data: 
hesperidin and narirutin were the predominant flavanones in both blond and blood orange 
juice; higher total flavanone content was found in made-from-concentrate orange juice 
in comparison to not-from-concentrate orange juice.  
 
In the present study flavanone-rich blond orange juice did not significantly improve 
cardiac electrical activity, blood pressure, vascular compliance, peripheral blood flow, 
pulse transit time and pulse wave velocity in an acute manner, which is in agreement 
with the findings of a randomised controlled crossover study investigating acute effects 
of orange juice and hesperidin (Schär et al., 2015). However, it should be noted that the 
approaches used in these two studies (plethysmography and RH-PAT, respectively), 
although validated, are not as sensitive as FMD. Therefore, favourable effects on 
endothelial function was observed acutely (2-7 h post blond orange juice consumption) 
using FMD under the challenge of double high-fat meal (Rendeiro et al., 2016).   
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Given that the favourable effect of flavonoid-rich products on endothelial function is 
relatively small (Kay et al., 2012), a more sensitive approach might be better to detect 
this small but clinically meaningful difference post consumption. Hence, FMD was used 
for the following in vivo investigation on regular consumption of flavanone-rich 
products. A flavanone-rich blood orange juice was selected for this intervention, given 
that blood orange juice has been less studied than blond orange juice and its effect on 
cardiovascular health is largely unknown. With additional anthocyanins, there might be 
additive or synergistic activity of anthocyanins and flavanones, resulting in enhanced 
effect on outcomes of interest.  
 
One of the novelties in this study design is that only subjects of European origin were 
recruited, in light of distinct genotypes observed between different ethnic groups, which 
play a crucial role in absorption and metabolism of flavonoids (Cassidy and Minihane, 
2016). Specifically, LPH is a key enzyme in the initial hydrolysis of flavonoid glycosides 
and therefore is of great importance to the following absorption and metabolism of 
flavonoids. However, LPH deficiency is prevalent in African and Asian adults but very 
rare in European adults. Furthermore, gut microbiome also plays an important role in the 
biotransformation of not only flavonoids but also their phase I and II metabolites 
(Williamson and Clifford, 2010). Indeed, large variability in microbial-derived 
metabolite profiles has been observed between Western and Asian populations. For 
instance, it is estimated that 50-70%  of Asians can produce the microbial-derived 
metabolite equol following consumption of soya products, whereas there are only 25-
30% of equol producers in Western populations (Setchell et al., 2013). Therefore, 
investigation regarding the effect of blood orange juice on subjects of European origin, 
instead of subjects from mixed ethnic groups, narrows down the genotype-associated 
variations in the bioavailability of flavonoids, thereby reducing potential confounding 
factors in bioactivity of flavonoids and their metabolites. Another novelty in this study 
is the consideration of female hormone impact on evaluation of endothelial function by 
FMD in premenopausal women, thereby reducing confounding effects of high oestrogen 
levels on endothelial NO production.  
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In this study (Chapter 4), given that healthy overweight/obese subjects were recruited, 
their baseline endothelial function (primary outcome), blood pressure, lipid profile and 
hsCRP were generally within healthy ranges. Following 2-week regular consumption of 
blood orange juice, a significant increase was observed in endothelial function (pre: 
8.15% ± 2.92%, post: 10.16% ± 3.31%) (time by treatment interaction: P=0.002), 
whereas endothelial function did not change following consumption of the control drink 
(pre: 8.11% ± 2.52%, post: 7.77% ± 2.43%). In addition, no significant changes were 
observed in oestrogen levels and shear rate (AUCpeak), indicating the increase in FMD 
was not due to those factors. Furthermore, a strong and significant correlation between 
AUCpeak and absolute FMD was only observed post 2-week consumption of blood 
orange juice (r=0.603, p=0.017), further indicating improved endothelial function. 
Moreover, the effects of the juices on FMD did not differ with gender (p=0.922), 
suggesting premenopausal women responded similarly to blood juice and control drink 
as men. Interestingly, this favourable effect of blood orange juice on endothelial function 
was only observed in overweight subjects but not in obese subjects. Other outcomes, 
such as blood pressure, lipid profile and hsCRP, were generally within healthy ranges 
during the intervention and were not altered.  
 
5.2 Impact and implications of this thesis 
The work from this thesis investigated how selected citrus flavonoids modulated the 
expression of eNOS and cytoprotective genes in human endothelial cells to explore the 
mechanisms by which flavanones impact endothelial function, flavanone content in 
commercial orange juices, the acute effect of a flavanone-rich blond orange juice on 
vascular function in healthy subjects as well as effect of regular consumption of a 
flavanone-rich blood orange juice on endothelial function, blood pressure, lipid profile, 
inflammation in overweight/obese subjects of European origin. The in vitro and in vivo 
methods established in this thesis can be used to explore the effect of other flavonoids 
and metabolites on endothelial function. The results provide novel insights into how 
citrus flavonoids regulate endothelial function, both in vitro and in vivo, as well as other 
cardiovascular biomarkers in healthy subjects. The investigations regarding the effects 
of citrus flavonoids on cardiovascular health in this thesis, both in vitro and in vivo, were 
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conducted under healthy conditions, given that CVD can be prevented to some extent 
and prevention is better than treatment.  
 
Among citrus flavonoids tested, nobiletin was most potent at inducing NO production 
and cytoprotection as well as inhibiting vasoconstrictor ET-1 mRNA expression at higher 
concentrations. This novel finding, together with its anti-inflammatory effect (Chen et 
al., 2017) and neuroprotective effect (Zhang et al., 2016), makes it a promising 
supplement. Given that the citrus peel and seeds are abundant in numerous flavonoids, 
including narirutin, naringenin, hesperidin and nobiletin, utilisation of these by-products 
into functional supplements may be of great interest as it will not only reduce substantial 
amounts of agricultural and food by product waste, but also provide functional 
supplements from natural sources. 
 
Shear rate (AUCpeak) as the stimulus for FMD is crucial to the interpretation of FMD 
data and the understanding of endothelial function. Importantly, if shear rate is not 
carefully controlled by reactive hyperaemia created with accurate cuff occlusion, it will 
give rise to variations in the resultant FMD, which might be mistaken as a ‘functional 
change’ after an intervention (a type I error). This might to some extent account for the 
conflicting evidence in the literature. However, shear rate has rarely been calculated and 
discussed in the literature when investigating effects of polyphenols on endothelial 
function. In the present study, unchanged shear rate confirmed the increase in FMD was 
not due to increased stimulus, thereby indicating improved endothelial function. Future 
studies investigating effect of polyphenols or any given factors (for example continuous 
or interval exercise) should calculate and report shear rate, together with resting branchial 
artery diameter and FMD (absolute and relative values). Caution should be taken when 
examining FMD data, given that 1% decrease in FMD is associated with 13% increase 
in CVD risk. Therefore, associations between shear rate and FMD should also be 
explored to provide additional information on endothelial function. Furthermore, 
confounding factors such as oestrogen levels in premenopausal subjects and recent 
physical activity should be controlled and monitored when conducting FMD for 
evaluation of endothelial function, in order to examine the effect of an applied factor in 
an intervention study. This applies to any research area that involves FMD measurement.  
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With increasing understanding of flavonoid absorption and metabolism, its complexity 
has now been more recognised, due to numerous factors such as age, gender, genotype, 
gut microbiota and lifestyle. Investigations into a specific subject group might narrow 
down variations and provide information on the effect of flavonoids on this specific 
group. The recruitment of overweight/obese subjects of European origin, as performed 
in this thesis, is a good example. Controlling ethnicity in order to narrow down variations 
in genotypes is important, in light of the wide inter-individual variability observed 
between different ethic groups, probably due to distinct habitual dietary patterns and 
genetic variations. Otherwise, recruitment of subjects with mixed characteristics might 
obscure an existing effect following flavonoid intake in a responsive subgroup but not in 
others. For instance, equol has been recognised to be more bioactive than its food 
precursor daidzein. Beneficial effects of equol can only be seen in equol producers but 
not in non-producers. Therefore, future RCTs should be focused on specific subject 
groups (based on age, gender, ethnicity/genotype, BMI, CVD risk).  
 
Another novel finding of this thesis is the differential responses in endothelial function 
observed between overweight and obese subjects following blood orange juice 
consumption, again highlighting the importance of characterising subjects into specific 
subgroups. Although the sample size in the present study is small and present results 
warrant further confirmation in larger cohorts, the differential responses based on BMI 
in the present study might not be a simple coincidence, as supported by other studies 
where favourable effects in inflammatory markers were only observed in overweight 
subjects but not in obese subjects following consumption of blood orange juice for 12 
weeks (Azzini et al., 2017). The lack of favourable effects in obese subjects on 
endothelial function observed in the present study and inflammatory markers observed 
in the previous study by Azzini et al. (2017) might be explained by obesity-induced 
imbalance between the NO pathway and the vasoconstrictor ET-1 (Iantorno et al., 2014) 
as well as obesity-induced imbalance between pro-inflammatory and anti-inflammatory 
adipokines, which contributes to the development of chronic inflammation and therefore 
increases the risk of systemic metabolic dysfunction and CVD (Nakamura et al., 2014).  
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Fruit and vegetable juices contribute to five daily portions of fruit and vegetables. 
Importantly, it is recommended that daily consumption of juice should be limited to 150 
ml (National Health Service, 2015), given the lack of fiber and abundance of sugar in 
juice. The intake of free sugars should be less than 10% of total energy intake and a 
further reduction to below 5% might provide additional benefits to maintain healthy body 
weight and reduce dental caries (World Health Organization, 2015). Excessive sugar 
intake has been linked with dental caries (Peres et al., 2016), obesity (Gulati and Misra, 
2014) and type 2 diabetes mellitus (Malik et al., 2010). In the present study, subjects 
were asked to consume 200 ml of blood orange juice or a control drink with breakfast 
and with dinner (400 ml/day), which was higher than the recommendation but below the 
doses (500-1000 ml/day for 4 weeks) supplemented in some RCTs (Constans et al., 2015; 
Giordano et al., 2012; Morand et al., 2011). No adverse effects were observed in any 
outcomes measured following overnight fasting in the present study. In contrast, 
endothelial function in overweight subjects significantly improved following 2-week 
consumption of blood orange juice whereas no changes in endothelia function were 
observed in obese subjects, which might be explained by obesity-induced endothelial 
dysfunction. Furthermore, the beneficial effects of flavonoids might not outweigh the 
detrimental effects of high sugar content on obese subjects. Whether juice consumption 
could be beneficial for obese subjects still warrants future investigation in larger cohorts.   
 
Taken together, the present work will have strong potential to impact the field of 
polyphenols and health research,  in providing insight into mechanisms of action and in 
vivo evidence of the effect of flavanone-rich orange juice on cardiovascular health in a 
acute manner and following regular consumption, highlighting the importance of 
examining effect of polyphenols on specific subject groups as well as establishing in 
vitro and in vivo methods to evaluate polyphenols for their potential in improving 
cardiovascular health. Furthermore, suggestions on FMD measurement, data calculation 
and interpretation go beyond the field of polyphenols and health research and apply to 
any research area that involves FMD. 
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5.3 Limitations and future perspectives 
There are some limitations to the present work. With flavanone metabolism better 
understood in recent years, the effect of flavanone metabolites should also be examined 
on the expression of eNOS and cytoprotective genes. Plethysmography utilised in the 
acute study might not be sensitive enough for detection of small changes in vascular 
function following orange juice consumption. In addition, control drinks matched for all 
the macro- and micro-nutrients except flavanones in both in vivo studies would have been 
better to distinguish the effects of flavanones. However, having a control drink matched 
for all the macro- and micro-nutrients except flavonoids has been difficult in RCTs in 
the literature, given the availability of  facilities to manufacture such control drinks and 
the additional cost.  
 
Despite emerging evidence in absorption and metabolism of citrus flavonoids, this is still 
not fully understood. Ideally, isotopically labelled flavanones can be used for 
identification and quantification of flavanone phase II metabolites and gut-derived 
phenolic derivatives. The next step is to synthesise the major phase II metabolites and 
gut-derived phenolic derivatives at physiologically achievable concentrations to examine 
how they modulate the gene expression of eNOS, ET-1 and cytoprotective genes, as well 
as different pathways in inflammation and cytoprotection. In addition, the impact of age, 
gender, BMI and the microbiome on absorption and metabolism of flavonoids is largely 
unknown and requires further investigation in clinical studies. Furthermore, distinct  
variability in bioavailability of flavonoids from different sources (for example, orange 
juice and hesperidin supplement) has been observed. However, the mechanisms 
underlying this remain to be resolved in future studies before the consumption of 
flavonoid extract or supplement can be recommended.  
 
As discussed, long term RCTs on flavanone-rich products with macro- and micro-
nutrients matched control products are required to fully understand how flavanones 
impact endothelial function and other cardiovascular biomarkers according to subject 
profile (age, gender, BMI, ethnicity/genotype, CVD risk). Urine samples need to be 
collected for at least 24 h for quantification of metabolites and catabolites post 
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consumption. Association between the observed effects and concentrations of 
metabolites and catabolites should also be explored.  
 
Additionally, it would be interesting to see if chronic consumption of flavanones results 
in not only functional changes but also structural changes in endothelial function. The 
randomised, placebo-controlled, cross-over study  by West et al. (2014) demonstrated 
that prolonged consumption of flavonoid-rich food increases resting brachial artery 
diameter and basal blood flow. Specifically, in this previous study, baseline brachial 
artery diameter and basal blood flow significantly increased after 4-week consumption 
of dark chocolate and coca drink (total flavanols=814 mg/d) in healthy overweight and 
moderately obese subjects (BMI 25–37 kg/m2, aged 40–64 y). Notably,  peak diameter 
post cuff deflation also significantly increased following 4-week consumption of dark 
chocolate and coca drink, resulting in unchanged FMD (West et al., 2014). However, 
further studies are needed to confirm changes in resting brachial artery diameter and 
basal blood flow, induced by regular consumption of flavonoid-rich foods or beverages.  
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Appendices 
Appendix 1: Ethics approval for Chapter 3 
Performance, Governance and Operations 
Research & Innovation Service 
Charles Thackrah Building 
101 Clarendon Road 
Leeds LS2 9LJ  Tel: 0113 343 4873 
Email: ResearchEthics@leeds.ac.uk 
 
 
David Hauton 
School of Food Science and Nutrition 
University of Leeds 
Leeds, LS2 9JT 
MaPS and Engineering joint Faculty Research Ethics Committee (MEEC FREC) 
University of Leeds 
4 June 2018 
Dear David 
Title of study SUPPLEMENTS AFFECTING DAILY ACTIVITIES (The effect 
of food supplements on breathing, blood pressure and heart rate 
in daily activities) 
Ethics reference MEEC 14-028 
The above project was reviewed by the MEEC Faculty Research Ethics Committee at 
its virtual meeting of 11th May 2015. The following documentation was considered: 
 
Document    Version Date 
MEEC 14-028 Ethical_Review_Form_V3-D Hauton-Supplements & Activities-
version Ia.doc 
1 14/04/15 
MEEC 14-028 Risk assessment-Breathing altered gas mixtures-D Hauton.doc 1 14/04/15 
MEEC 14-028 Risk assessment-Supplements&Blood Collection-D Hauton.doc 1 14/04/15 
MEEC 14-028 Draft-subject recruiting poster-Supplements&Activities.pptx 1 14/04/15 
MEEC 14-028 Draft Subject Information Sheet-Diet&Activities-D Hauton.docx 1 14/04/15 
MEEC 14-028 Draft-Consent form-Supplements& Daily Activity-D Hauton.docx 1 14/04/15 
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On the basis of the information provided, the Committee requested further information/ 
clarification on the following matters before approval can be granted: 
 
 
Application 
section 
Comment Response 
required/ 
amended 
application 
required/ for 
consideration 
A9 Please could you confirm the safety of a dose of 70g per 
day of ketone esters? This seems very high. 
Response 
required 
A10 Regarding the question about naming the phlebotomist 
this is not necessary as long as a trained phlebotomist is 
used. 
For 
consideration 
Participant 
information 
sheet 
Adverse reaction to cold/ Reynaud’s should probably be 
added to the list of exclusion criteria on the participant 
information sheet (it is listed on the application).  
Amended 
participant 
information 
sheet required 
Consent form The Committee suggests adding a statement to the 
consent form asking participants to confirm they are not 
aware of having any food allergies and they do not have 
any of the conditions, on medication etc. that are listed 
on the information sheet? 
Amended 
consent form 
required 
General 
comment 
A9 is supposed to give a short summary, this was too 
long and too much detail which could have been 
summarised and included in other section  e.g. C1 and C2 
which were also overly long. 
For 
consideration 
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A response should be sent to the Committee which addresses each of these points, and 
further consideration will be given to your response. Please highlight or use a different 
colour font to indicate the changes to your application form and supporting documents.  
 
The Committee is not able to approve your application at this stage so you are unable to 
begin your research. Please do not hesitate to contact us if you have any questions. 
 
Yours sincerely 
Jennifer Blaikie 
Senior Research Ethics Administrator, Research & Innovation Service 
On behalf of Professor Gary Williamson, Chair, MEEC FREC 
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Appendix 2: Ethics approval for Chapter 4 
Research & Innovation Service 
Level 11, Worsley Building 
University of Leeds 
Leeds, LS2 9NL  
Tel: 0113 343 4873 
Email: ResearchEthics@leeds.ac.uk  
 
 
Biological Sciences Faculty Research Ethics Committee 
University of Leeds 
 
Lu Li   
PhD student  
School of Food Science and Nutrition  
University of Leeds 
LS2 9JT 
4 June 2018 
Dear Lu Li 
Title of study: The impact of citrus products on cardiovascular health 
Ethics reference: BIOSCI 15-030 amendment Nov 16 
 
I am pleased to inform you that the application for the ethical review of an amendment 
to the above project has been reviewed by the Chair of the Biological Sciences Faculty 
Research Ethics Committee and I can confirm a favourable ethical opinion on the basis 
of the information provided in the following documents: 
 
Document    Version Date 
BIOSCI 15-030 amendment Nov 16 Ethical review LL V4.doc 1 14/11/16 
BIOSCI 15-030 Amendment_form_LL .doc 1 10/11/16 
BIOSCI 15-030 flyer LL V3.pdf 1 10/11/16 
BIOSCI 15-030 info sheet LL V3.docx 1 10/11/16 
BIOSCI 15-030 consent form LL V3.doc 1 10/11/16 
BIOSCI 15-030 citrus drink consumption record form LL V1.docx 1 10/11/16 
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BIOSCI 15-030 Ethical review LL V3.doc 3 11/07/16 
BIOSCI 15-030 info sheet LL V2.docx 2 11/07/16 
BIOSCI 15-030 consent form LL V2.doc 2 11/07/16 
BIOSCI 15-030 Participant Screening Questionnaire LL V2.docx 2 11/07/16 
BIOSCI 15-030 summarry of clarifications.docx 1 11/07/16 
BIOSCI 15-030 flyer LL V1.pub 1 18/05/16 
BIOSCI 15-030 vascular assessment 2016.doc 1 18/05/16 
BIOSCI 15-030 Food frequency questionnaire LL V1.docx 1 18/05/16 
BIOSCI 15-030 food record LL V1.docx 1 18/05/16 
 
Please notify the committee if you intend to make any further amendments to the original 
research as submitted at date of this approval, including changes to recruitment 
methodology. All changes must receive ethical approval prior to implementation. The 
amendment form is available at http://ris.leeds.ac.uk/EthicsAmendment.    
 
Please note: You are expected to keep a record of all your approved documentation, as 
well as documents such as sample consent forms, and other documents relating to the 
study. This should be kept in your study file, which should be readily available for audit 
purposes. You will be given a two week notice period if your project is to be audited. 
There is a checklist listing examples of documents to be kept which is available at 
http://ris.leeds.ac.uk/EthicsAudits.  
 
We welcome feedback on your experience of the ethical review process and suggestions 
for improvement. Please email any comments to ResearchEthics@leeds.ac.uk.  
Yours sincerely 
Jennifer Blaikie 
Senior Research Ethics Administrator, Research & Innovation Service 
On behalf of Prof Edward White, Chair, BIOSCI Faculty Research Ethics Committee 
 
CC: Student supervisor(s)  
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Appendix 3: Participant information form  
 
Information for participants 
The impact of citrus products on cardiovascular health 
 
You are being invited to take part in a research study at the University of Leeds. Before 
you decide to take part, it is important that you understand the purpose of the study and 
what it will involve. Please take time to read through the following information carefully. 
If you are unclear about anything or would like more information, please feel free to ask 
us. Take time to decide whether or not you wish to take part.  
What is the purpose of the study?  
Consumption of citrus products (for example, grapefruit, orange juice and supplements) 
has been associated with benefits for cardiovascular health. The aim of the study is to 
test whether blood orange juice compared to a control drink will improve your blood 
vessel function and other health indicators (such as blood pressure and blood lipids).  
Am I suitable to take part? 
We want to study female and male adults aged between 20 and 60 years who are 
generally fit and healthy with a body mass index (the body mass divided by the square 
of the body height) over 25 kg/m2. Smokers and anyone with health problems, such as 
diabetes, liver or kidney disease will not be able to take part. Women who are pregnant 
or breastfeeding will be excluded. We will ask about your health in a short questionnaire. 
Suitable volunteers should not be taking dietary supplements (e.g. vitamins, extracts from 
plants) on a regular basis. If you are suitable based on the questionnaire, you will be 
invited to take part in the study. 
What will the study involve?  
You will be asked to consume either blood orange juice or juice drink together with 
breakfast and dinner on a daily basis for 2 weeks, and after 3-7 days you will be asked to 
consume the other drink for 2 weeks. You will be invited to the research centre on four 
separate days (altogether four visits) for the assessment of your cardiovascular health. 
For the measurement of blood vessel function, you will be lying down on your back. A 
blood pressure cuff will be put around your lower arm and inflated for 5 minutes. This is 
a standardized and safe procedure but will cause a little discomfort towards the end of 
the 5 minutes. This discomfort will disappear when the cuff is released. We will hold a 
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probe on your upper arm to assess vessel function using ultrasound (like checking an 
unborn baby in the womb).  
At the first session, we will explain the study and all procedures in detail with you. You 
will complete some questionnaires regarding your health status and diet. The 
measurement of blood vessel function will be conducted before and after 2 weeks’ 
consumption. You’ll be asked to make a tick in the Citrus Drink Record Form each time 
you consume the drink. A small blood sample (15 ml which is about a tablespoon) will 
be taken from the crook of the arm at each visit. You will be asked to provide one urine 
sample (50 ml) at each visit. Blood and urine samples will be used to analyse metabolic 
changes following citrus consumption and how they impact on cardiovascular health.  
What are the benefits and risks of taking part in the study? 
Benefits 
You will be provided with citrus drinks each for 2 weeks and your cardiovascular health 
will be examined. Your participation in this study will allow a better understanding of 
how to improve cardiovascular health through diet, which together with future studies 
may help people better prevent cardiovascular diseases in the future. In order to 
compensate for your time, you will receive a £40 voucher on completion. 
Risks  
There might be a risk of bruising and infection associated with blood collection; to 
minimize this risk, blood will be taken by a qualified phlebotomist and all blood safety 
measures will be in place. Participants who are allergic to tape or cotton wool will be 
provided with tissue and alternative tape.  
Can I withdraw from the study at any timeʔ  
Yes, you will be able to withdraw at any point before completion of the study without 
consequences. If you withdraw before you finish all the sessions, the data already 
collected will be removed from the data set, with your urine samples and blood samples 
destroyed. On completion of all the sessions, it will not be possible to exclude your data 
from the study. 
How confidential are the results? 
All personal information and results are kept strictly confidential. Once you decide to 
participate, you will be given a participant code and this code will be linked to data. 
Therefore the data will not be identifiable to researchers. Anonymized findings will be 
published in scientific journals and presented at scientific conference.  
Do I have to change my diet?  
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You will be requested to maintain your dietary habits generally but try to refrain from 
high consumption of citrus foods and the consumption of flavonoid-rich beverages 
(coffee, tea, cocoa, fruit juices and wine). Consumption of other supplements before or 
during this study is not recommended. We do ask you to inform us if you are ill and are 
prescribed any medication during the study.   
What will happen to the results of the research study? 
The results of this study will be analysed and presented at conferences and in peer 
reviewed journals. Remember that your own results are confidential and that your name 
will not be associated with any information published from this study. All data will be 
kept for 5 years and then destroyed. 
Who is organising and funding the research? 
This research is being organised by Dr Christine Bosch and Dr Karen Birch of School 
of Food Science and Nutrition and the Centre for Sport and Exercise Sciences, 
respectively. The funding for this research has been made available from China 
Scholarship Council and the University of Leeds. 
Who has reviewed this study? 
This research study has been reviewed by the University of Leeds Research Ethics 
Committee and ethical approval granted. 
 
Contact for further information: 
Miss Lu Li 
School of Food Science and Nutrition 
University of Leeds  
Leeds 
LS2 9JT 
Email: fslli@leeds.ac.uk 
Phone:  +44(0) 7761426194 
 
Dr Christine Bosch 
Lecturer in Nutrition 
School of Food Science and Nutrition 
University of Leeds  
Leeds 
LS2 9JT 
Email: c.bosch@leeds.ac.uk 
Phone: +44(0) 113-3430268 
 
Dr Karen Birch 
Senior Lecturer in Exercise Physiology 
Centre for Sports and Exercise Sciences 
Institute of Membrane and Systems Biology 
University of Leeds 
Leeds 
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Appendix 4: Consent form 
Consent to take part in the impact of citrus products on 
endothelial function 
Please tick next 
to the statement 
if you agree 
I confirm that I have read and understand the participant information 
sheet explaining the above research project and I have had the 
opportunity to ask questions about the project. 
 
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and without there 
being any negative consequences*.  
 
I understand that the information generated will be anonymous and that no 
individual results will be published. 
 
I agree for the data collected from me to be stored and used in relevant 
future research in an anonymised form. 
 
I understand that the DNA isolated from my blood samples will be 
destroyed after the study is finished and the results have been analysed.  
 
I understand that relevant sections of the data collected during the 
study, may be looked at by auditors from the University of Leeds or 
from regulatory authorities where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my 
records. 
 
I agree to take part in the above research project and will inform the 
lead researcher should my contact details change. 
 
I understand that I will receive £40 voucher on completion of the study 
(at the final session) as compensation of my time and participation. 
 
 
Name of Participant 
 
 
Name of Researcher 
 
Participant’s 
Signature 
 
 
Researcher’s 
Signature 
 
Date  Date**  
 
* You can contact Lu Li via email (fslli@leeds.ac.uk) if you have any further questions. If you decide to withdraw 
from this study before you finish all the sessions, your data are going to be deleted permanently. On completion of 
all the sessions, it will not be possible to exclude data from the study. 
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**To be signed and dated in the presence of the participant.  
Once this has been signed by all parties the participant should receive a copy of the signed and dated participant 
consent form, the letter/ pre-written script/ information sheet and any other written information provided to the 
participants. A copy of the signed and dated consent form should be kept with the project’s main documents which 
must be kept in a secure location.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study (BIOSCI 15-030) has been approved by Faculty Research Ethics Committee of University of 
Leeds on 22/11/16. 
 
 
- 163 - 
 
Appendix 5: Participant Screening Questionnaire 
Participant Screening Questionnaire 
Participant Code:                       Date:      
Please provide brief information about yourself by filling in the form or ticking the 
appropriate answer and provide additional information where necessary. 
Section 1: Basic information 
Name 
 
Gender Male Female 
Age  
 
Ethnicity 
 
Mobile number 
 
Email address 
 
Height (metres)  Weight (kg)  
Section 2: About your lifestyle and health status 
  Yes NO 
Do you smoke? 
  
  
Have you ever been diagnosed with a disease of the heart, lungs 
or blood vessels? 
  
Females only: Are you pregnant, lactating or actively trying to 
conceive? 
  
Females only: Are you currently using any contraceptive 
treatment or hormone replacement therapy? 
  
Females only: Do you have a regular menstrual cycle?   
Are you currently taking any medication?     
If YES, please give details     
Do you take dietary supplements (vitamins, antioxidants)?     
If YES, please give details     
Do you drink coffee regularly?    
If YES, how much                   /day 
Are you on any kind of diet?    
Do you regularly play sport or exercise?     
If YES, do you take part in sports or exercise on more than 2 
days per week?     
Do you have lactose intolerance?   
Do you have other food intolerance or allergy?     
If YES, please give details     
Thank you for your time
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Appendix 6: Food Frequency Questionnaire                 
                                               Food Frequency Questionnaire                Date:                   Participant code: 
Please indicate how often you have consumed certain types of food and drink during the last 12 months by ticking the appropriate answer 
and provide additional information where necessary. 
 
 Daily    Weekly   Monthly     
 (1=whole fruit) 1 2 3 1-2 3-4 5-6 <1 1 2 3 Never 
Frequency of fruit 
consumption in general            
The most frequently consumed 
fruits No.1:            
The most frequently consumed 
fruits No.2:            
The most frequently consumed 
fruits No.3:            
Orange            
Grapefruit            
Lemon            
Lime            
Tangerine            
Clementine (seedless)            
Other (please specify):            
Fruit juice: (1=100 ml) 
Orange juice            
Grapefruit juice            
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Other (please specify):            
Canned fruit: (1=1/3 regular sized can, or 1 small can) 
Type (please specify):            
Marmalade: (1=amount thinly spread on 1 piece of toast) 
Orange marmalade            
Grapefruit marmalade            
Other (please specify):            
 Daily    Weekly   Monthly     
 1 2 3 1-2 3-4 5-6 <1 1 2 3 Never 
Tea (1=1 cup)            
Coffee            
Coffee (decaffeinated)            
Cocoa, hot chocolate            
Dark chocolate (1=50 g)            
 
 
 
Thank you for your time! 
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Appendix 7: Citrus drink consumption record form 
Citrus drink consumption record form 
Participant code:                       Date:           
Please tick in the following boxes each time you consume 200 ml of a citrus drink and also record the time you consume it.                   
Week 1 Mon Tues Weds Thur Fri Sat Sun 
citrus drink with 
breakfast        
citrus drink with 
dinner        
 
Week 2 Mon Tues Weds Thur Fri Sat Sun 
citrus drink with 
breakfast        
citrus drink with 
dinner        
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Appendix 8: Food record form 
Food record (3 days) 
Participant code:                       Date:                            
Please record the food and drink directly after consumption during the last 2 days 
before the measurement and during the day of the measurement.  
time meal type where food or drink  amount brand name 
6 am to 8 am 
 
 
 
 
     
8 am to 12 noon 
 
 
 
 
     
12 noon to 3 pm 
 
 
 
 
     
3 pm to 5 pm 
 
 
 
 
     
5 pm to 8 pm 
 
 
 
 
     
8 pm to 12 am  
 
 
 
 
     
12 am to 6 am  
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-Meal type: breakfast, lunch, dinner, snack… 
-Where: home, bar, restaurant… 
-Amount: description of portion size of food or drink consumed, e.g. 2 slices (white 
bread)… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
